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 2 
Summary 
 
The hexosamine pathway (HP) requires products from carbohydrate, amino acid, 
fatty acid and nucleotide metabolism to synthesize the aminosugar uridine 
diphosphate N-acetylglucosamine (UDP-GlcNAc). This molecule is an essential 
precursor for diverse protein glycosylation reactions and the production of abundant 
biomolecules. Thus, many metabolic pathways can influence the HP and the HP, 
likewise, impacts multiple cellular processes. The first step of the HP determines the 
rate of UDP-GlcNAc synthesis and is catalyzed by glutamine fructose 6-phosphate 
aminotransferase (GFAT-1). Two important recent discoveries implicate GFAT-1 and 
the HP in the modulation of protein quality control (PQC). First, it was demonstrated 
that GFAT-1 is a transcriptional target of the unfolded protein response (UPR). 
Second, a boost in HP activity by gain-of-function (gof) mutations in gfat-1 itself 
improves PQC and prolongs life in the nematode Caenorhabditis elegans 
(C. elegans). However, it remains unclear how GFAT-1 might regulate the complex 
protein homeostasis machinery and in my PhD I set out to address this important 
question.  
In this study I confirmed a regulation of GFAT-1 protein during stress. In particular 
stress within the endoplasmic reticulum led to a strong induction of GFAT-1 
expression specifically in the worm intestine. While gfat-1 gof mutations and GFAT-1 
overexpression (OE) under the gfat-1 promoter protected animals from tunicamycin 
toxicity, it did not, however, confer general stress resistance. Despite the broad 
positive effect of gfat-1 gof mutations on PQC mechanisms and the strong 
enrichment in the cellular metabolite UDP-GlcNAc we could not detect major 
changes in transcriptome or proteome compared to wildtype controls.  
To better understand and dissect the role of GFAT-1, we generated tissue-specific 
GFAT-1 OE C. elegans lines. Intestinal GFAT-1 OE appeared detrimental as the 
animals of multiple transgenic lines were characterized by small body size and sick 
appearance. In contrast, the pan-neuronal and muscular GFAT-1 OE resulted in 
healthy worms. They exhibited an elevation in autophagic flux relative to controls. 
While we did, however, not observe a decrease in proteotoxicity in different tissues of 
nematodes with pan-neuronal GFAT-1 OE, we noticed a large, cell autonomous 
reduction in polyglutamine (polyQ) toxicity in C. elegans with muscle-specific GFAT-1 
OE. Not only did it strongly suppress the load of polyQ aggregates but also it 
prevented the progressive paralysis typical for muscular protein aggregation models. 
Interestingly, OE of mutant enzymatic dead GFAT-1 mildly improved polyQ toxicity, 
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suggesting that the effect can be only partially attributed to UDP-GlcNAc production. 
To identify downstream effectors of GFAT-1 OE that mediate improved PQC we 
performed a GFAT-1 pulldown experiment to determine physical interactors. We then 
carried out a selective RNAi suppressor screen on these interactors as well as 
further candidate genes, using the strong motility phenotype as a readout. Among 15 
identified candidates, we deemed ABCF-3 the most interesting. This protein is known 
to co-regulate the activation of GCN-2 kinase by uncharged tRNAs and to thereby 
modulate the integrated stress response (ISR). I showed that ABCF-3 associates 
with GFAT-1 and that the health benefits of muscular GFAT-1 OE in a polyQ model 
are completely dependent on ABCF-3. Furthermore, GFAT-1 OE led to a slight 
elevation of eIF2α phosphorylation and ATF-5 expression, which are critical 
hallmarks of an activated ISR. 
We conclude that GFAT-1 exercises its positive effects on PQC by modulation of the 
ISR through interaction with ABCF-3 and that this novel connection of the HP and the 
ISR is of particular importance in the maintenance of healthy muscle tissue. 
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Zusammenfassung 
 
Der Hexosamin Biosyntheseweg (HP) setzt metabolische Intermediate aus 
Kohlenhydrat-, Aminosäure-, Fettsäure- und Nukleotidmetabolismus um und 
sythetisiert den Aminozucker Uridindiphosphat-N-acetylglucosamin (UDP-GlcNAc). 
Dieses Molekül ist ein essentieller Baustein für diverse Protein-
glykosylierungsreaktionen und für die Produktion weit verbreiteter Biomoleküle. Viele 
Stoffwechselwege können somit den HP beeinflussen und der HP nimmt 
gleichermaßen Einfluss auf zahlreiche zelluläre Prozesse. Der erste enzymatische 
Schritt des HP bestimmt die Geschwindigkeit der Produktion von UDP-GlcNAc und 
wird durch Glutamin-Fructose-6-phosphataminotransferase (GFAT-1) katalysiert.  
Zwei wichtige aktuelle Entdeckungen zeigen zudem, dass GFAT-1 und der HP in die 
Modulation der Proteinqualitätskontrolle (PQC) eingebunden sind. Zum einen wurde 
gezeigt, dass GFAT-1 ein transkriptionelles Zielgen in der Antwort auf ungefaltete 
Proteine (UPR) im endoplasmatischen Retikulum (ER) ist. Zum anderen erhöhen 
funktionsverstärkende (gof) Mutationen in gfat-1 die HP Aktivität und verbessern 
dadurch die PQC und verlängern die Lebensspanne des Fadenwurms 
Caenorhabditis elegans (C. elegans). Es blieb jedoch weiterhin unklar, wie GFAT-1 
die komplexen Systeme zur Erhaltung der Proteinhomöostase beeinflusst. Ziel 
meiner Doktorarbeit war es diese wichtige Frage zu beantworten. 
Mit den Ergebnissen dieser Studie konnte ich bestätigen, dass die Expression von 
GFAT-1 durch Stress reguliert ist. Insbesondere ER-Stress führte zu einer starken 
Induktion von GFAT-1 im Darm der Würmer. Obwohl gfat-1 gof Mutationen und 
GFAT-1-Überexpression (OE) unter Kontrolle des gfat-1 Promotors vor Tunicamycin 
Toxizität schützten, verlieh dies keine allgemeine Stressresistenz. Trotz der 
umfassenden positiven Wirkung von gfat-1 gof Mutationen auf PQC-Mechanismen 
und der starken Anreicherung des zellulären Stoffwechselprodukts UDP-GlcNAc 
konnten wir im Vergleich zu Wildtyp-Kontrollen keine größeren Veränderungen des 
Transkriptoms oder Proteoms nachweisen.  
Um die verschiedenen Funktionen von GFAT-1 besser zu verstehen stellte ich 
gewebespezifische GFAT-1 OE C. elegans Linien her und untersuchte diese. Die OE 
von GFAT-1 im Darm schien hierbei nachteilig zu sein, da auch die Herstellung 
mehrerer transgener Linien nur zu Tieren mit geringer Körpergröße und krankem 
Aussehen führte. Im Gegensatz dazu waren transgene Würmer mit neuronaler oder 
muskulärer GFAT-1 OE augenscheinlich gesund und nicht von wildtypischen 
Würmern zu unterscheiden. Gegenüber den Kontrollen zeigten sie eine leichte 
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Erhöhung des Autophagie Prozesses. Im Falle der neuronalen GFAT-1 OE führte 
dies nicht zu einer Abnahme der Proteotoxizität in verschiedenen untersuchten 
Geweben. Im Gegensatz dazu konnte ich eine starke zellautonome Reduktion der 
Polyglutamin (polyQ)-Toxizität in Nematoden mit muskel-spezifischer GFAT-1 OE 
feststellen. Nicht nur war die Zahl der polyQ Aggregate stark reduziert, sondern es 
wurde auch die für Protein-aggregationsmodelle im Muskel typische, progressive 
Lähmung verhindert. Interessanterweise verbesserte die OE von mutiertem GFAT-1 
ohne enzymatische Aktivität die PolyQ Toxizität noch in geringem aber signifikantem 
Maße, was darauf hindeutet, dass der Effekt der GFAT-1 OE nur teilweise auf die 
UDP-GlcNAc Produktion zurückzuführen ist.  
Im Folgenden führte ich Ko-Immunpräzipitation durch um mögliche Bindungspartner 
von GFAT-1 zu identifizieren. Anschließend testete ich die Abhängigkeit der 
beobachteten PQC Verbesserung von diesen GFAT-1 Interaktoren und von weiteren 
Kandidaten. Hierfür führte ich einen selektiven RNAi Screen mit 
Motilitätsverbesserung als kritischem Phänotyp durch. Aus den 15 identifizierten 
Kandidaten wählten wir ABCF-3 zur weiteren Analyse aus. Es ist bekannt, dass 
dieses Protein die Aktivierung der GCN-2 Kinase durch ungeladene tRNAs reguliert 
und dadurch die integrierte Stressantwort (ISR) moduliert. Ich konnte zeigen, dass 
ABCF-3 ein mit GFAT-1 assoziiert und dass die gesundheitlichen Vorteile der 
muskulären GFAT-1 OE im PolyQ-Modell vollständig von ABCF-3 abhängen. 
Darüber hinaus führte GFAT-1 OE zu einer leichten Erhöhung der eIF2α 
Phosphorylierung und der ATF-5 Expression, beides wichtige Merkmale einer 
aktivierten ISR. 
Zusammenfassend schließen wir, dass GFAT-1 seine positive Wirkung auf die PQC 
durch direkte Interaktion mit ABCF-3 und resultierender Modulation der ISR ausübt 
und dass diese bisher nicht beschriebene Verbindung von HP und ISR für die 
Erhaltung von gesundem Muskelgewebe von besonderer Bedeutung ist. 
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Abbreviations 
 
Acetyl-CoA    Acetyl-Coenzyme A 
ACN     acetonitrile 
AD     Alzheimer´s disease 
AMPK    adenosine monophosphate (AMP)-activated 
protein kinase 
ATF4     activating transcription factor 4 
ATF6     activating transcription factor 6 
ATFS-1 activating transcription factor associated with 
stress-1 
ATP     adenosine triphosphate 
C. elegans    Caenorhabditis elegans 
cAMP     cyclic adenosine monophosphate 
CFP     cyan fluorescent protein 
CITE     cap-independent translation enhancer 
CMA     chaperone mediated autophagy 
CP     20S core particle 
DAF/daf abnormal dauer formation 
dsRNA     double-stranded RNA 
ECM     extracellular matrix 
eIF     eukaryotic initiation factor 
ER     endoplasmic reticulum 
ERAD     endoplasmic reticulum-associated degradation 
ERSE     ER stress response element 
FDR     false discovery rate 
FOXO forkhead box class O 
Fruc-6-P    Fructose 6-phosphate 
FT     flow-trough 
GAG     glycosaminoglycan 
GALE     UDP-galactose-4-epimerase 
GCN2     general control non-depressible 2 
GEF     guanine nucleotide exchange factor 
GFAT-1 Glutamine-fructose 6-phosphate 
aminotransferase 1, also abbreviated as GFPT1 
(mice, humans) or GFA1 (yeast) 
GFAT-2 Glutamine-fructose 6-phosphate 
aminotransferase 2 
Glc-6-P    Glucose 6-phosphate 
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GlcNAc-1-P    N-acetylglucosamine 1-phosphate 
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Gln     Glutamine 
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gof     gain-of-function 
HD     Huntington´s disease 
HLH-30    helix loop helix 30 
HP     hexosamine pathway 
HRI     heme-regulated inhibitor 
HSF1     heat shock transcription factor 1 
HSR     heat shock response 
IP     immunoprecipitation 
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IRE1     inositol-requiring protein-1 
Met-tRNAMet    methionine-loaded methionyl-transfer RNA  
mRNA     messenger RNA 
MS     mass spectrometry 
mTORC1    mechanistic target of rapamycin complex 1 
NGM     nematode growth medium 
OE     overexpression 
OGA O-GlcNAcase 
OGT     O-GlcNAc transferase 
OGT O-GlcNAc transferase 
ORF     open reading frame 
OST     oligosaccharyltransferase 
PAM     protein aggregate myopathy 
P-eIF2α    phosphorylated eukaryotic initiation factor 2α 
P-PMK-1    phosphorylated PMK-1 
PD     Parkinsons´s disease 
PERK     PKR-like ER kinase 
PIC     pre-initiation complex 
PKA     protein kinase A 
PKR     protein kinase R 
PMK-1     P38 Map Kinase family member 1 
polyQ     polyglutamine 
polyUb     polyubiquitin 
ppGalNAcT polypeptide N-acetyl-α-galactosaminyl-
transferase 
PTM     posttranslational modification 
qRT-PCR  quantitative reverse transcription PCR 
  (polymerase chain reaction) 
RIDD     regulated IRE1-dependent decay 
RNAi     RNA interference 
RP     19S regulatory particle 
S. cervisiae    Saccharomyces cervisiae 
SDS     sodium dodecyl sulfate 
Ser51     serine 51 
SILAC     Stable isotope labeling with amino acids in (cell 
culture) 
TFEB     transcription factor EB 
TOR     target of rapamycin 
tRNA     transfer RNA 
Ub     ubiquitin 
UDP     uridine diphosphate 
UDP-GalNAc    UDP-N-Acetyl galactosamine 
UDP-GalNAc    UDP-N-acetylgalactosamine 
UDP-GlcNAc    UDP-N-Acetyl glucosamine 
UDP-HexNAc    UDP-GlcNAc and UDP-GalNAc 
uORF     upstream open reading frame 
UPR     unfolded protein response 
UPR     unfolded protein response 
UPRE     UPR element 
UPRER     unfolded protein response of the ER 
UPRmt     the mitochondrial unfolded protein response 
UPS     ubiquitin-proteasome system 
UTP     uridine triphosphate 
UTR     untranslated region 
UTR     untranslated region 
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xbp-1s     spliced xbp-1 (active form) 
XBP1     X-box binding protein 1 
XBP1s     spliced XBP1 
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1.   INTRODUCTION 
 
 
1.1   The aging process 
 
 
1.1.1   Regulation of aging 
 
Aging can be defined as the universal time-dependent decline in physiological 
functions essential for organismal integrity, fertility, and survival. This entropic 
process is not regulated, however, longevity and the rate of aging are. Life- and 
healthspan are under evolutionary selection, depend on the ecological context and 
can be genetically manipulated (Kirkwood and Austad, 2000, Bonsall, 2006). In the 
following passage I will describe several pieces of evidence that emphasize the 
genetic basis of longevity and of healthspan plasticity. 
 First, the lifespan of organisms can differ strongly even between related 
species that might share similar environments and physical properties. Probably the 
most famous example of an exceptionally long-lived species is the naked mole rat 
(Heterocephalus glaber). It can reach beyond 30 years, thereby growing almost ten 
times as old as its relative the house mouse (Mus musculus) (Gorbunova et al., 
2014). Strikingly, the mortality hazard of the naked mole rat does not increase as a 
function of chronological age. While the mortality risk of other mammals grows 
exponentially starting with sexual maturity, the risk of dying remains constant and 
very low for the naked mole even when they exceed the age of sexual maturity by 
25-fold (Ruby et al., 2018). Although the molecular basis for this extreme longevity 
cannot be completely explained yet, it was found that the naked mole rat is extremely 
resistant to cancer, shows elevated protein translation fidelity at the ribosome, and 
largely maintains physiological youthfulness into high age (Buffenstein, 2008, 
Delaney et al., 2013, Azpurua et al., 2013). Another particularly long-lived species is 
the ocean quahog (Arctica islandica), a clam species endemic at the Icelandic shelf, 
with a lifespan of up to 400 years (Wanamaker et al., 2008). The maximal reported 
lifespan of the taxonomically related northern quahog (Mercenaria mercenaria) is just 
above 100 years. Again, the underlying cause for the outstanding longevity could not 
INTRODUCTION 
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yet be conclusively clarified, but it was hypothesized that an increased resistance to 
oxidative stress might be a contributor (Abele et al. 2008, Ungvari et al., 2011). 
Second, life- and healthspan are clearly determined by genetic factors and 
can be altered by single gene mutations. On the one hand, specific mutations can 
lead to progeroid syndromes, dramatically accelerating the occurrence of age-
associated clinical symptoms and diseases and leading to premature death. The 
Werner syndrome is one such genetic disorders. Loss of function of the WRN RecQ 
like helicase involved in DNA replication, repair and recombination, telomere 
maintenance, and apoptosis is the underlying cause for this dramatic syndrome (Yu 
et al., 1996, Huang et al., 1998, Spillare et al., 1999, Edwards et al., 2015). It is 
striking how mutations in this single gene potently accelerate whole organism aging 
while leaving early development unaffected. Classically, the first symptom is the 
missing characteristic growth spurt during teenage years resulting in a short stature. 
Manifestations of premature aging such as graying and receding hair, skin atrophy 
and cataracts appear as early as the third decade of life. Because patients with 
Werner syndrome also develop typical age-associated disorders like cancer, 
arteriosclerosis and cardiovascular diseases prematurely, the median age at death is 
between only 47 and 54 (Werner, 1904, Epstein et al. 1966, Muftuoglu et al., 2008). 
In any case, conclusions gained by studying models of premature aging should be 
treated with caution, as they can never fully recapitulate the phenotype of normally 
aged individuals. It is debated whether these models merely lead to sick animals with 
an aging-like phenotype or whether they can truly stand in for naturally aged subjects 
(Miller, 2004, Vanhooren and Libert, 2013). On the other hand, single gene mutations 
can stave off the aging process and cause an extraordinarily long health- and 
lifespan. One well-established example is reduced function of the insulin/IGF 
receptor tyrosine kinase. Originally, it was discovered that missense mutations in 
abnormal dauer formation 2 (daf-2), the insulin receptor ortholog in Caenorhabditis 
elegans (C. elegans), can extend the lifespan of nematodes about twofold and that 
this longevity is dependent on downstream signaling via the forkhead transcription 
factor daf-16 (FOXO) (Kenyon et al., 1993, Larsen et al., 1995, Kimura et al., 1997, 
Lin et al., 1997, Ogg et al., 1997). Consecutive studies in flies and mice, as well as 
association studies between phenotype and genome in humans could prove a strong 
conservation of this nutrient sensing pathway and its implication in lifespan regulation 
(Clancy et al., 2001, Tatar et al., 2001, Blüher et al., 2003, Holzenberger et al., 2003, 
Bonafè et al., 2003, Hwangbo et al., 2004, van Heemst et al., 2005, Willcox et al., 
2008, Soerensen et al., 2010, Deelen et al., 2013). It is important to note that 
longevity is often directly linked to general stress resistance and extended health 
INTRODUCTION 
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span. Indeed, this holds true for genetic variants which modulate insulin signaling 
(Hitt et al., 1999, Murakami, 2006, Ambrogini et al., 2010, Demontis and Perrimon, 
2010, Martins et al., 2016). Consequently, genes that maximize life expectancy are of 
outstanding interest as they very probably also control the general fitness and 
susceptibility to disease of an organism. It is of paramount importance to better 
understand the aging process as it is accompanied by decreased fitness and by a 
strongly increased risk for severe diseases posing a public health problem and a 
major socioeconomic challenge to our aging society. 
 
 
1.1.2   Demographic changes in our society 
 
Our world currently hosts roughly 7.6 billion people. While the world 
population increased only very little during human history until the year 1800 when it 
reached around 1 billion, it has seen a vast growth since then as the number of 
people multiplied by seven in just above 200 years (World Population Prospects: The 
2017 Revision, United Nations) As global birth rates are steadily decreasing this is 
especially remarkable and traces back to a substantial increase in life expectancy. 
This is caused by a strong reduction of mortality of young children under the age of 
five, which posed a problem in the least developed countries. Within the last fifteen 
years it could be decreased from 7% to 4.8% worldwide. Additionally, the number of 
people reaching high and very high age is constantly growing, which is reflected in a 
sharp increase in the population´s median age (Figure 1A). Globally, the proportion 
of people aged 60 and above is ever rising and in 2017 amounts to 25% within 
Europe (World Population Prospects: The 2017 Revision, United Nations). This trend 
can also be represented by the more and more rapidly growing number of 
centenarians throughout recent history. In 1990 the number of centenarians 
worldwide was estimated to be 96,000 and has reached 451,000 in 2015 (World 
Population Prospects: The 2015 Revision, United Nations, Robine and Cubaynes, 
2017). And while this exceptionally long-lived cohort of people show increased 
resistance towards certain common causes of death like cancer, aging in general is 
accompanied by deteriorating health (Smith, 1997, Bonafè et al., 2002, Niccoli and 
Partridge, 2012, Partridge et al., 2018).  
 
INTRODUCTION 
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1.1.3   Age-associated diseases 
 
Aging is accompanied by a decline in essential molecular machines, which for 
example maintain proteostasis, genome stability and stem cell function (López-Otín 
et al., 2013). Consequently, aging is the main risk factor for multiple, very distinct 
diseases. And while some of these disorders such as cardiovascular diseases and 
cancer also occur in the very young, albeit with much lower prevalence, some 
neurodegenerative diseases like Alzheimer´s (AD), Parkinson´s (PD) and 
Huntington´s disease (HD) are tightly linked to advanced age (Niccoli and Partridge, 
2012, Masters et al., 2015). Worldwide, the number of people over the age of 60 
years diagnosed with AD, the most common form of dementia, amounted to 46.8 
million in 2016 (Prince et al., 2016). The progressive loss of cognitive ability most 
often completely disrupts the lives of the affected individuals, their family and friends. 
Beyond that, the huge and growing number of patients with AD and other forms of 
dementia (Figure 1B) poses a major socio-economic challenge. The U.S. alone spent 
an estimated $259 billion on the health care, long-term care and hospice of 
Alzheimer´s patients in 2017. The cost is expected to rise to $1.1 trillion by the year 
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Figure 1. Strong increase in cases of dementia in our aging society. A. Development of median 
age from 1950 to 2015 and expected future trends. Japan and Germany (green) are shown as the top 
two countries, Niger and Uganda (blue) as the last two countries regarding median lifespan in 2015. 
Worldwide average is depicted in orange. Datasource. United Nations, Department of Economic and 
Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision. 
B.  Increasing numbers of people living with dementia. Current estimates of worldwide population aged 
60 years and above and anticipated rise in population affected by dementia as published by the 2009 
(green) and 2015 (blue) World Alzheimer Report. 
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2050 if no effective treatment will be developed (www.alz.org). This specific example 
helps to demonstrate the necessity and importance of aging research. Only if the 
fundamental consequences of increasing age on cellular and molecular integrity are 
understood, can we hope to decrease the burden of age-associated disease and 
promote healthy aging. 
Although progressive diseases of the nervous system, such as AD, PD, and 
HD manifest with distinctive pathological symptoms, they share a key characteristic: 
the gradual aggregation and accumulation of misfolded proteins in the brain. Gene 
mutations coding for aggregation-prone protein variants are at the basis of the 
disorder in case of HD and the rare familial forms of AD and PD (Goate et al., 1991, 
The Huntington's Disease Collaborative Research Group, 1993, Levy-Lahad et al., 
1995, Rogaev et al., 1995, Polymeropoulos et al., 1996, Selkoe, 2001, Funayama et 
al., 2002, Singleton et al., 2003, Zimprich et al., 2004). The multifactorial causes for 
the much more common sporadic forms of AD and PD are less well defined: genetic 
variants of multiple genes as well as several environmental conditions leading to 
mitochondrial dysfunction and production of oxidative stress were identified to be risk 
factors for the manifestation of disease (Chai and Lim, 2013, Zetterberg and 
Mattsson, 2014). While these risk factors may concur and combine, young individuals 
are still protected from AD and PD by cellular proteostasis mechanisms that fold, 
maintain and degrade proteins. With age, these processes become faulty and 
deregulated and, when facing extraordinary challenges, are no longer sufficient to 
sustain a healthy proteome (Blake et al., 1991, Terman, 1995, Carrard et al., 2002, 
Ferrington et al., 2005, Ben-Zvi et al., 2009, Brehme et al., 2014, Labbadia and 
Morimoto, 2015). It is of paramount importance to understand this age-specific 
decline to be able to counteract these severe diseases. 
 
 
1.1.4   C. elegans as a genetic model for aging research 
 
In the 1970s, the soil nematode C. elegans was first described as a tool for 
genetic research by Sydney Brenner (Brenner, 1974). Since then, it evolved into a 
popular model organism in basic biological research due to its many positive 
features: Its small size (about 1 mm) and cost-effective culture allows maintenance 
and analysis of large numbers of individuals. The transparency of the nematodes 
makes it ideally suited to study expression patterns of proteins, cell divisions or the 
embryonic cell lineage in vivo (Sulston et al., 1983). C. elegans can reproduce by 
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self-fertilization as well as sexually, after the production of males in adverse 
environmental conditions. Therefore, clonal expansion and genetic variation by 
crossing males and hermaphrodites are both feasible. Furthermore, the completely 
sequenced and curated genome, big databases and extensive worm libraries enable 
fast analysis of single gene deletions, mutations and overexpression. Additionally, 
targeted gene knock-down is very straightforward as nematodes can be fed bacteria, 
expressing double-stranded RNA of a specific gene, leading to RNA interference 
(RNAi) (Fire et al., 1998, Timmons and Fire, 1998, Timmons et al., 2001). This 
technique as well as random chemical mutagenesis combined with whole genome 
sequencing make it is possible to interrogate the whole genome for modifiers of 
certain traits like lifespan or drug resistance. 
C. elegans is an especially popular model organism in aging research for 
several reasons: First, worms exhibit phenotypic aging. The visible signs of tissue 
deterioration associated with aging for example include disintegration of germline, 
pharynx and muscle, also leading to a functional decline in fertility, pharyngeal 
pumping and motility (Herndon et al., 2002, Garigan et al., 2002, Glenn et al., 2004, 
Chow et al., 2006). Second, many diseases can be modeled in C. elegans. 
Transgenically expressed Aβ or polyglutamine repeats for example are used to 
model AD or HD, respectively. In both cases, protein aggregates are deposited and, 
if expressed in muscle, a progressive paralysis can be observed (Link, 1995, Link, 
2001, Wang et al., 2006, Kaletta and Hengartner, 2006). Third, survival curves can 
be determined easily and quickly, because the nematode has a short lifecycle - from 
egg over for larval stages to young adult and gravid, reproducing adult - and mean 
lifespan of roughly 20 days under standard conditions (Tissenbaum and Guarente, 
2002). 
Variations in genetic makeup or in environmental conditions can, however, 
strongly influence life expectancy of the nematodes. For instance, modulation of 
insulin/IGF-1 signaling by specific genetic polymorphisms for example in downstream 
effector kinase ageing alteration 1 (age-1) (phosphoinositide 3-kinase, PI3K) or 
phosphatase daf-18 (phosphatase and tensin homolog, PTEN), was discovered to 
greatly prolong C. elegans lifespan (Friedman and Johnson, 1988, Kenyon et al., 
1993, Larsen et al., 1995, Morris et al., 1996, Mihaylova et al., 1999). Consecutive 
studies also associated this pathway with longevity in Drosophila, mice and even 
humans (Clancy et al., 2001, Tatar et al., 2001, Hsieh et al., 2002, Holzenberger et 
al., 2003, Bonafè et al., 2003, van Heemst et al., 2005, Kappeler et al., 2008, Harries 
et al., 2012, Ortega-Molina et al., 2012, Proshkina et al., 2015). The progression of 
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research proved C. elegans a valuable tool in discovering novel regulators of health- 
and lifespan. 
 
 
  
 
Figure 2. Conserved players of the PI3K signal transduction pathway downstream of the insulin 
receptor. Many components, like the insulin receptor (DAF-2/ dInR/ InR), its downstream effector kinase 
(AGE-1/dPI3K/PI3K) and its respective phosphatase (DAF-18/ dPTEN/ PTEN), are strongly connected 
to longevity. While single genes code for most components in C. elegans and D. melanogaster, 
mammals often express several isoforms. AKT, v-akt murine thymoma viral oncogene homologue 1; 
dFoxO, Drosophila forkhead box, sub-group O transcription factor; DILPs, Drosophila insulin-like 
peptides; dInR, Drosophila insulin receptor; dPDK-1, Drosophila phosphatidylinositide‐dependent 
protein kinase 1; dPI3K, Drosophila phosphoinositide 3-kinase; dPTEN, Drosophila phosphatase and 
tensin homolog; Foxo, forkhead family of transcription factor; ILPs, insulin-like peptides; InR, insulin 
receptor; IRS, insulin receptor substrate; IST-1, insulin receptor substrate ‐like adaptor; PDK-1, 
phosphatidylinositide‐dependent protein kinase 1 (adapted from Martins et al. 2016) 
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1.2   Synthesis, maintenance and degradation of proteins 
 
 
1.2.1   Regulation of protein synthesis 
 
Proteostasis describes the concept of multiple integrated biological processes 
that ensure integrity of the intra- and extracellular proteome by controlling and 
executing protein synthesis, folding, trafficking and degradation. Proteostasis is 
essential for cells to survive. Maintaining a healthy proteome is, however, very costly. 
The synthesis of proteins alone constitutes one of the most energy intensive 
processes in a cell, accounting for roughly 20 percent of total energy demand (Reeds 
et al., 1985, Buttgereit and Brand, 1995). For this reason the translation of mRNA 
into protein is regulated at the level of initiation, elongation, termination as well as 
ribosome recycling. The tightest control happens hereby at the level of translation 
initiation, which is rate-limiting in protein synthesis (Sonenberg and Hinnebusch, 
2009). 
In eukaryotes, the canonical pathway of translation initiation is the cap-
dependent scanning mechanism which comprises multiple steps (Kozak, 1989, 
Hinnebusch, 2014). First, the 40S ribosomal subunit forms the pre-initiation complex 
(PIC) together with the ternary complex consisting of GTP bound eukaryotic initiation 
factor (eIF) 2 and methionine-loaded methionyl-transfer RNA (Met-tRNAMet). The PIC 
attaches proximally to the capped 5´untranslated region (UTR) of the mRNA with the 
assistance of several other eIFs and scans the 5´UTR until it identifies the first start 
codon (Figure 4A). Here, eIF2 bound GTP is hydrolyzed with the help of even further 
eIFs. Thus, the interaction between PIC, mRNA and tRNA stabilizes and eIFs 
dissociate, resulting in an arrest of the scanning process. Subsequently, the 60S 
ribosomal subunit is recruited and the 80S initiation complex is assembled, 
whereupon the transition into the elongation phase of protein synthesis begins 
(Kozak, 2002, Jackson et al., 2010, Aitken and Lorsch, 2012, Lacerda et al., 2017). 
Besides the canonical pathway, there are cap-independent mechanisms of 
translation initiation. A well-studied example is the internal ribosome entry site 
(IRES)-mediated translation initiation (Pelletier and Sonenberg, 1988, Macejak and 
Sarnow, 1991). The 40S ribosome can be recruited to the proximity of a start codon 
on the mRNA regardless of the 5´cap structure. This mechanism can even function 
without the assistance of eIFs and is relatively prevalent (Lozano and Martínez-
Salas, 2015, Lacerda et al., 2017). It is estimated that about 10% of cellular mRNAs 
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are translated using IRES-mediated translation initiation, which is particularly 
important under conditions of stress when protein synthesis via the canonical 
pathway is stalled (Spriggs et al., 2008, Thakor and Holcik, 2012, Weingarten-
Gabbay et al., 2016,	Shi et al., 2016, Philippe et al., 2016). 
Another way to ensure mRNA translation under circumstances that shut down 
the canonical pathway is via cap-independent translation enhancers (CITEs). These 
elements, first identified in the 3´UTR of plant viruses (Wu and White, 1999), interact 
with factors of the translation initiation machinery and direct them to the AUG start 
codon. In mammals as well, CITEs located in the 5`UTR of certain mRNAs can 
attract multiple components of the translation apparatus to facilitate translation 
initiation (Shatsky et al., 2010, Andreev et al., 2012, Lacerda et al., 2017). 
Generally, functioning mRNA translation and its fine-tuned regulation are 
absolutely essential for survival under standard conditions, adaption to stress and 
even controlled cell death under continuous stress. Intriguingly and opposingly, 
mutations that disturb normal translation and decrease the overall rate of protein 
synthesis can promote longevity in baker´s yeast, fruit flies and nematodes (Hansen 
et al., 2007, Pan et al., 2007, Syntichaki et al., 2007, Bjedov et al., 2010, Mehta et al., 
2010). Additional studies suggest a conservation of this mechanism to extend 
lifespan up to mammals (Hsieh and Papaconstantinou, 2004, Sharp and Bartke, 
2005, McElwee et al., 2007, Karunadharma et al., 2015). Currently, there are 
different hypotheses that try to explain this paradox: The differential expression of a 
protein or a select group of proteins that directly influence aging under conditions of 
perturbed translation is one possibility. Another one is that a decreased load of newly 
synthesized proteins would allow for improved protein quality control of existing 
proteins. Furthermore, it was suggested that the energy balance might be improved 
and shifted from reproduction and anabolic processes towards somatic maintenance, 
when the generation of biomass is limited (Ravikumar et al., 2004, Hansen et al., 
2007, Pan et al., 2007, Steffen et al., 2008, Mehta et al., 2010, Dhondt et al., 2016). It 
is also conceivable, that a reduction in translation rate poses stress to cells and is not 
beneficial itself. Instead, it activates stress responses, which then impart resistance 
to unfavorable conditions and lifespan extension (Wang et al., 2010b, Li et al., 2011, 
Robida-Stubbs et al., 2012). However, there is still insufficient evidence to definitively 
understand this phenomenon. 
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1.2.2   Challenges to the healthy proteome and protein misfolding diseases 
 
The great majority of proteins can only fulfill their function if they assume their 
correct, thermodynamically stable, three-dimensional conformation. Alterations in the 
amino acid sequence can lead to non-functional proteins or to misfolded, aggregation 
prone and toxic protein species. It was reported that only one random missense 
mutation causes a functional loss of a protein in roughly 35% of the cases (Guo et 
al., 2004). To achieve and maintain proper protein folding and to degrade misfolded 
proteins, a lot of energy is allocated to the elaborate proteostasis network (PN). But 
protein homeostasis is constantly challenged by extrinsic factors, like radiation, toxins 
or heavy metals, and especially intrinsic factors: 
First, reactive oxygen species (ROS) are a natural byproduct of a cell´s 
energy metabolism, detoxification mechanisms and enzymatic activity of certain 
proteins, but the modifications they evoke on biomolecules can be extensive. In 
proteins, ROS can modify certain amino acids like arginine, proline or cysteine 
specifically or have a more general effect on protein structure, for example by leading 
to carbonyl formation (Hawkins and Davies, 2001, Dröge, 2002). All of those 
modifications, some of which are irreversible, compromise protein function. They do 
so by leading to conformational changes or to alterations in biophysical properties of 
affected proteins, by interfering with binding of interaction partners, or by resulting in 
aggregation (Höhn et al., 2014). 
Second, the process of protein synthesis is less than perfect. It was estimated 
that missense errors in translation happen every 1.000 to 10.000 codons (Neidhardt, 
1987, Drummond and Wilke, 2008). Although this number and therefore the fidelity of 
mRNA translation seems quite high, it means that about 15% of newly synthesized 
proteins contain an incorrect amino acid (Drummond and Wilke, 2009). 
Finally, DNA mutations in protein coding genes can result in alterations of the 
amino acid sequence, potentially leading to truncated, non-functional, misfolded, or 
aggregation prone and toxic proteins.  
With increasing age, the exposure time to all the extrinsic and intrinsic risk 
factors rises while, at the same time, the efficiency of the protective mechanisms 
declines (Bulteau et al., 2000, Morley and Morimoto, 2004, Cuervo, 2008). This is the 
starting point for diverse age-associated degenerative disorders such as AD, PD or 
polyglutamine (polyQ) diseases. AD and PD are sporadic diseases in the majority of 
cases. Contrarily, polyQ diseases as HD, spinal and bulbar muscular atrophy or 
spinocerebellar ataxia always have a genetic component, which is the repeat 
expansion of the glutamine coding CAG trinucleotide in distinct genes (La Spada et 
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al., 1991, Di Prospero and Fischbeck, 2005). This expansion, once it reaches a 
specific threshold, causes aggregation of the affected protein and constitutes the 
molecular basis of disease. The length of the CAG stretch directly correlates with the 
protein’s propensity to aggregate and thus, with its toxicity, which is reflected in age 
of disease onset, rate of progression and severity of symptoms (Duyao et al., 1993, 
Brinkman et al., 1997, Reddy et al., 1998, Scherzinger et al., 1999). Loss of function 
of the affected protein is likely to promote disease manifestation, but gain of toxic 
function is very probably causative for disease development (Duyao et al., 1995, 
Faber et al., 1999, Dragatsis et al., 2000, Reiner et al., 2001). In fact, it is not only the 
mutated protein that aggregates, but other unaffected proteins can be sequestered 
within the aggregates (Perutz et al., 1994). It was shown that natural interaction 
partners of the wildtype protein as well as non-pathogenic proteins that contain a 
short glutamine stretch and associate via glutamine-glutamine interactions can be 
enclosed in the polyQ aggregates (Preisinger et al., 1999, Chai et al., 2001, Chen et 
al., 2001, Perez et al., 1998, Kazantsev et al., 1999). Oligomers of the disease 
protein can additionally expose sticky, hydrophobic surfaces that trigger aberrant 
interactions with any protein in close proximity (Olzscha et al., 2011,	 Breydo and 
Uversky, 2015). The resulting imbalance and depletion of important cellular 
components might contribute to disease phenotypes (Steffan et al., 2000, Nucifora et 
al., 2001, Kim et al., 2016). Beyond this, players of the PN recognize and bind to the 
misfolded proteins. In the attempt to re-fold or degrade them, chaperones and the 
26S proteasome are trapped within aggregates (Cummings et al., 1998, Chai et al., 
1999). This further contributes to protein folding stress as key components of the 
protein quality control machinery are missing in action (Bence et al., 2001, Holmberg 
et al., 2004). 
It is important to understand that a single misfolding protein can, 
consequently, impact the folding of other vulnerable proteins by consuming an 
abnormally high proportion of the limited capacity of the PN, which fails to adapt to 
chronic protein misfolding stress (Gidalevitz et al., 2006, Morimoto, 2008, Park et al., 
2013). It is still unclear why proteostasis mechanisms are effectively induced by 
acute stress to restore homeostasis but are so ill-adapted to respond to persistent 
proteotoxic stress. If the PN could be modified to recognize and counteract chronic 
stress, posed for example by the accumulation of misfolding and aggregating 
proteins, it could be a great asset in preventing numerous age-related diseases.  
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1.2.3   Network of protein quality control mechanisms 
 
An intricate and interlinked network of protein quality control (PQC) pathways 
manages protein folding, disaggregation and degradation (Figure 3). All branches of 
the PN are constantly active to maintain protein homeostasis but still have the 
capacity to improve their efficiency under challenging conditions like heat stress, 
hypoxia, or burst in protein synthesis (Lindquist and Craig, 1988, Gass et al., 2002, 
Dohi et al., 2012). 
 The correct three-dimensional structure of a protein is installed in its amino-
acid sequence and many proteins can spontaneously fold into their correct shape in 
vitro (Dobson et al., 1998). Still, in the crowded environment of a cell, where proteins 
tend to aggregate, most proteins require assistance to achieve their native state (Ellis 
and Hartl, 1999) 
Chaperones bind to nascent polypeptide chain during synthesis at the 
ribosome and ensure its folding into a thermodynamically stable, yet flexible protein 
(Preissler and Deuerling, 2012). It can also become necessary to refold or unfold 
proteins, after their stress-induced denaturation. These processes are always 
dependent on adenosine triphosphate (ATP) hydrolysis and the executing 
chaperones, large and complex multicomponent machines, often require cofactors 
for specific protein binding (Hartl et al., 2011). One well-studied example of ER 
resident chaperones involved in de novo protein folding is the highly expressed and 
stress-inducible heat-shock-protein 70 (HSP70) binding immunoglobulin protein (BiP/ 
HSP-4) (Gething, 1999). Like many other chaperone families, the HSP70 chaperones 
have additional functions in protein disaggregation, translocation and degradation 
(Chiang et al., 1989, Bercovich et al. 1997, Glover and Lindquist, 1998, Kabani et al., 
2003, Hartl et al. 2011, Mattoo et al., 2013, Rout et al., 2014, Clerico et al., 2015, 
Craig, 2018) (Figure 3). 
In response to heat stress, the expression of many chaperones increases due 
to an elevated demand to refold denatured proteins. This is termed the cytosolic 
heat-shock response (HSR) and it is induced by the master regulator heat shock 
transcription factor 1 (HSF1/HSF-1) among other HSFs (Wu, 1995, Morimoto, 1998, 
McMillan et al., 1998, Anckar and Sistonen, 2007). HSF1 gains DNA binding activity 
under stress conditions by trimerization after its release from associated chaperones, 
which keep it in an repressed state (Sarge et al., 1993, Zou et al., 1998, Guisbert et 
al., 2013, Neef et al., 2014) (Figure 3). The resulting transcriptional response is not 
restricted to increase in expression of chaperones but also of translational regulators 
and to ubiquitin, important for protein degradation (Gomez-Pastor et al., 2018). 
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Proteolytic mechanisms represent another arm of the proteoastasis network. 
Protein degradation is essential for different reasons: to recycle amino acids for 
protein synthesis under starvation conditions, to modulate the level of specific 
proteins in the cell, or to dispose of unfolded, misfolded, and toxic proteins and 
aggregates. Degradation by the ubiquitin-proteasome system (UPS) and autophagy 
(greek: self eating) are the two distinct mechanisms that enable breakdown of cellular 
components (Figure 3).  
Autophagy is the process in which cytosolic components, big aggregates, 
parts of organelles or whole organelles are enclosed by membranes and delivered to 
lysosomes for their degradation by lysosomal enzymes at low pH (de Duve, 1963, de 
Duve, 1966). There are distinct types of autophagy:  
In chaperone-mediated autophagy (CMA), this recycling process is highly 
selective for one specific protein at a time. A cytosolic, constitutive chaperone 
recognizes a pentapeptide motif in the substrate protein, which is consequently 
bound, targeted to the lysosome and unfolded. With the help of a lysosomal 
chaperone, the client protein is translocated to the lysosomal lumen, where it is 
degraded (Chiang et al., 1989, Salvador et al., 2000, Bandyopadhyay et al., 2008, 
Cuervo and Wong, 2014) Different studies indicate that this form of autophagy is 
promoting the ability of cells to adapt to unfavorable conditions like long-term 
starvation or hypoxia (Cuervo et al., 1998, Lv et al., 2011, Ferreira et al., 2013, 
Kaushik and Cuervo, 2018). 
In microautophagy, cytosolic cargo is engulfed by the invaginating lysosomal 
membrane, which pinches off into the lysosomal lumen where it is directly digested 
(de Duve 1966, de Duve, 1983, Kunz et al., 2004, Li et al., 2012). 
By contrast, substrates of macroautophagy are enclosed by a cytosolic 
double-membrane structure. Sources of this expanding membrane structure, the 
phagophore, are reported to include the ER, the Golgi apparatus, mitochondria and 
even the plasma membrane (Axe et al., 2008, van der Vaart et al., 2010, Ravikumar 
et al., 2010, Mari et al., 2010, Hailey et al., 2010, Feng et al., 2014, Nascimbeni et 
al., 2017). Once phagophores are sealed and the cargo is sequestered at their 
inside, there are termed autophagosomes. The outer membrane of these 
autophagosomes fuses with lysosomes and, prior to this, may also fuse with 
endosomes, to enable degradation of cargo and inner autolysosomal membrane 
(Tooze et al., 1990, Gordon et al., 1992, Liou et al., 1997, Berg et al., 1998) 
(Figure 3). The disintegrated cargo is shuttled to the cytosol by permeases and efflux 
carriers, where the monomeric units are then available as building material for 
nucleic acids, proteins and lipids (Sagné et al., 2001, Yang and Klionsky, 2007). 
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Lysosomal membrane components can be recycled in a process called autophagic 
lysosome reformation (Yu et al., 2010, Rong et al., 2011).  
In general, all types of autophagy play an important role in biomolecule 
turnover and in the recycling of limited resources. Beyond this, macroautophagy 
specifically operates to discard of aggregation-prone proteins and damaged 
organelles (Riley et al., 2010, Rogov et al., 2014). Thereby, it constantly counteracts 
the development of diverse severe diseases, particularly neurodegenerative, protein 
misfolding diseases	(Ravikumar et al., 2004,	Hara et al., 2006, Komatsu et al., 2007, 
Levine and Kroemer, 2008).  
Likewise, the other system for degradation – the UPS – is absolutely required 
to assure a healthy proteome and cell survival. In fact, in mammalian cells, the great 
majority of proteins is broken down by the UPS (Collins and Goldberg, 2017) 
(Figure 3). To be destined for turnover by this pathway, proteins must be modified by 
polyubiquitin (polyUb) chains at lysine residues (Finley, 2009). A cascade of three 
enzymes label the substrate proteins for degradation: the E1 ubiquitin(Ub)-activating 
enzyme expends ATP to activate Ub by adenylation and then transfers it to the active 
site of the E2 Ub-conjugating enzyme (Lake et al., 2001, Huang et al., 2007, Lee and 
Schindelin, 2008, Olsen and Lima, 2013). The E2 enzymes in turn catalyze the Ub 
transfer directly to the target protein or an E3 Ub ligase as intermediate acceptor 
(Hamilton et al., 2001, Wu et al., 2003, Pruneda et al., 2011, Dou et al., 2012, 
Stewart et al., 2016). The substrate specificity of the ubiquitylation process is 
guaranteed by the E3 Ub ligases. The E3 enzymes recognize the substrate and 
either mediate the interaction between Ub-loaded E2 enzyme and substrate to aid 
the final Ub transfer to the substrate or, alternatively, catalyze the Ub ligation to the 
substrate themselves (Huang et al., 1999, Pruneda et al., 2012, Kamadurai et al., 
2013, Maspero et al., 2013, Scott et al., 2014).  
The next steps in the degradation process involve the 26S proteasome, which 
consist of a barrel-shaped 20S core particle (CP), capped on one or both ends by the 
19S regulatory particle (RP) (Tomko and Hochstrasser, 2013, Budenholzer et al., 
2017). The RP and associated proteins, such as Rpn10 and Rpn13, mediate 
recognition and binding of the ubiquitinated substrates, recycling of the ubiquitin tag, 
substrate unfolding and shuttling to the CP (Deveraux et al., 1994, van Nocker et al., 
1996, Yao and Cohen, 2002, Verma et al., 2002, Verma et al., 2004, Husnjak et al., 
2008, Schreiner et al., 2008, Matyskiela et al., 2013, Śledź et al., 2013). Within the 
secluded interior of the CP, the three proteolytically active subunits with 
chymotrypsin-like, trypsin-like and caspase-like activities cleave the substrate protein 
into small peptides, which are released into the cytosol and further broken down to 
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free amino acids by cytosolic peptidases (Rivett, 1989, Seemüller et al., 1995, 
Brannigan et al., 1995, Orlowski et al., 1997, Heinemeyer et al., 1997, Groll et al., 
1999, Kisselev et al., 1999, Vabulas and Hartl, 2005).  
For protein degradation, the UPS again needs more than a third of the energy 
required for total protein synthesis. This immense demand of ATP necessitates a 
high level of control of UPS activity and substrate specificity (Collins and Goldberg, 
2017). Indeed, the 26S proteasome is transcriptionally induced after stress and 
features determining its efficiency like ATPase activity, substrate affinity and 
proteolytic activity are regulated by diverse post-translational modifications such as 
phosphorylation, ubiquitination or acetylation at multiple subunits (Meiners et al., 
2003, London et al., 2004, Kikuchi et al., 2010, Isasa et al., 2010, Li et al., 2011, 
Wang et al., 2013, Zhang and Manning, 2015, Lokireddy et al., 2015, Livneh et al., 
2016). Furthermore, deubiquitinating enzymes can act fast and selectively and impart 
an additional level of substrate specificity (Crosas et al., 2006, Lee et al., 2016). This 
high investment of cells into the UPS is indispensible, considering that dysfunction of 
the 26S proteasome is strongly associated with multiple proteotoxic diseases like 
HD, frontotemporal dementia and bovine spongiform encephalitis (Mad Cow 
Disease) (Holmberg et al., 2004, Bennett et al., 2007, Deriziotis et al., 2011, Myeku 
et al., 2016).  
Chaperones, the lysosomal-autophagosomal system, and the UPS are the 
three mechanisms of a cell to directly ensure proteostasis by enabling proper protein 
folding and degradation of terminally misfolded proteins. However, there are further 
pathways that facilitate and regulate these PQC systems that must be mentioned 
here: 
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Figure 3. The eukaryotic PN. Schematic representation of the concerted action of chaperones, heat 
shock response (HSR), UPR, ERAD, UPS, and autophagy to maintain a healthy proteome. Chaperones 
aid to achieve native structure of unfolded and misfolded proteins. The HSR is activated by heat shock 
factor-1 (HSF1), which is released of the inhibitory interactions with HSP90 chaperone, trimerizes and is 
transported to the nucleus to induce heat shock response target genes after detection of misfolded 
proteins. The IRE1, PERK, and ATF6 branch of the UPR sense unfolded or misfolded proteins within 
the ER and trigger the expression of UPR target genes and, in case of PERK, halt general translation to 
counter ER stress and restore protein homeostasis, for example by boosting ERAD and autophagy, or 
initiate cell death. ERAD describes the process by which misfolded proteins are shuttled from ER to 
cytosol, followed by their ubiquitination and proteasomal degradation. The UPS targets proteins for 
degradation by covalent linkage of ubiquitin, followed by proteolytic cleavage by the 26S proteasome. 
Additionally, protein aggregates and damaged organelles are sequestered and degraded by lysosomal 
enzymes at low pH via autophagy (modified from Mardones et al. 2015). 
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The ER is a major site of protein synthesis. All proteins destined for the 
secretory pathway, which amount to about one third of the proteome, are synthesized 
at the ER by associated ribosomes (rough ER) (Palade, 1975, Chen et al., 2005). 
The oxidative environment of the ER lumen with its specialized enzymes allows 
modification of the secretion-bound proteins and membrane proteins by disulfide 
bonds and – in collaboration with the Golgi apparatus – N-linked and O-linked 
glycosylation, essential for protein folding and function (Hirschberg and Snider, 1987, 
Appenzeller-Herzog and Ellgaard, 2008, Braakman and Bulleid, 2011, Stanley, 2011, 
Aebi, 2013, Oka and Bulleid, 2013). Diverse ER resident chaperones such as 
GRP94/ENPL-1 or BiP/HSP-3 and HSP-4 of the HSP90 and HSP70 families are 
employed to manage the folding and re-folding of the immense load of proteins 
(Braakman and Bulleid, 2011, Behnke et al., 2015, Marzec et al., 2012). However, 
the ER itself does not accommodate a system to degrade proteins that are either 
misfolded beyond repair or which have to be downregulated. Instead, it relies on 
translocation of these proteins back to the cytosol, where they are broken down by 
the UPS. This process is termed endoplasmic reticulum-associated degradation 
(ERAD) (Hiller et al., 1996, Avci et al., 2014) (Figure 3). N-linked glycosylation plays 
an important role in the recognition of ERAD substrates, because specific processing 
of the sugar moieties can generate a direct signal for destruction. Specialized lectins 
like OS-9/F48E8.4 can bind the sugar moieties and speed up retrotranslocation and 
elimination by the proteasome significantly, compared to non-glycosylated ERAD 
substrates (Aebi et al., 2010, Benitez et al., 2011, Jaenicke et al., 2011). Besides 
lectins in the ER lumen, chaperones and the HRD ubiquitin ligase complex can 
perform the task of identifying misfolded proteins within the ER membrane (Taxis et 
al., 2003, Baldridge and Rapoport, 2016). Further components of the ERAD 
machinery are in charge of polyubiquitinating and unfolding misfolded proteins, 
forming channels for their retrotranslocation, generating the force to pull them into the 
cytosol and, finally, deliver them to the proteasome (Bodnar and Rapoport, 2017, 
Schulz et al., 2017, Berner et al., 2018). 
Another protein quality control system installed in the ER is the unfolded 
protein response (UPR). Its three parallel branches use different sensors to detect 
perturbations of ER homeostasis and, as a response, either modify the PN to 
counteract ER stress, downregulate global protein synthesis or induce cell death. All 
of the sensor proteins are located to the ER membrane. They have a luminal domain 
to query the protein folding status within the ER, and a cytosolic domain to transduce 
signals to the transcriptional and translational machineries (Ron and Walter, 2007, 
Dufey et al., 2014) (Figure 3).  
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The most conserved branch of the UPR is activated by dissociation of 
BiP/HSP-4 from and direct binding of unfolded proteins to the UPR sensor inositol-
requiring protein-1 (IRE1/IRE-1) (Cox et al., 1993, Mori et al., 1993, Bertolotti et al., 
2000, Okamura et al., 2000, Credle et al., 2005, Mori, 2009, Gardner and Walter, 
2011). The consecutive IRE1 oligomerization and trans-autophosphorylation enables 
activation of its RNAse domain. This in turn leads to regulated IRE1-dependent 
decay (RIDD) of a subset of mRNAs to specifically stall cell growth and proliferation 
and even induce cell death. Additionally, the decreased transcript levels might help to 
alleviate protein folding stress. (Hollien and Weissman, 2006, Kimata et al., 2007, 
Korennykh et al., 2009, Aragón et al., 2009, Hollien et al., 2009, Han et al., 2009, Li 
et al., 2010a, Walter and Ron, 2011, Maurel et al., 2014). Arguably the most 
important target of IRE1 RNAse activity is the X-box binding protein 1 mRNA 
(XBP1/XBP-1). Though instead of being degraded, XBP1 mRNA gets spliced 
(XBP1s) and translated to the potent XBP1s transcriptional activator, following IRE1 
activation. XBP1s binds to unfolded protein response elements (UPREs) and thereby 
induces a set of UPR target genes, such as ER chaperones, ERAD components and 
glycosylation enzymes, with the aim to counter ER stress and reinstall ER 
homeostasis (Yoshida et al., 2001, Lee et al., 2002, Calfon et al., 2002, Yoshida et 
al., 2003, Lee et al., 2003, Yamamoto et al., 2004).  
The sensor protein that activates the second branch of the UPR, PKR-like ER 
kinase (PERK/PEK-1), considerably resembles IRE1 in structure and mode of 
activation (Liu et al., 2000, Bertolotti et al., 2000). However, after detection of 
unfolded proteins in the ER, oligomerization and trans-autophosphorylation, the 
kinase domain of PERK phosphorylates its sole client: the eukaryotic translation 
initiation factor eIF2α. Phosphorylation of eIF2α inhibits global protein translation 
while simultaneously stimulating the translation of the transcription factor activating 
transcription factor 4 (ATF4/ATF-5) (Harding et al., 1999, Scheuner et al., 2001, 
Jackson et al., 2010). The downstream targets of ATF4 are expressed to antagonize 
ER stress (Harding et al., 2000b). This branch of the UPR is part of the integrated 
stress response (ISR). 
The third branch of the UPR is operated by the glycoprotein activating 
transcription factor 6 (ATF6). As an inactive precursor, it is clustered in the ER 
membrane (Nadanaka et al., 2007). Upon stress, its luminal domain dissociates from 
BiP/HSP-4 and ATF6 is packaged into vesicles, which are transported to the Golgi 
apparatus (Shen et al., 2002, Schindler and Schekman, 2009). Here, the luminal and 
transmembrane portions of ATF6 are clipped by two Golgi resident proteases, site-1 
protease and site-2 protease, respectively. The cleavage releases the N-terminal 
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cytosolic domain of ATF6. This active ATF6 fragment moves to the nucleus and acts 
as transcription factor at ER stress response elements (ERSEs) upstream of UPR 
target genes to expand the ER and enhance its folding capacity (Yoshida et al., 
1998, Haze et al., 1999, Roy and Lee, 1999, Ye et al., 2000, Okada et al., 2003, 
Yamamoto et al., 2004, Adachi et al., 2008, Bommiasamy et al., 2009, Mori, 2010). 
The ER is the ideal cellular compartment to monitor proper protein folding 
with the huge proportion of the proteome being modified in and shuttled through this 
organelle. For example, in human specialized tissues like salivary glands or the 
pancreas around or above 60% of all transcripts encode for secreted proteins, 
respectively (Uhlén et al., 2015).  
To maintain proteostasis is, however, not only essential within the ER, but 
also vital for mitochondrial function. Like the ER, mitochondria employ retrograde 
signaling to the nucleus to induce a specific transcriptional program designed to 
counter stress. This process is termed the mitochondrial unfolded protein response 
(UPRmt). The UPRmt is initiated when activating transcription factor associated with 
stress-1 (ATFS-1) - despite its mitochondrial localization signal - is not properly 
imported into mitochondria where it is degraded, but instead remains in the cytosol. 
Stress conditions that impair mitochondrial import, like depletion of mitochondrial 
DNA, perturbations of the electron transport chain or increased presence of unfolded 
proteins, trigger this accumulation of ATFS-1 (Martinus et al., 1996, Zhao et al., 
2002, Yoneda et al., 2004). As a consequence, the additionally present nuclear 
localization sequence of ATFS-1 causes its shuttling to the nucleus, where it induces 
UPRmt targets involved in protein quality control, detoxification, mitochondrial 
biogenesis, metabolism and innate immunity (Aldridge et al., 2007, Nargund et al., 
2012, Haynes et al., 2013, Wu et al., 2014, Schulz and Haynes, 2015). 
All of the players and modifiers of the PN mentioned above are important 
protective mechanisms that are set against the constant insults to a healthy 
proteome. Unfortunately, as damage accumulates with increasing age, those PQC 
pathways are progressively failing or become deregulated (Terman 1995, Vittorini et 
al., 1999, Cuervo and Dice, 2000, Donati et al., 2001, Carrard et al., 2002, Rabek et 
al., 2003, Ferrington et al., 2005, Balch et al., 2008, Nuss et al., 2008, Ben-Zvi et al., 
2009, Hamer et al., 2010, David et al., 2010, Taylor and Dillin, 2013, López-Otín et 
al., 2013, Jensen and Jasper, 2014, Münch and Harper, 2016, Frakes and Dillin, 
2017). Genetic or pharmacological inhibition of parts of the PN can provoke a 
premature aging phenotype as shown in several studies (Hsu et al., 2003, Simonsen 
et al., 2008, Zaglia et al., 2014, Higuchi-Sanabria et al., 2018). In Drosophila, genetic 
knockdown of a component of the proteasome lid, led to lifespan reduction and to 
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premature neurodegeneration in an HD model, to name one example (Tonoki et al., 
2009). In another fly study, the administration of the specific proteasome inhibitor 
PS-341 to adult animals impaired their motor function and also shortened their 
lifespan in a dose-dependent manner (Tsakiri et al., 2013). Modulation of proteasome 
activity is relevant in human aging as well: It was for instance observed, that 
pharmacological, partial proteasome inhibition induced premature senescence in 
human fibroblasts (Chondrogianni et al., 2003, Chondrogianni and Gonos, 2004). 
Together, these observations demonstrate the pivotal role of proteostasis during 
healthy aging. 
 
 
1.2.4   The integrated stress response 
 
It can be necessary to decrease or shut down cost intensive general 
translation under various stress conditions like amino acid or glucose starvation, heat 
shock, anoxia or accumulation of unfolded proteins in the ER. A well studied 
mechanism to achieve this is the reversible phosphorylation of the α subunit of eIF2 
at serine 51 (Ser51), as mentioned above in the context of PERK activation and the 
UPR. In the unphosphorylated state, GTP-bound eIF2 associates with Met-tRNAMet to 
form the ternary complex, which is then delivered to the small ribosomal subunit 
(40S). The resulting 43S pre-initiation complex is essential for translation initiation at 
the majority of transcripts as it scans the mRNA sequence to deliver methionine to 
the start codon (Jackson et al., 2010, Shirokikh and Preiss, 2018) (Figure 4A). 
Phosphorylated eIF2α (P-eIF2α) can still participate in the ternary complex. However, 
P-eIF2α strongly binds its guanine nucleotide exchange factor (GEF) eIF2B already 
in the TC, where this association and concomitant release of eIF5 has a destabilizing 
effect. After the hydrolysis of the bound GTP, and before the 80S initiation complex is 
assembled, P-eIF2-GDP is liberated from the TC but remains tightly bound to eIF2B 
(Unbehaun et al., 2004, Kapp and Lorsch, 2004, Jennings et al., 2017). This stable 
interaction abrogates the eIF2B GEF function and eIF2-GTP is not available to form 
TCs anew. Thereby, P-eIF2 is its own competitive inhibitor. It lowers the amount of 
free eIF2B and hence the amount of its own active form, eIF2-GTP (Sudhakar et al., 
2000, Sonenberg and Hinnebusch, 2009, Kashiwagi et al., 2016, Bogorad et al., 
2017) (Figure 4B). Consequently, phosphorylation of the α subunit of eIF2 attenuates 
translation initiation at mRNAs that are translated by the cap-dependent mechanism, 
which is the vast majority.  
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Simultaneous to the attenuation of global translation, the expression of a 
distinctive set of stress-related genes is elevated by the phosphorylation of eIF2α. 
The underlying cause for this particular expression signature is the specific 
translation of genes with at least two upstream open reading frames (uORFs), such 
as ATF4 (ATF-5) (Figure 4B). Under control conditions, the level of the P-eIF2α is 
low and translation initiation can proceed quickly. In this case, the ribosome 
transitions from the positive-acting 5´ proximal uORF (uORF1) in the ATF4 mRNA 
directly to the inhibitory second uORF (uORF2), where translation is reinitiated. As 
uORF2 overlaps with the ATF4 coding region, it is repressive and ATF4 is only 
expressed at a very low basal level. With rising P-eIF2α levels, reinitiation becomes 
delayed and ribosomes can skip uORF2. Instead there is increasing translation 
initiation at the coding region for ATF4, delivering an active transcription factor 
(Mueller and Hinnebusch, 1986, Mueller et al., 1987, Vattem and Wek, 2004, Lu et 
al., 2004, Zhou et al., 2008, Jackson et al., 2010). The broad transcriptional program 
activated by ATF4 and other factors that are regulated in a similar manner, like ATF5, 
is designed to re-establish cellular homeostasis or induce apoptosis (Harding et al., 
2000a, Natarajan et al., 2001, Hinnebusch and Natarajan, 2002, Harding et al., 2003, 
Lu et al., 2004, Jiang et al., 2004). 
The integration of many different signals, their convergence on 
phosphorylation of eIF2α, and the resulting translation attenuation and expression of 
specific stress relevant genes was termed the integrated stress response (ISR)	
(Harding et al., 2003). In mammals, four protein kinases achieve this integration of 
distinct stimuli by targeting eIF2α at Ser51: Protein kinase R (PKR) is activated by 
double-stranded RNA (dsRNA) and plays a role in antiviral immune defense (Levin et 
al., 1980, Meurs et al., 1990). Heme-regulated inhibitor (HRI) kinase is activated by 
heme deprivation in erythroid cells (Chen et al., 1991, Chen and London, 1995). 
PERK (PEK-1) detects and is activated by misfolded proteins in the ER lumen. It is 
part of the UPRER and helps to counter ER stress (Harding et al., 1999, Bertolotti et 
al., 2000). General control non-depressible 2 (GCN2/GCN-2) is activated by 
uncharged tRNAs under amino acid depletion, but further roles were described 
(Dever et al., 1992, Zhang et al., 2002, Jackson et al., 2010, Taniuchi et al., 2016): In 
C. elegans for example, GCN-2 is activated by hypertonic stress and is required to 
survive those conditions (Lee and Strange, 2012). Furthermore, it was shown that 
GCN-2 is necessary for lifespan extension caused by dietary restriction or inhibition 
of target of rapamycin (TOR) (Rousakis et al., 2013, Ferraz et al., 2016). 
In vivo, GCN2 requires assistance by additional proteins to phosphorylate 
eIF2α and activate the ISR. GCN1 (GCN-1) is a direct interaction partner of GCN2 as 
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well as the ribosome, and while it is dispensable for GCN2 kinase activity, it is 
essential for GCN2 activation by uncharged tRNAs (Ramirez et al., 1992, Marton et 
al., 1993, Garcia-Barrio et al., 2000, Kubota et al., 2000, Sattlegger and Hinnebusch, 
2000, Qiu et al., 2002, Pereira et al., 2005,	 Cambiaghi et al., 2014). GCN1 binds to 
the ribosome, where uncharged tRNAs are likely to occur as they inadvertently enter 
the ribosome acceptor site (A-site) and get stuck at the stalling translational 
machinery. Here, GCN1 is proposed to facilitate the liberation of the uncharged tRNA 
and its transfer onto GCN2 (Ramirez et al., 1991, Marton et al., 1997, Sattlegger and 
Hinnebusch, 2000, Sattlegger and Hinnebusch, 2005, Waller et al., 2012, Roffé et al., 
2013). The yeast GCN20 (ABCF3/ ABCF-3) protein forms a complex with GCN1 and 
was found to modulate the crucial ribosome binding of GCN1. Despite its own weak 
affinity to ribosomes, GCN20 can greatly enhance the polysome-associated fraction 
of GCN1/GCN20 complex. This activity is dependent on the energy status of a cell, 
which can be sensed by two domains within GCN20 that are highly similar to 
nucleotide binding domains in ATP binding cassette (ABC) transporters. In the 
presence of ATP the portion of GCN1 at polysomes is strongly promoted by GCN20 
(Vazquez de Aldana et al., 1995, Marton et al., 1997, Kerr, 2004). Interestingly, a 
residual activating function of GCN20 on GCN2 activity remains even if the ABC 
containing region is deleted (Marton et al., 1997). To conclude, while GCN1 is 
absolutely required for the activation of GCN2 under diverse stress conditions like 
amino acid, purine or glucose starvation or hypertonic stress, GCN20 is not essential 
under most conditions but can greatly enhance ribosome association of GCN1 and 
GCN2 and thereby tune the ISR (Rolfes and Hinnebusch, 1993, Marton et al., 1997, 
Yang et al., 2000a, Goossens et al., 2001, Narasimhan et al., 2004, Castilho et al., 
2014). Consistently, GCN1 is well conserved and has a clear homolog in mammals 
(www.uniprot.org/uniprot/Q92616). For GCN20 the situation is less clear, but ABCF1 
(also ABC50) is considered a functional homolog: Within the critical N-terminus that 
enables interaction with GCN1, human ABCF1 has 20% sequence identity and 30% 
sequence similarity to yeast GCN20. Although ABCF1 cannot substitute for GCN20 
in a yeast deletion strain, it does associate with GCN2 and ribosomes and fulfills 
functions in regulation of mRNA translation as well as start codon selection (Tyzack 
et al., 2000, Paytubi et al., 2008, Paytubi et al., 2009, Castilho et al., 2014, Stewart et 
al., 2015).  
The ISR and many of its players also exist in C. elegans: GCN-2 and PEK-1 
have been identified as homologs of the eIF2α kinases GCN2 and PERK, 
respectively. Furthermore, GCN-1 is conserved in the nematode and ABCF-3 is 
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expressed as the functional homolog of yeast GCN20 (Zhao et al., 2007, Hirose and 
Horvitz, 2014). 
 
A
B
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1.2.5   Improved protein quality control at the basis of longevity 
 
The progressive failure of PQC mechanisms and resulting loss of proteostasis 
is a hallmark of aging and the accumulation and aggregation of misfolded proteins is 
a common feature of many neurodegenerative diseases like AD, PD and HD (López-
Otín et al., 2013). Intriguingly, a study of related species with great differences in 
lifespan, such as house mouse and naked mole rat, revealed differences in the 
capacities of their proteostasis mechanisms. The long-lived species showed higher 
expression of chaperones and elevated levels of autophagy and proteasome activity 
compared to their shorter-lived relatives (Salway et al., 2011, Pride et al., 2015, 
Rodriguez et al., 2016). With this in mind, it is interesting to ask whether improved 
proteostasis is causative and sufficient for longevity and healthy aging and whether it 
can decrease the incidence of neurodegenerative and other age-associated 
diseases. Many of the studies addressing this question are carried out in C. elegans 
with its easy genetics and high degree of conservation of important signaling 
pathways and PQC mechanisms: 
First, induction of the heat shock response by overexpression of HSF-1 or 
short, hormetic heat treatment promotes stress resistance and longevity and delays 
the accumulation of protein aggregates in C. elegans disease models (Hsu et al., 
2003, Baird et al., 2014, Kumsta et al., 2017). Additionally, increased abundance of 
key players of the chaperone network such as the chaperonin-containing T-complex 
Figure 4. Simplified schemes of the regulatory role of eIF2 on mRNA translation. A. eIF2, GTP 
and Met-tRNAMet form the ternary complex, which associates with the 40S ribosomal subunit, 
supported by additional factors, such as eIF3 and eIF1A (1A). The resulting 43S pre-initiation 
complex binds to mRNA, which is circularized and primed by the 7-methyl-GTP (m7GTP) cap 
structure-binding complex, consisting of eIF4E (4E), eIF4G and eIF4A (4A), and by the poly(A)-
binding protein (PABP). The assembled 48S pre-initiation complex can start the scanning process to 
identify the AUG start codon, followed by binding of the large, 60S ribosomal subunit and mRNA 
translation. B. eIF2-GTP binary complex binds to Met-tRNAMet to form the ternary complex, which 
then associates with the 40S ribosomal subunit to initiate mRNA translation. After start-codon 
identification, GTP is hydrolyzed and eIF2-GDP is released. The GEF eIF2B converts inactive 
eIF2-GDP to active eIF2-GTP. This process is inhibited by phosphorylation (P) of the α-subunit of 
eIF2 catalyzed by four eIF2α kinases. P-eIF2-GDP is a competitive inhibitor of eIF2B, and thereby 
lowers the level of active eIF2B and ternary complexes. This, in turn, reduces general translation but 
increases translation of mRNAs containing uORFs, such as GCN4, ATF4 and CCAAT/enhancer-
binding protein (C/EBP) (adapted from Klann and Denver 2004). 
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can extend nematode lifespan (Noormohammadi et al., 2016). Second, the 
overexpression of the key autophagy regulator helix loop helix 30 (HLH-30), the 
nematode homolog of the mammalian transcription factor EB (TFEB), as well as its 
pharmacological activation prolong C. elegans lifespan (Lapierre et al., 2013, Wang 
et al., 2017a). Third, enhanced proteasome abundance or activity can confer 
resistance to proteotoxic stress and extend the life of nematodes (Hassan et al., 
2009, Vilchez et al., 2012, Chondrogianni et al., 2015). Furthermore, an 
enhancement of a combination of protein quality control pathways was achieved by 
activation of the hexosamine pathway, which produces an amino sugar essential for 
protein glycosylation. The moderate increase in autophagy, proteasome activity and 
ERAD in combination, lead to improved proteostasis and longevity	 (Denzel et al., 
2014). Lastly, also the manipulation of modifiers of the PN can have beneficial effects 
on the health and lifespan of organisms. For example, the activation of the IRE-1 
branch of the UPRER by neuronal expression of constitutively active spliced XBP-1 
leads to stress resistance and longevity in the nematode (Taylor and Dillin, 2013). 
Many of the health- and lifespan promoting effects of these pathways are 
conserved to mammals. To give a few examples, the genetic or pharmacological 
activation of HSF1 can decrease cytotoxicity in cell culture and extend health- and 
lifespan in protein folding disease mouse models (Kieran et al., 2004), (Fujimoto et 
al., 2005, Neef et al., 2010, Liangliang et al., 2010, Pierce et al., 2010, Calamini et 
al., 2011). Similarly, the activation of autophagy by overexpression of Atg5, a protein 
involved in autophagic vesicle formation, prolongs health- and lifespan in mice and 
elevates stress resistance (Pyo et al., 2013). Beyond this, analysis of samples from 
healthy human centenarians revealed an elevated abundance and activity of the 
proteasome compared to other elderly subjects and increased levels of the 
autophagy regulator BECLIN 1 (Chondrogianni et al., 2000, Emanuele et al., 2014). 
It is important to note that longevity usually comes at a price. In C. elegans, 
several distinct longevity models exist and many display obvious trade-offs in 
accordance with the antagonistic pleiotropy theory of aging (Williams, 1957): For 
instance, slowed down development, small body size or reduced reproductive fitness 
are phenotypes that can be observed in stress-resistant and long-lived genetic 
variants with modified insulin signaling (e.g. daf-2), food intake (e.g. eat-2) and 
mitochondrial function (e.g. isp-1) among others (Gems et al., 1998, Jenkins et al., 
2004, Chen et al., 2007b, Hughes et al., 2007, Chen et al., 2007a). In contrast to this, 
there are longevity models based on improved protein quality control which lack 
obvious detrimental effects (Denzel et al., 2014). It could be interesting to perform 
more systematic studies of mutants with elevated PQC regarding their life history 
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traits, as targeting the PN could turn out to be a very sensible therapeutic way to 
improve human health span. However, it will be necessary to transiently induce 
proteostasis mechanisms or fine tune their activation, because chronic and 
overshooting responses of PQC mechanism can be pro-apoptotic as well as auxiliary 
to tumor growth (Upton et al., 2012, Chen et al., 2014, Mariño et al., 2014, Dai and 
Sampson, 2016, Levy et al., 2017, Higuchi-Sanabria et al., 2018). 
 
 
1.3   The hexosamine pathway 
 
 
1.3.1   The hexosamine pathway as metabolic hub 
 
The hexosamine pathway (HP) is a major anabolic pathway that produces 
uridine diphosphate-N-Acetylglucosamine (UDP-GlcNAc). This aminosugar is an 
essential precursor for protein N- and mucin-type O-glycosylation, O-GlcNAcylation, 
and the synthesis of biopolymers such as hyaluronic acid and chitin, and of GPI 
anchored proteins and proteoglycans among other things. 
UDP-GlcNAc is produced from Fructose 6-phosphate (Fruc-6-P) in four 
consecutive steps by the designated enzymes of the HP (Figure 5). Around 2 to 5 % 
of cellular glucose enter the HP as Fruc-6-P, an intermediate product of glycolysis 
(Marshall et al., 1991). Glutamine-fructose 6-phosphate aminotransferase (GFAT-1), 
the first enzyme of the HP, uses Glutamine (Gln) as nitrogen donor to convert 
Fruc-6-P to Glucosamine 6-phosphate (GlcN-6-P) (Figure 5). This is the rate-limiting 
step of the HP and, consequently, GFAT-1 activity controls the consumption of 
Fruc-6-P and production of UDP-GlcNAc. The second enzymatic step of the HP is 
executed by Glucosamine 6-phosphate N-acetyltransferase, which requires 
Acetyl-Coenzyme A (Acetyl-CoA) to form N-acetylglucosamine 6-phosphate 
(GlcNAc-6-P) from GlcN-6-P. The third enzyme, Phosphoacetylglucosamine mutase, 
converts GlcNAc-6-P to its reactive isomer N-acetylglucosamine 1-phosphate 
(GlcNAc-1-P). Finally, uridine triphosphate (UTP) is utilized by 
UDP-N-acetylglucosamine pyrophosphorylase to produce UDP-GlcNAc (Ghosh et al. 
1960) (Figure 5).  
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Taken together, the production of one high energy molecule UDP-GlcNAc 
depends on Fruc-6-P from glycolysis, Gln from amino acid metabolism, Acetyl-CoA 
from fatty acid oxidation and UTP from nucleotide metabolism. Hence, the HP is 
ideally positioned to sense the energy status of a cell and to integrate signals from 
multiple metabolic pathways. Indeed, flux through the HP corresponds to Glucose 
availability (Wells et al., 2003, Marshall et al., 2004, Nakajima et al., 2010, Abdel 
Rahman et al., 2013). Furthermore, it was reported that the reversible attachment of 
single UDP-GlcNAc molecules to peptides at serine or threonine residues by the 
enzyme O-GlcNAc transferase (OGT, discussed in detail below) is a way to signal 
energy availability and metabolic state (Torres and Hart, 1984, Kreppel et al., 1997, 
Lubas et al., 1997). Studies that support this idea show a low affinity of OGT to 
UDP-GlcNAc and, in vitro, a strong responsiveness of the enzyme to an 
exceptionally wide range of UDP-GlcNAc concentrations. Additionally, the affinity of 
OGT to peptide substrates seems to be tuned by UDP-GlcNAc concentrations. On 
the one hand this allows successful O-GlcNAc modification even at low metabolite 
levels. On the other hand the presence of nutrients and resulting UDP-GlcNAc 
production can directly be coupled to alterations in post-translational protein 
modifications (Haltiwanger et al., 1992, Kreppel and Hart, 1999, Walgren et al., 2003, 
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Figure 5. Production of the high energy metabolite UDP-GlcNAc. The HP uses products from 
carbohydrate (green), amino acid (red), fatty acid (orange), and nucleotide metabolism (blue) to 
produce UDP-GlcNAc. The first enzymatic reaction of the HP, conversion of Fruc-6-P to GlcN-6-P 
under Glutamine expenditure, is catalyzed by GFAT1 and is rate-determining. This limitation can be 
bypassed by providing GlcN (turquoise) (modified from Tan et al., 2017). 
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Bond and Hanover, 2013). Consistently, changes in HP activity and O-GlcNAc 
signatures were implicated in diseases that either lead to or require altered glucose 
metabolism, such as diabetes and cancer (Marshall et al., 1991, Patti et al., 1999, 
Yang et al., 2008, Caldwell et al., 2010, Slawson et al., 2010, Lynch et al., 2012, 
Taparra et al., 2016).  
It is important to note that the generation of UDP-GlcNAc does not increase 
proportionally with available resources, but that GFAT-1 and thereby the whole HP is 
regulated more intricately. The best described mode of regulation of GFAT-1 is its 
strict feedback inhibition by its own product GlcN-6-P and the pathway’s endproduct 
UDP-GlcNAc (Kornfeld, 1967, DeHaven et al., 2001,	 Niimi et al., 2001, Broschat et 
al., 2002). Further modulations of GFAT-1 activity for example by phosphorylation 
are less well understood and detailed later. 
 
 
1.3.2   Diverse functions of the HP products 
 
The HP consumes high energy intermediates and products of several 
metabolic pathways to produce UDP-GlcNAc. This aminosugar can be interconverted 
into its isomer UDP-N-Acetyl galactosamine (UDP-GalNAc) in a reversible enzymatic 
step catalyzed by UDP-galactose-4-epimerase (GALE) (Thoden et al., 2001, Holden 
et al., 2003). Both molecules are essential for the assembly of diverse biomolecules 
as well as co- and posttranslational sugar modifications of proteins (Moussian, 2008, 
Corfield and Berry, 2015). Especially GlcNAc is highly abundant in nature. It is the 
sole building block of chitin, the most common natural polymer second only to 
cellulose. Chitin is a prevailing component of the cell wall of fungi, the exoskeleton of 
arthropods and the egg shell of nematodes like C. elegans (Rudall and Kenchington 
1973, Zhang et al., 2005, Ruiz-Herrera, 2016). Furthermore, GlcNAc accounts for 
half of the sugar molecules used to construct the peptidoglycan layer of bacterial cell 
walls (Leyh-Bouille et al., 1966, Osborn, 1969, Bugg and Walsh, 1992).  
In eukaryotes, aminosugars are found in a layer surrounding single cells as 
well: the extracellular matrix (ECM). It contains fibrous proteins like the highly 
abundant collagens or elastins and fibronectins. Moreover, the ECM contains 
glycosaminoglycans (GAGs), which are long unbranched polysaccharide chains 
comprising acetylated aminosugars such as UDP-GlcNAc and UDP-GalNAc. These 
GAGs are typically linked to a core protein to form proteogylcans like heparan 
sulphate, heparin, or keratan sulphate, or, in the case of hyaluronic acid, exist freely 
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in the ECM (Frantz et al., 2010, Hynes and Naba, 2012) (Figure 6). Obviously, the 
ECM presents an extracellular scaffold and has a structural and mechanical role in 
tissue architecture. Beyond that, it interacts with cell surface receptors, growth 
factors and pathogens and thus fulfills manifold functions including roles in cell 
adhesion, proliferation, migration, differentiation, and survival (Panayotou et al., 
1989, Meredith et al., 1993, Engler et al., 2006, Wang et al., 2008a, Rozario and 
DeSimone, 2010,	 Plotnikov et al., 2012, Lee-Sayer et al., 2015, Mecham and 
Ramirez, 2018).  
 
 
 
 
Figure 6. Schematic representation of major glycan types and the prevalence of GalNAc and 
GlcNAc. Glycosaminoglycans are common structures of the extracellular matrix. The long carbohydrate 
chains can, in case of Hyaluronan, exist freely or be linked to proteins to form proteoglycans. Another 
class of glycans are glycosphingolipids, which consist of a membrane-anchored ceramide modified by 
oligosaccharides. Different posttranslational modifications involve the attachment of carbohydrate 
structures: Glycosylphosphatidylinositol (GPI) anchors are glycolipid moieties that allow membrane 
tethering of proteins. Exceptionally complex, branched oligosaccharides are found on secreted and 
membrane-bound N-glycans and O-glycans, where they modulate protein stability, interactions and 
biophysical properties. The transient modification of intracellular O-GlcNAc glycoproteins by single 
GlcNAc molecules fulfills important signaling functions. GalNAc, N-Acetylgalactosamine; GlcNAc, 
N-Acetylglucosamine; Gal, Galactose; Glc, Glucose; Man, Mannose; Fuc, Fucose; Xyl, Xylose; GlcA, 
Glucuronic acid; IdoA, Iduronic acid (modified from Varki et al., 2009a). 
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Furthermore, GlcNAc and GalNAc are part of integral components of 
biological membranes. They are precursors for the diverse group of 
glycosphingolipids, which typically constitute a transmembrane glucosyl or galactosyl 
ceramide core modified by an extracellular oligosaccharide chain (Sandhoff and 
Kolter, 2003, D'Angelo et al., 2013) (Figure 6). In general, glucosylceramide-derived 
glycosphingolipids are essential for embryonic development in mammals, but also 
C. elegans (Yamashita et al., 1999, Marza et al., 2009, Jennemann et al., 2012, 
Boland et al., 2017). Depending on the composition of the saccharide chain they are 
involved in numerous fundamental biological processes like intracellular trafficking, 
apoptosis, nerve myelination, immunity and fertility, just to name a few (Pasquini et 
al., 1989, Yamashita et al., 1999, Sprong et al., 2001, Sillence et al., 2002, 
Jennemann et al., 2005, Watanabe et al., 2010, Kuan et al., 2010, D'Angelo et al., 
2013, Allende and Proia, 2014) 
Additionally, UDP-GlcNAc and UDP-GalNAc are essential building blocks for 
different types of protein modifications: UDP-GlcNAc is a key molecule for the 
synthesis of glycosylphosphatidylinositol (GPI) anchors (Figure 6). This complex 
PTM is characterized by the addition of a widely conserved glycolipid structure to 
select proteins in the ER. GPI anchors allow the tethering of target proteins to 
membranes, in particular the outer sheet of the cell membrane (Homans et al., 1988, 
Miyata et al., 1993). The inhibition of enzymes required for GPI anchor biogenesis 
leads to severe defects in several biological processes, including blood coagulation, 
neurological function and fertility (Nozaki et al., 1999, Almeida et al., 2006, Ueda et 
al., 2007, Fujita and Kinoshita, 2012). 
Importantly, UDP-GlcNAc and UDP-GalNAc are also required for protein 
glycosylation, highly abundant modifications that are conserved between all three 
domains of life (Van den Steen et al., 1998, Apweiler et al., 1999, Schwarz and Aebi, 
2011, Zielinska et al., 2012). There are three distinct types of protein glycosylation: 
protein N-glycosylation, mucin-type O-glycosylation and O-linked attachment of a 
single GlcNAc molecule termed O-GlcNAcylation (Corfield and Berry, 2015) 
(Figure 6). 
N-glycosylation occurs in the ER and is thus limited to secreted and 
membrane-associated proteins. It is essential and universal, with all living cells being 
coated with a dense layer of glycans, the glycocalyx (Varki, 2011). In N-glycosylation, 
specialized glycosyltransferases preassemble a core oligosaccharide on an ER 
membrane integral lipid carrier, namely dolichyl-pyrophosphate in most eukaryotes 
(Kornfeld and Kornfeld, 1985, Abeijon and Hirschberg, 1992, Burda et al., 1999). 
Certain assembly steps of the glycan structure occur in the cytosol, others in the ER 
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lumen. Hence, the glycan biosynthesis requires translocation of sugar molecules 
across the ER membrane and flipping of initial sugar structures from cytosol to ER 
lumen (Snider et al., 1980, Hanover and Lennarz, 1982, Snider and Rogers, 1984, 
Kean, 1991, Bickel et al., 2005, Chantret et al., 2005, Gao et al., 2005, Sanyal and 
Menon, 2010) (Figure 7A). After complete construction on dolichyl-pyrophosphate, 
the Glc3Man9GlcNAc2 core glycan is transferred on bloc to asparagine residues, 
characterized by the asparagine-X-serine/threonine (N-X-S/T) consensus sequence 
(in place of X there may be any amino acid except proline), in unfolded peptide 
chains (Marshall, 1972, Welply et al., 1983, Wieland et al., 1985). This reaction is 
catalyzed in the ER by the key enzyme oligosaccharyltransferase (OST) and can 
occur co-translationally or post-translationally (Chen et al., 1995, Karaoglu et al., 
2001, Ruiz-Canada et al., 2009, Lizak et al., 2011). After attachment to the protein 
substrates, the core oligosaccharides are modified in the ER and Golgi apparatus to 
generate mature glycoproteins (Figure 7B). At first, the early glycoprotein undergoes 
stepwise removal of glucose residues in the ER (Hubbard and Ivatt, 1981, Peyrieras 
et al., 1983, Parodi, 2000, Kalz-Füller et al., 1995). “Trimming” and transient re-
glycosylation is necessary so that the lectin chaperones calnexin and calreticulin 
recognize the carbohydrate structure and assist in the folding of the glycoprotein into 
its native conformation (Trombetta et al., 1991, Sousa and Parodi, 1995, Hebert et 
al., 1997, Schrag et al., 2001, Kapoor et al., 2003, Trombetta and Parodi, 2003). If 
misfolded, the glycoprotein is, at first, retained within the positive folding environment 
of the ER by the chaperones. After prolonged failure to fold, it is delivered to the 
cytosol for degradation after further glycan trimming by ER mannosidases, (Su et al., 
1993, Hammond et al., 1994, Ermonval et al., 2001, Frenkel et al., 2003, Deprez et 
al., 2005, Avezov et al., 2008). Thereby, early modification of the attached glycan can 
generate a signal for binding of the carrier protein by chaperones, transport to the 
cytosol for degradation or anterograde trafficking to further pass through the 
secretory pathway. Then, while the proteins traverse the sub-compartments of the 
Golgi apparatus, their sugar moieties undergo an organism-specific and even cell 
type-specific series of additional trimming and extension steps carried out by a 
multitude of glycan processing enzymes (Rabouille et al., 1995, Igdoura et al., 1999, 
Papanikou and Glick, 2009, Moremen et al., 2012). The resulting mature 
glycoproteins exhibit elaborate N-oligosaccharides of immense variety, which can be 
clustered into three distinct groups according to their composition and branching: 
oligomannose, complex and hybrid type (Varki et al., 2009b, Wang et al., 2017b). In 
the Deuterostome lineage, including vertebrates, an exceptional degree of 
glycoprotein diversity is achieved by refined modification of sialic acid (not present in 
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C. elegans), the sugar molecule that caps most glycan branches (Harduin-Lepers et 
al., 2005, Cummings et al., 2009).  
The great investment in and complicated logistics of N-glycan assembly and 
maturation are justified by its important and versatile functions: The attachment of 
N-glycans can accelerate and aid folding, monitor the folding status and stabilize the 
native state of proteins thereby preventing aggregation and serving as protein quality 
control mechanism (Kern et al., 1992, Helenius, 1994, Wang et al., 1996, Ellgaard et 
al., 1999, Hanson et al., 2009, Roth et al., 2010). Consequently, preventing protein 
glycosylation causes ER stress, and genes involved in N-glycan production are 
induced by the UPRER in order to alleviate protein folding stress (Doerrler and 
Lehrman, 1999, Travers et al., 2000, Ng et al., 2000, Shang et al., 2002). Beyond 
that, N-glycosylation is involved in nutrient uptake, metabolism, cell proliferation and 
differentiation (Lau et al., 2007, Abdel Rahman et al., 2015). Furthermore, N-glycans 
are strongly implicated in cell adhesion, cell signaling, cell-cell interactions and 
immunity (Dennis et al., 1987, Hakomori, 1996, Partridge et al., 2004, Dennis et al., 
2009, Kariya et al., 2010, Kariya and Gu, 2011). Indeed, the immense diversity of 
glycan structures, presented by proteins at the cell surface, is best understood in light 
of co-evolution between host and pathogens. While invading microbes require an 
attachment structure on the host cell and invest in avoiding its defenses, the host cell 
has a sustained interest in prohibiting close contact. In this regard, N-glycans can be 
seen as a protective sheath that can be greatly variegated to not be recognized by 
pathogens anymore but simultaneously leaving the original protein function unaltered 
(Varki, 2006, Varki, 2011, Le Pendu et al., 2014, Cohen, 2015).  
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Figure 7. N-glycoprotein synthesis and processing in ER and Golgi. A. The assembly of the 
N-glycan core oligosaccharide is initiated on the lipid carrier dolichyl-pyrophosphate (Dolichol-P) at 
the cytoplasmic side of the ER membrane. Flipping of Dolichol-P allows the translocation of single 
sugar molecules and the preassembled carbohydrate structure, consisting of GlcNAc and mannose, 
to the ER lumen. Here, further mannose and glucose residues are attached, before the 
Glc3Man9GlcNAc2 core glycan is attached en bloc to the protein acceptor. B. The biosynthesis of 
N-glycoproteins involves collaboration between different cellular compartments. The lipid-linked core 
glycan is assembled in cytoplasm and ER (1) and is transferred en bloc to nascent polypeptides 
within the ER (2). The glycoprotein is, after initial glycan trimming (3) and protein folding within the 
ER, shuttled to the Golgi apparatus. It traverses the organelle where it is further processed by 
trimming steps, modification of the glycan branch structure and addition of further intermediate and 
terminal sugar residues (3). Finally, native glycoproteins are secreted to the extracellular space or 
delivered to the plasma membrane, where they fulfill their functions (adapted from Taylor and 
Drickamer 2011). 
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Mucin-type O-glycosylation is a posttranslational protein modification that is 
mainly executed within the Golgi apparatus (Watkins, 1966, Hanover et al., 1982, Gill 
et al., 2011). A family of highly conserved and partially redundant polypeptide N-
acetyl-α-galactosaminyltransferases (ppGalNAcTs) catalyzes multiple of the 
consecutive biosynthesis steps (Sugiura et al., 1982, Sørensen et al., 1995, Wandall 
et al., 1997, Hagen and Nehrke, 1998, Schwientek et al., 2002, Hagen et al., 2003, 
Bennett et al., 2012, Las Rivas et al., 2018). The initial reaction is the α-glycosidic 
linkage of GalNAc to the hydroxyl group of Serine or Threonine residues (McGuire 
and Roseman, 1967, Weissmann and Hinrichsen, 1969, Coltart et al., 2002). The 
attached single GalNAc represents the inner most core common to all mucin-type 
O-glycans and is their simplest example. Then again, along with further Golgi-
resident glycosyltransferases, the ppGalNAcTs can generate carbohydrate trees of 
extraordinary complexity that exceed the size, degree of branching and heterogeneity 
of N-glycans by far (Shogren et al., 1989, Carraway and Hull, 1991, McMaster et al., 
1999, Hanisch, 2001, Perdivara et al., 2009, Jin et al., 2017). Due to their elaborate 
structure, mucin-type O-glycans are difficult to study and many of their key 
characteristics like their biological role, the regulation of their production and the 
identities of the modified proteins still remain elusive (Jensen et al., 2010, Hurtado-
Guerrero, 2016). Accordingly, it is not known, whether a consensus sequence 
defines the Ser/Thr residues targeted by ppGalNAcTs. Rather, the amino acid 
composition and already existing PTMs in the vicinity of the glycosylation site as well 
as secondary and tertiary structure of proteins entering the Golgi were shown to be 
decisive factors (Gooley and Williams, 1994, Nehrke et al., 1996, Nehrke et al., 1997, 
Gerken et al., 1997, Müller et al., 1997, de Haan et al., 1998, Kirnarsky et al., 1998, 
Hanisch et al., 1999, Asada et al., 1999, Elhammer et al., 1999, Hanisch et al., 2001, 
Takeuchi et al., 2002, Gerken et al., 2002, Steentoft et al., 2013). Once a protein is 
modified by O-glycans, it becomes protected from proteolytic cleavage and, hence, is 
more stable (Kozarsky et al., 1988, Garner et al., 2001). Their biophysical properties 
furthermore facilitate the hydration, lubrication and shielding of cellular surfaces 
(Gendler and Spicer, 1995, Tabak et al., 1982). Moreover, the expression of 
O-glycans is strongly implicated in cell adhesion and polarity, underscored by their 
essential role in embryonic development and involvement in cancer formation (Bleil 
and Wassarman, 1980, Fukuda, 2002, Xia et al., 2004, Alexander et al., 2006, Ten 
Hagen et al. 2009, Zhang et al., 2010, Gill et al., 2013, Hussain et al., 2016, Nguyen 
et al., 2017). Additional functions in protein secretion and cellular trafficking have 
been suggested (Huet et al., 1998, Alfalah et al., 1999, Altschuler et al., 2000, 
Jablonka-Shariff et al., 2002, Liebl and Featherstone, 2005, Zhang and Hagen, 
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2010). Like N-glycans, mucin-type O-glycans fulfill crucial roles in host-pathogen 
interaction and the immune system (Yang et al., 2000b, Tenno et al., 2007, Morozov 
et al., 2018, Dias et al., 2018). For instance, they can interact with pathogens and 
either prohibit or foster infection, serve as antigens and modulate the inflammatory 
response (Schroten et al., 1992, Sieling et al., 1995, Ellies et al., 1998, Vlad et al., 
2002, Bäcklund et al., 2002, Hang and Bertozzi, 2005, Parsons et al., 2014, Everest-
Dass et al., 2017). 
O-GlcNAcylation describes the post-translational modification of cytosolic and 
nuclear proteins by single β-GlcNAc molecules (Torres and Hart, 1984, Love et al., 
2003, Hanover et al., 2003, Banerjee et al., 2015). Hereby, cellular signals are 
generated as a function of the metabolic state of a cell (Chatham and Marchase, 
2010, Bond and Hanover, 2015). OGT is the sole enzyme catalyzing the O-linked 
bond formation between the sugar donor UDP-GlcNAc and the hydroxyl group of 
serine and threonine residues (Torres and Hart, 1984, Haltiwanger et al., 1992, 
Kreppel et al., 1997, Cummings et al., 2009). Recently, it was discovered that 
GlcNAc can, in rare cases, also be linked to tyrosine and cysteine residues (Jank et 
al., 2015, Maynard et al., 2016). Only one additional enzyme is relevant for 
O-GlcNAc cycling: the glycoside hydrolase O-GlcNAcase (OGA) can remove the 
attached sugar from proteins and directly counteract OGT, which makes O-GlcNAc a 
highly dynamic PTM (Braidman et al., 1974, Gao et al., 2001). The importance of 
O-GlcNAc cycling is reflected in the fact that OGT and OGA are highly conserved, 
ubiquitous and essential (Lubas et al., 1997, Shafi et al., 2000, Wells et al., 2002, 
O'Donnell et al., 2004, Yang et al., 2012).  
Three different splice variants are produced from the single OGT gene in 
humans. While the catalytic domain is identical, the isoforms comprise distinct 
numbers of N-terminal tetratricopeptide repeats (Kreppel et al., 1997, Lazarus et al., 
2006). The encoded antiparallel α-helix pairs mediate protein-protein interactions and 
thereby shape substrate specificity (Blatch and Lässle, 1999, Jínek et al., 2004, 
Martinez-Fleites et al., 2008, Lazarus et al., 2011, Levine et al., 2018). Furthermore, 
the isoforms differ in their subcellular localization. The long and short isoform are 
distributed throughout cytosol and nucleus, whereas the OGT isoform of intermediate 
length contains a mitochondrial targeting sequence and also acts within the organelle 
(Lazarus et al., 2006). The enzymatic activity, expression level and substrate 
selection of OGT are additionally influenced by multiple factors such as local 
UDP-GlcNAc availability as well as input from other metabolic pathways, the aa 
sequence in proximity of the glycosylation site within substrates, PTMs of OGT itself 
and its substrates, stress stimuli and interacting proteins (Haltiwanger et al., 1992, 
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Kreppel et al., 1997, Wang et al., 1998, Iyer et al., 2003, Zachara et al., 2004, 
Whisenhunt et al., 2006, Cheung and Hart, 2008, Ryu and Do, 2011, Shen et al., 
2012, Rafie et al., 2017). Interestingly, in Drosophila OGT was originally identified as 
a member of the conserved polycomb transcriptional repressor family, which have a 
pivotal role in development. Mutations in OGT resulted in pupal lethality and 
transformations of multiple body segments caused by misexpression of multiple 
homeotic genes. These observations identified OGT as potent modulator of gene 
expression (Gambetta et al., 2009). 
Like OGT, OGA is expressed as splice variants with differential localization. 
Although the glycoside hydrolase domain at the N-terminus is identical between both 
isoforms, the long isoform of primarily cytoplasmic expression shows a much higher 
catalytic efficiency than the short isoform, which is mainly located to nucleus and was 
suggested to also be found at the surface of lipid droplets (Comtesse et al., 2001, 
Gao et al., 2001, Wells et al., 2002, Kim et al., 2006, Macauley and Vocadlo, 2009, Li 
et al., 2010b, Keembiyehetty et al., 2011). Consequently, the C-terminus, a histone 
acetyltransferase like domain, exclusively expressed in the long isoform, seems to be 
relevant for enzymatic activity, proper folding or binding of co-factors (Schultz and 
Pils, 2002, Toleman et al., 2004, Toleman et al., 2006, Butkinaree et al., 2008). OGA 
recognizes its substrates by forming hydrogen bonds with the protein-bound GlcNAc 
moiety itself. The amino acid composition of the substrate protein can hinder the 
interaction with OGA and thus modulates its specificity (Shen et al., 2012, Schimpl et 
al., 2012, Li et al., 2017a, Elsen et al., 2017, Roth et al., 2017). Most of the selectivity 
of O-GlcNAc is, however, achieved by the intricate regulation of OGT activity. 
O-GlcNAcylation resembles protein phosphorylation with regards to being a 
rapidly and transiently occurring PTM. There is extensive crosstalk between both 
modifications and they even compete for a proportion of their molecular targets. 
Hereby, O-GlcNAc modification can prohibit phosphorylation at consensus sites, but 
O-GlcNAc also modulates phosphorylation at adjacent sites and vice versa (Comer 
and Hart, 2001, Kamemura et al., 2002, Wang et al., 2008b, Ande et al., 2009, 
Zeidan and Hart, 2010, Hart et al., 2011, Kaasik et al., 2013, Zhong et al., 2015, Tian 
et al., 2016). This is one of the features of O-GlcNAc cycling that help to understand 
how this PTM can be involved in the regulation of an enormous number of biological 
processes. These include chromatin remodeling, regulation of gene transcription and 
immune responses, protein solubility, stability and degradation, just to name a few 
(Han and Kudlow, 1997, Zhang et al., 2003, Wang et al., 2008b, Srikanth et al., 2010, 
Ranuncolo et al., 2012, Yuzwa et al., 2012, Hanover et al., 2012, Guo et al., 2017, 
Leturcq et al., 2017, Li et al., 2017b, de Jesus et al., 2018). 
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1.3.3   The enzyme Glutamine-fructose 6-phosphate aminotransferase (GFAT) 
 
The structure of bacterial as well as eukaryotic GFAT-1 is divided into two 
domains connected by a hinge region. The glutaminase domain catalyzes the 
hydrolysis of glutamine to glutamate and, via an ammonia channel, provides 
ammonia as nitrogen source to the isomerase domain. Here, Fruc-6-P is transformed 
into its isomer Glucose 6-phosphate (Glc-6-P) and ammonia is transferred to Glc-6-P 
to generate GlcN-6-P (Denisot et al., 1991, Teplyakov et al., 2001, Olchowy et al., 
2007, Durand et al., 2008). In the bacterial GFAT homolog glucosamine-6-phosphate 
synthase (GlmS), dimerization of and cooperation between two GlmS molecules is 
required for enzymatic activity, while eukaryotic GFAT-1 is an active enzyme in a 
homotetrameric state (Kornfeld, 1967, Raczynska et al., 2007, Richez et al., 2007). 
Two isoforms of gfat-1, which are products of alternative splicing, are 
expressed. Both isoforms merely differ in the length of the hinge region between 
isomerase and glutaminase domain and their expression pattern. In mice, the shorter 
splice variant lacking amino acids 229-246 (in C. elegans lacking amino acids 
226-238) is ubiquitously und uniformly expressed, while the long isoform is 
predominantly expressed in skeletal muscle (DeHaven et al., 2001, Niimi et al., 
2001). As the HP product UDP-GlcNAc is an essential building block for diverse 
biopolymers and distinct posttranslational protein modifications, it is plausible that it is 
well conserved between species. In fact, gfat-1 exhibits 99% sequence homology 
between humans and mice and still 60% sequence homology between humans and 
the distant relative C. elegans. Residues with important functions, such as formation 
of a channel to transport ammonia between the two enzyme domains, generation of 
binding pockets for educts, shielding reaction space from solvent, or catalytic activity 
itself are almost identical even between E. coli and these species (McKnight et al., 
1992, Sayeski et al., 1994, Teplyakov et al., 2001, DeHaven et al., 2001, Mouilleron 
et al., 2006). 
Additionally, a second gene with around 75% amino acid sequence homology 
to gfat-1 was identified in mouse and human and termed gfat-2 (Oki et al., 1999). 
Like gfat-1, gfat-2 is well conserved between organisms with known homologs in 
C. elegans, flies, yeast and even plants (www.ncbi.nlm.nih.gov/homologene/68439). 
While gfat-1 and gfat-2 are clearly distinct genes, their protein products both fulfill the 
same function: catalyzing the first enzymatic reaction of the HP. In contrast to the 
ubiquitous expression of GFAT-1, GFAT-2 shows a more limited expression pattern 
in mice and humans, mainly being detected in the central nervous system (Zhou et 
al., 1995, Oki et al., 1999, De Haven et al., 2001, Zhang et al., 2004). Whether 
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GFAT-1 and GFAT-2 fulfill gene specific functions besides producing GlcN-6-P is not 
yet known, but both GFAT-1 splice variants and GFAT-2 exhibit distinct enzyme 
kinetics. Differences in affinities for educts and products, which serve as feedback 
inhibitors, likely reflect the specific needs of the tissues, where the distinct GFAT 
variants are expressed (Kornfeld, 1967, De Haven et al., 2001, Niimi et al., 2001, 
Broschat et al., 2002).  
To additionally adapt UDP-GlcNAc production to transiently high or low 
requirements and general energy availability, GFAT harbors multiple sites for 
posttranslational modifications (PTMs) (www.phosphosite.org). To which extent and 
in which context these PTMs influence GFAT stability or activity is, however, largely 
still unknown. Few studies exist that describe the phosphorylation of Ser205 and 
Ser235 by protein kinase A (PKA) (Zhou et al., 1998, Chang et al., 2000, Hu et al., 
2004). At rising concentrations of the second messenger cyclic adenosine 
monophosphate (cAMP) (triggered by hormones and neurotransmitters but also 
regulated by glucose, intracellular pH, ATP, bicarbonate and calcium) cAMP 
molecules bind to PKA regulatory subunits. As a consequence, the catalytic subunits 
become liberated and are able to phosphorylate PKA target proteins (Kamenetsky et 
al., 2006, Tamaki, 2007, Kim et al., 2007, Ramos et al., 2008, Sjoberg et al., 2010, 
Zippin et al., 2013, Smith et al., 2013). The effects of GFAT phosphorylation by PKA 
remain still unclear as they are described inconsistently by different research groups: 
While phosphorylation at Ser235 does not result in a measurable change of 
enzymatic activity, phosphorylation at Ser205 was characterized in one publication to 
be diminishing and in another publication to be boosting GFAT activity (Zhou et al., 
1998, Chang et al., 2000). A third study found phosphorylation at Ser205 in GFAT-1 
to be decreasing and the corresponding phosphorylation at Ser202 in GFAT-2 to be 
increasing enzymatic activity (Hu et al., 2004). 
Apart from PKA, adenosine monophosphate (AMP)-activated protein kinase 
(AMPK) is able to phosphorylate GFAT (Li et al., 2007, Eguchi et al., 2009, Zibrova et 
al., 2017). AMPK, as central mediator of cellular energy homeostasis, senses rising 
AMP/ATP and adenosine diphosphate (ADP)/ATP ratios and becomes active at low 
energy availability. Thereupon, AMPK phosphorylates numerous substrates, 
including mechanistic target of rapamycin complex 1 (mTORC1). Thus, it decreases 
cap-dependent protein synthesis and increases autophagy, among other things 
(Gwinn et al., 2008, Kim et al., 2011, Egan et al., 2011, Hardie et al., 2012, Xu et al., 
2012, Burgos et al., 2013). The consequences of AMPK-mediated Ser243 
phosphorylation in GFAT are only poorly understood. While Li and colleagues 
reported an increase in GFAT enzymatic activity upon phosphorylation, two different 
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research groups described an inhibitory effect (Li et al., 2007, Eguchi et al., 2009, 
Zibrova et al., 2017). Interestingly, mTOR complex 2 was recently also identified as 
modulator of GFAT-1 Ser243 phosphorylation and a promoting effect of 
phosphorylation on HP flux was reported (Moloughney et al., 2018). 
Besides phosphorylation sites, multiple studies could identify ubiquitination 
sites in GFAT (www.phosphosite.org). Thus, GFAT degradation might well be 
mediated by the proteasome and GFAT stability could be another way to control HP 
flux.  
Lastly, several sites in the GFAT peptide sequence are predicted to be 
modified by O-GlcNAc (www.cbs.dtu.dk/services/YinOYang/). This can potentially 
add another layer to the feedback regulation of the HP, by involving OGT and OGA in 
the tuning of GFAT activity. As the HP is critical to cellular metabolism and 
organismal integrity is important to gain a more complete insight into the complex 
regulation of GFAT-1 activity as well as its abundance. 
 
 
1.3.4   Intersection of the hexosamine pathway with protein quality control 
 
The HP produces the essential molecule UDP-GlcNAc, which is a building 
block for a large variety of biomolecules and PTMs that play a central role in 
numerous signaling pathways. Hence, it is conceivable that there are various points 
of contact between the HP and the complex network of PQC mechanisms.  
Multiple studies describe the influence of protein O-GlcNAcylation as a 
function of cellular energy status on autophagy. Elevated O-GlcNAc attachment was 
shown to enhance autophagic flux in certain conditions by manipulating activity of 
FOXO (DAF-16) transcription factor and by directly targeting components of the 
autophagy core machinery (Housley et al., 2008, Housley et al., 2009, Wang and 
Hanover, 2013, Zhu et al., 2018). In the majority of reports however, a decrease in 
O-GlcNAc promoted the induction of autophagy and the maturation of autophagic 
vesicles (Marsh et al., 2013, Guo et al., 2014, Park et al., 2015, Fahie and Zachara, 
2016, Wani et al., 2017, Zhang et al., 2018). These controversial observations 
emphasize the complex participation of O-GlcNAc, which is only one of the outputs of 
the metabolic HP, in the regulation of different steps of autophagic recycling. 
O-GlcNAc signaling is also implicated in distinct steps of protein degradation 
via the UPS, ranging from regulation of gene expression of proteasomal subunits, 
over crosstalk with ubiquitination at shared substrates, to direct modification of 
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components of the proteasome and consequently modulation of proteolytic capacity 
(Zhang et al., 2003, Sümegi et al., 2003, Guinez et al., 2008, Overath et al., 2012, 
Sekine et al., 2018). Again, the effects of increased O-GlcNAc were complex. They 
included not only inhibition of proteolytic cleavage by the proteasome, but also 
positive correlation with proteasome abundance (Zhang et al., 2003, Keembiyehetty 
et al., 2011, Sekine et al., 2018). 
In the context of aging and disease, the tau protein, a binding partner of 
tubulin that is essential for the formation of microtubules, is one well-characterized 
example for the influence of O-GlcNAcylation on protein solubility versus aggregation 
(Weingarten et al., 1975). Hyperphosphorylated tau is aggregation prone and a major 
constituent of neurofibrillary tangles, a hallmark of AD (Kosik et al., 1986, Wood et 
al., 1986, Grundke-Iqbal et al., 1986, Bancher et al., 1989). Increasing O-GlcNAc 
modifications on tau prevents tau hyperphosphorylation and directly counteracts its 
aggregation, which results in measurable cognitive benefits and generally improved 
health in mouse models of AD (Liu et al., 2004, Yuzwa et al., 2012, Borghgraef et al., 
2013, Yuzwa et al., 2014b, Graham et al., 2014, Yuzwa et al., 2014a, Lim et al., 
2015, Hastings et al., 2017, Frenkel-Pinter et al., 2018). One conflicting study could, 
however, not identify extensively O-GlcNAc modified endogenous tau in vivo (Morris 
et al., 2015). 
Beyond affecting the physical properties of specific proteins, a very broad 
protective and stabilizing role was suggested for co-translationally occurring 
O-GlcNAc at nucleocytoplasmic nascent polypeptide chains. Co-translational 
O-GlcNAc modifications were found to exert their protective role through modulating 
ubiquitination and by preventing premature proteasomal degradation (Zhu et al., 
2015). For protein N-glycosylation a general protective role, assistance in protein 
folding and monitoring of protein conformation by modification with intricate 
carbohydrate structures is already well established for proteins of the secretory 
pathway (Joao and Dwek, 1993, Rudd et al., 1994, Mer et al., 1996, Sinha and 
Surolia, 2007, Hanson et al., 2009, Glozman et al., 2009, Jayaprakash and Surolia, 
2017). Due to its prevalence and positioning at the nexus of aminosugar and protein 
biosynthesis, N-glycosylation is, furthermore, ideally suited to integrate energy 
availability and expenditure as well as different stress cues. Hence, improper protein 
glycosylation can potently induce the UPR to restore cellular homeostasis (Doerrler 
and Lehrman, 1999, Travers et al., 2000, Ng et al., 2000, Shang et al., 2002, Wang 
et al., 2015, McCaffrey and Braakman, 2016). 
But although O-GlcNAcylation and protein N-glycosylation affect a huge pool 
of proteins in multiple biological processes and signaling pathways, they are only 
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singular outputs of the HP. Only in recent years, it became clear that tuning the 
activity of the HP directly would also shape PQC mechanisms. Wang and colleagues 
worked with ischemia/reperfusion (I/R) in the mouse heart, which causes calcium 
imbalance and a burst of mitochondrial reactive oxygen species production, resulting 
in protein misfolding. They demonstrated that I/R elevated XBP1s levels by activation 
of the IRE1 branch of the UPR. This in turn led to induction of HP enzyme 
expression, confirming GFAT1 as direct target of the UPR. Concomitantly, there was 
an overall increase in O-GlcNAc protein modifications in vitro and in vivo. Elevated 
O-GlcNAcylation was also observed after exposing cells to distinct stress conditions, 
suggesting a general role for HP and OGT activation downstream of the UPR. In 
case of I/R, XBP1s overexpression could protect from I/R injury and cell death. 
Importantly, this effect was dependent on GFAT-1 and GFAT-1 overexpression by 
itself was cardioprotective (Wang et al., 2014). 
Denzel and co-workers in the Antebi/host laboratory showed a beneficial 
effect of HP activation on multiple proteostasis mechanisms culminating in longevity 
in the model organism C. elegans. Initially, they identified gain-of-function (gof) 
mutations in GFAT-1 to confer resistance to the drug tunicamycin, which triggers ER 
stress by interfering with protein N-glycosylation. When they characterized these 
mutants, they observed an increase in lifespan and a decrease in aggregation and 
toxicity of aggregation-prone proteins. The benefits were likewise achieved in 
wildtype worms by feeding GlcNAc, a UDP-GlcNAc precursor. The positive effects on 
lifespan and PQC were dependent on UPR, ERAD and autophagy and gfat-1 gof 
animals exhibited slightly elevated ERAD, autophagy and proteasome activity 
(Denzel et al., 2014). 
In summary, these findings indicate that the ubiquitous and essential HP, 
which is entangled in a myriad of biological processes, has an especially tight 
connection to PQC pathways. Not only does the HP seem to mediate responses to 
protein folding stress, but also it participates in the control of distinct proteostasis and 
protein recycling mechanisms under basal conditions. The coordinated upregulation 
of multiple PQC mechanisms achieved by HP activation could be particular effective 
in countering proteotoxicity. To exploit this for potential treatment strategies of protein 
aggregation diseases and age-dependent failure of the PN it is critical to better 
understand the regulation and diverse functions of GFAT-1. It will be essential to 
identify downstream effectors of GFAT-1 responsible for the improved PQC and also 
to determine tissue-specificity and possible negative effects.  
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1.4   Aims of this study 
 
Evidently, multiple complex processes ensuring proper protein synthesis, 
folding, maintenance and degradation join forces to preserve PQC during the lifetime 
of an organism. With rising age, the proteostasis machinery increasingly fails to meet 
the demanding challenge of sustaining a healthy proteome with severe 
consequences including the growing incidence of protein folding diseases. As 
longevity and extended healthspan can be linked to improved PQC a better 
understanding of the regulation and integration of proteostasis mechanisms is critical 
in our efforts to reduce the burden of age-associated diseases.  
The metabolic HP is implicated in the folding process of glycoproteins within 
the ER by producing the essential precursor molecule UDP-GlcNAc. It was shown 
only recently that the connection of the HP and PQC is, in fact, far deeper and more 
intricate than previously expected. GFAT-1 is a target of the UPR and, at the same 
time, GFAT-1 activation by gof mutations causes longevity by mildly inducing multiple 
pathways of the PN (Wang et al., 2014, Denzel et al., 2014). Whether GFAT-1 fulfills 
a specific role under stress conditions remains unknown. Furthermore, knowledge 
about the processes and downstream effectors mediating between GFAT-1 and PQC 
mechanisms is missing. Hence, I addressed the following three major aims and 
questions during my doctoral study: 
Aim 1: Is GFAT-1 expression regulated by environmental stress and does GFAT-1 
overexpression (OE) and HP activation influence stress resistance? 
Aim 2: What role might tissue-specific GFAT-1 OE play in C. elegans cell 
autonomous and cell non-autonomous PQC? 
Aim 3: What are the downstream effectors of GFAT-1 activation/OE responsible for 
improvement of PQC? 
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2.   RESULTS 
 
 
2.1   Regulation of GFAT-1 under stress 
 
As an essential component of a cell´s metabolism, the HP is constantly active 
to produce UDP-GlcNAc. Additionally, recent studies provided first evidence of HP 
regulation by ER stress and nutrient shortage (Wang et al., 2014, Chaveroux et al., 
2016, Moloughney et al., 2016). Up to now, there are, however, no comprehensive 
studies on the regulation of gfat-1 in response to diverse environmental challenges.  
In order to address this gap in knowledge, we exposed worms to different 
stress conditions and assessed gfat-1 mRNA and protein levels. Exposure to 30°C 
heat for 8 hours led to clearly elevated xbp-1 and xbp-1s mRNA levels, which served 
as marker for an activated UPRER. However, this treatment did not influence gfat-1 
mRNA levels. Likewise, induction of protein folding stress in the ER by tunicamycin 
slightly upregulated xbp-1 and xbp-1s but had no effect on gfat-1 transcript 
(Figure 8A). Furthermore, gfat-1 levels remained unchanged during starvation or high 
glucose treatment, although these conditions alter the availability of the gfat-1 
substrate fructose-6 phosphate. Moreover, induction of oxidative stress by paraquat 
or perturbations of the ER calcium homeostasis by thapsigargin did not influence 
gfat-1 mRNA amount (Figure 8B). Included in the assay are gst-4 as oxidative stress 
responsive gene and cdc-42 as second housekeeping gene and both serve as 
additional controls (Tawe et al., 1998, Leiers et al., 2003, Hoogewijs et al., 2008, 
Zhang et al., 2012) (Figure 8B). 
As no stress-induced changes in gfat-1 mRNA level were detected, we 
analyzed GFAT-1 protein expression using a translational reporter strain. Under 
standard growth conditions, GFAT-1 was mainly expressed in pharynx and seam 
cells of C. elegans and showed a smooth distribution pattern. Interestingly, ER stress 
caused by tunicamycin and thapsigargin led to a strong elevation of GFAT-1 protein, 
specifically in the worm intestine. An upregulation of GFAT-1 was also observed after 
heat, paraquat and high glucose treatment. In this case, pharynx and seam cells 
remained the tissues of highest expression, but a shift from smooth to a more 
granular and punctate expression pattern was observed (Figure 8C and 8D).  
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In mice, it was reported before that gfat-1 transcript levels respond to ER 
stress and xbp-1 splicing as consequence of UPRER activation (Wang et al., 2014). 
Although we could not detect a regulation of gfat-1 mRNA level by ER stress in 
C.	elegans, we further investigated the link between UPR signaling and HP flux. 
Figure 8. Regulation of protein level in response to stress. A. and B. Relative mRNA amount of 
worms exposed to stress conditions on NGM plates and OP50 for 8 h after culture on NGM plates with 
OP50 to late L4 stage, measured by qRT-PCR (A) or exposed to stress conditions in liquid culture with 
OP50 (B), shown is mean +SEM, expression normalized to ama-1, N=3, statistical analysis 2way 
ANOVA, Dunnett´s multiple comparisons test, *, p<0.05; **, p<0.01; ****, p<0.0001. C. Representative 
fluorescence images, gfat-1P::Flag::HA::CFP::gfat-1 worms cultured on NGM and OP50 to late L4 
stage, images after 14h stress exposure, worms cultured on NGM plates with OP50 without being 
submitted to stress served as control. D. Quantification of absolute pixel intensity (CFP signal) per 
worm area of gfat-1P::Flag::HA::CFP::gfat-1 strain, 10 worms per experiment, shown mean +SEM, 
N=3, *, p<0.05; **, p<0.01. Stress conditions were as follows: Heat 30°C, Tunicamycin 10 µg/ml, 
starvation in M9, Paraquat 100mM, Thapsigargin 5 µM, Glucose 2%. 
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There is a specific UPR element (UPRE) encoded in the mammalian gfat-1 promoter, 
which is missing in C. elegans. However, we could identify sequences similar to the 
ER stress response element (ERSE) and UPRE in the region upstream of the gfat-1 
open reading frame (ORF) (Yoshida et al., 1998, Roy and Lee, 1999, Wang et al., 
2000, Yamamoto et al., 2007) (Figure 9A). This observation could argue for a 
transcriptional regulation of gfat-1 by ER stress. In order to examine functional 
induction of the HP by the UPRER we made use of a genetic model overexpressing 
xbp-1s in nematode neurons. It was previously established that this tissue-specific 
OE is sufficient for a systemic UPR activation (Taylor and Dillin, 2013). Although we 
could measure an elevation of xbp-1s mRNA levels, we did, also in this system, not 
detect any change in gfat-1 mRNA expression consistent with our previous results 
(Figure 9B and 8A). Interestingly, neuron-specific xbp-1s OE resulted in a small but 
distinct accumulation of the HP end product UDP-GlcNAc in worms (Figure 9C). 
Altogether these observations suggest that GFAT-1 expression and tissue-
distribution may be regulated mainly through post-transcriptional mechanisms. 
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The observation that GFAT-1 expression and HP activity is induced by stress 
conditions led us to ask whether GFAT-1 fulfills a function in stress responses. 
Hence, we assessed mRNA levels of various detoxifying genes, namely superoxide 
dismutases (sod-1, sod-2, sod-3), glutathione-S transferase (gst-4) and catalases 
(ctl-1, ctl-2). These genes reportedly counteract oxidative stress and are, beyond 
that, implicated in modulating lifespan (Zhou et al., 2011). Increased HP flux by 
Figure 9. Activation of the HP as response to ER stress. A. Sequences resembling the ER stress 
response element (ERSE) consensus sequence CCAAT-N9-CCACG and the UPR element (UPRE) 
consensus sequence TGACGTGG/A upstream of C. elegans gfat-1 ORF. B. Relative mRNA quantity in 
late L4 larvae of N2 control and rap-3P::xbp-1s strain as measured by qRT-PCR, shown is mean 
+SEM, expression normalized to ama-1, N=3, 2way ANOVA, Sidak´s multiple comparisons test, 
***, p<0.001 C. LC-MS analysis of UDP-HexNAc levels, shown is mean +SEM, N=9, unpaired t-test, 
*, p<0.05. 
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gfat-1 gof did not result in an increased transcript level of any of the tested genes, 
with the exception of a slight elevation of gst-4 mRNA in gfat-1 gof (dh784), the strain 
with particularly high UDP-GlcNAc levels (Denzel et al., 2014) (Figure 10A). In 
agreement with the overall unchanged expression of genes counteracting oxidative 
stress, we did not observe a heightened resistance of gfat-1 gof worms against acute 
paraquat treatment. As positive control daf-2 mutants showed an increased 
survivorship in this assay (Figure 10B). We, furthermore, induced protein unfolding, 
misfolding and aggregation in C. elegans by heat stress and scored the worms ability 
to recover. While daf-2 mutants did, again, exhibit augmented stress resistance, 
gfat-1 gof mutants were not distinguishable from the wildtype controls (Figure 10C). 
Tunicamycin prevents N-linked protein glycosylation in the ER and thereby 
causes protein folding stress (Elbein, 1987). Originally, gfat-1 gof mutations were 
identified in a forward genetic screen selecting for worms resistant to this drug 
(Denzel et al., 2014). Here, we confirmed the exceptional resistance to tunicamycin 
with one representative gfat-1 gof line over a broad range of drug concentrations. 
The striking difference between controls and gfat-1 gof worms becomes especially 
apparent at 10 µg/ml tunicamycin: while no control animal developed from egg to L4 
larvae, C. elegans harboring the gfat-1 gof mutation were completely resistant and 
grew from egg into adults within 4 days (Figure 10D).  
From the described experiments we concluded that the amount of GFAT-1 
protein is upregulated in C. elegans by a multitude of distinct stress conditions. 
Despite the responsiveness of the HP to stress, elevated UDP-GlcNAc levels do not 
seem to be involved in detoxification and general stress resistance, but specifically 
protect from tunicamycin toxicity. 
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Figure 10. Tunicamycin resistance, but not general stress resistance conferred by gfat-1 gof. 
A. qRT-PCR of late L4 larvae of N2 control and gfat-1 gof strains, shown is mean +SEM, expression 
normalized to ama-1, N=3, 2way ANOVA, Dunnett´s multiple comparisons test, *, p<0.05 B. Oxidative 
stress/ Paraquat resistance, late L4 larvae were transferred to NGM plates with OP50 containing 50mM 
Paraquat, scored was survival after 24h, 60 worms per strain, shown is mean +SEM, N=3, unpaired 
t-test, *, p<0.05 C. Heat Recovery, worms switched to 33°C at day1 adult stage for 6h, rescued to 
20°C, and survival scored after 48h, 75 worms per strain, N≥3, unpaired t-test, *, p<0.05 
D. Development of eggs to L4 or adult stage after 4 days on 0, 4, 6, 8 or 10 µg/ml Tunicamycin, shown 
is  mean +SEM, N=3, 2way ANOVA, Sidak´s multiple comparisons test, ****, p<0.0001. 
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2.2   Transcriptome and proteome of gfat-1 gof mutants 
 
The increased production of UDP-GlcNAc by gfat-1 gof mutations induces 
PQC pathways and prolongs life in C. elegans (Denzel et al., 2014). The molecular 
mechanism that lead to these benefits are, however, still completely unknown. To get 
an unbiased view of potential changes resulting from HP activation and to address 
this open question we performed transcriptomic and proteomic analyses in gfat-1 gof 
worms. Surprisingly, there were only very few genes with mildly changed 
transcriptional profile between gfat-1 gof and wildtype control (Figure 11A). The 
upregulation in mRNA expression of these few candidate genes was confirmed by 
quantitative reverse transcription PCR (qRT-PCR) (done by Martin Denzel, data not 
shown) but was not detectable on protein level. Stable isotope labeling with amino 
acids in (cell) culture (SILAC) was used for direct proteomic comparison of gfat-1 gof 
mutants with wildtype worms. With this technique we did not identify any protein that 
was expressed differentially at a significant level (Figure 11B). We performed forward 
and reverse labeling growing gfat-1 gof and control worms on bacteria incubated with 
heavy 13C6/15N2 or light lysine and pooled cross-labeled samples for analysis. The 
compiled analysis of all reverse labeling experiments did not generate any candidate 
responsible for the gfat-1 gof induced benefits, as not a single protein was 
significantly (p<0.05) enriched or decreased in either gfat-1 gof strain compared to 
controls (Figure 11B). The same observation was made analyzing all forward 
labeling experiments and even combining forward and reverse labeling experiments 
(data not shown), which increases statistical power by elevating the number of 
independent repeats and eliminates effects of the labeling itself.  
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Among the very few genes that were transcriptionally mildly induced in gfat-1 
gof mutants, we found the MAP kinase pmk-1 to be the most interesting candidate. If 
worms are challenged by oxidative stress or pathogens, pmk-1 becomes activated by 
phosphorylation and in turn promotes skn-1 (Nrf2 in mammals) nuclear localization 
(Inoue et al., 2005). As a result, skn-1 mounts defense mechanisms, induces the 
UPRER, and promotes longevity (An and Blackwell, 2003, Tullet et al., 2008, Hoeven 
et al., 2011, Glover-Cutter et al., 2013). These downstream effects of pmk-1 
 
 
Figure 11. No major transcriptomic or proteomic changes induced by gfat-1 gof mutations. 
A. Regulated genes in day 1 adult gfat-1 gof (dh468) relative to wildtype control identified by 
RNAsequencing, experiment performed by Martin Denzel. B. No significant changes in protein 
expression detected by SILAC and MS analysis between gfat-1 gof mutants and wildtype controls at 
day 1 of adulthood, shown are compiled results of independent biological replicates of reverse labeling 
(control strain grown on bacteria that incorporated heavy 13C6/15N2 lysine), N=3 for gfat-1 gof (dh468) 
and gfat-1 gof (dh784), N=2 for gfat-1 gof (dh785), logFC, log(fold change) of mutant/control. 
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activation partially overlap with the observed phenotype of gfat-1 gof mutants and we 
wondered whether the pmk-1–skn-1 signaling axis is hyperactive in gfat-1 gof worms 
and might be responsible for the improved proteostasis and longevity (Denzel et al., 
2014). 
To test this hypothesis, we assessed PMK-1 phosphorylation as proxy for 
PMK-1 activity in gfat-1 gof worms compared to controls. Interestingly, we observed 
a considerable accumulation of phosphorylated PMK-1 (P-PMK-1) in two of the three 
analyzed gfat-1 gof mutants (Figure 12A). However, there was a strong variability 
between biological replicates and despite the strong increment in P-PMK-1 in some 
of the experiments, the increase did not reach significance (Figure 12B). The 
expression pattern and signal strength of total PMK-1 was comparable between 
wildtype control and gfat-1 gof strains (Figure 12C and 12D). As a second readout for 
PMK-1 activation and its downstream signaling, we measured the transcript levels of 
the putative immune factors C17H12.8, K08D8.5 and T24B8.5. These peptides are 
known to be robustly elevated by the innate immune response and active pmk-1 
(Troemel et al., 2006, Shivers et al., 2010). We found their mRNA level to be 
unaltered by gfat-1 gof mutations (Figure 12E).  
To test the implication of PMK-1 in gfat-1 gof induced downstream benefits by 
another method, we studied the effect of complete pmk-1 deletion on the lifespan of 
gfat-1 gof worms. Loss of pmk-1 decreased the lifespan of gfat-1 gof (dh468) and the 
wildtype control in a similar manner (Figure 12F). However, this experiment was 
performed only once and should be repeated to represent conclusive evidence. 
Nevertheless, it is likely that pmk-1 deletion leads to a reduced general fitness of 
C. elegans and there are no indications that this is an effect specific for gfat-1 gof 
mutants. Accordingly, no conclusions can be drawn to whether the gfat-1 gof induced 
lifespan extension is dependent on pmk-1.  
Overall, we established that the level of PMK-1 phosphorylation is increased 
in the presence of gfat-1 gof mutations but is enormously variable between different 
gfat-1 gof lines and even biological replicates. Beyond that, PMK-1 activation does 
not correlate with HP activation and the amount of accumulated UDP-GlcNAc 
(highest level measured in gfat-1 gof (dh784) (Denzel et al., 2014)). We concluded 
that PMK-1 is unlikely to mediate the benefits of HP activation on PQC and lifespan. 
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Figure 12. Role of MAPK PMK-1 signaling downstream of gfat-1 gof. A. Representative Western 
blot from young adult worms. B. Expression of P-PMK-1 relative to Actin and normalized to control 
animals. Quantification of Western Blots from young adults (like in A.), N=4, unpaired t-test, 
****, p<0.0001 C. Representative images of PMK-1::GFP expression in day 1 adult pmk-1P::pmk-1::gfp 
and pmk-1P::pmk-1::gfp, gfat-1 gof (dh785) worms D. Expression of total PMK-1 in gfat-1 gof relative to 
control animals. Quantification from images of pmk-1P::pmk-1::gfp strain (like in C.). Shown is mean 
+SEM, N≥3, 1way ANOVA, Dunnett´s multiple comparisons test, no significant difference. E. Relative 
mRNA quantity in late L4 larvae of N2 control and gfat-1 gof strains as measured by qRT-PCR, shown 
is mean +SEM, expression normalized to ama-1, N=3, 2way ANOVA, Dunnett´s multiple comparisons 
test, no significant difference. E. Kaplan-Meier survival curves of controls and gfat-1 gof (dh468) worms, 
and the influence of pmk-1 deletion in both backgrounds, N=1. 
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2.3   Tissue-specific gfat-1 OE 
 
To better understand how modulating gfat-1 in C. elegans leads to improved 
protein homeostasis we set out to dissect the role of gfat-1 in a tissue-specific 
manner and to address the question of cell autonomy and cell non-autonomy. For 
that purpose, we molecularly cloned vectors enabling the overexpression of gfat-1 
under the control of the gfat-1 endogenous promoter (done by Martin Denzel (Denzel 
et al., 2014)), a muscle-specific promoter (myo-3P), a pan-neuronal promoter 
(rgef-1P) and an intestine-specific promoter (ges-1). We inserted a Flag- and HA-tag 
as well as a cyan fluorescent protein (CFP) at the 5´end of the gfat-1 ORF to be able 
to detect the transgene in biochemical assays and under the microscope 
(Figure 13A). Under its endogenous promoter GFAT-1 was observed to be most 
highly expressed in pharynx and seem cells. The transgenic lines myo-3P::gfat-1 and 
rgef-1P::gfat-1 showed the expected expression pattern: the GFAT-1::CFP signal 
was detected throughout the body wall muscle in the myo-3P::gfat-1 lines and in 
head-and tail ganglia as well as ventral and dorsal nerve chords in the rgef-1P::gfat-1 
lines (Figure 13B). Unfortunately, the multiple transgenic C. elegans lines generated 
by microinjection of the ges-1P::gfat-1 OE construct all exhibited only patchy CFP 
expression, had a very low plasmid transmission rate (<10%), showed slowed 
development and decreased body size (data not shown). Overall, worms with 
intestinal GFAT-1 OE appeared unfit and were excluded from all further experiments. 
For the remaining transgenic lines, the expression of GFAT-1 fusion protein was 
confirmed by Western blot analysis. The level of expression differed strongly 
between the lines with relatively low expression in both neuronal OE lines and 
considerably strong expression in myo-3P::gfat-1 (2) and particularly gfat-1P::gfat-1 
(Figure 13C). In the two strains with highest GFAT-1 transgene expression we 
measured UDP-HexNAc levels to compare their degree of HP activation to wildtype 
controls and gfat-1 gof worms. Interestingly, the UDP-HexNAc level was strongly 
elevated by the gfat-1 gof mutation but remained completely unaltered by GFAT-1 
OE (Figure 13D). This suggests that wildtype GFAT-1 is efficiently feedback-inhibited 
even if its amount is strongly increased.  
RESULTS 
62 
 
Figure 13. Tissue-specific overexpression of gfat-1. A. Cloning scheme of gfat-1 OE constructs 
under tissue-specific promoters; gfat-1P for endogenous OE, myo-3P for muscle-specific OE, rgef-1P 
for pan-neuronal OE, ges-1P for intestine-specific OE. B. Representative images of different gfat-1 OE 
strains at late L4 larval stage, DIC image (left panel) and overlay of TexasRed (expression of 
pharyngeal co-injection marker) and CFP channel (GFAT-1 expression) (right panel) are shown, arrows 
indicate tissue of transgenic GFAT-1 expression C. Representative Western blot from L4 larvae shows 
transgene expression at expected molecular weight. D. LC-MS analysis of UDP-HexNAc, shown is 
mean +SEM, N=5, 1way ANOVA, Tukey´s multiple comparisons test, ****, p<0.0001. E. Development 
of C. elegans on 0, 4, 6, 8 or 10 µg/ml Tunicamycin, animals that reach L4 larval or adult stage from 
egg after 4 days were designated the resistant fraction, shown is mean +SEM, N=4, 2way ANOVA, 
Dunnett´s multiple comparisons test, ****, p<0.0001. 
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As an alternative readout for functional HP activation, we used the same 
C. elegans lines to assess tunicamycin resistance, which directly corresponds to 
UDP-GlcNAc production (Denzel et al., 2014). While, in wildtype controls, the ability 
to develop from eggs into mature worms is reduced by roughly 60% at the lowest 
tested tunicamycin concentration and entirely abolished at higher concentrations, 
gfat-1 gof mutants are completely protected (Denzel et al., 2014). Overexpression of 
gfat-1 under its endogenous promoter also rendered animals strikingly resistant to 
tunicamycin, which demonstrates that our transgene is a functional enzyme although 
we did not detect changes in steady state UDP-GlcNAc levels. Contrarily, in this 
assay, neither neuronal nor muscular gfat-1 OE strains were protected from 
tunicamycin, which argues that these are likely not the relevant tissues to confer 
resistance (Figure 13E). 
Given the functionality of the transgene, we asked whether gfat-1 OE could 
stimulate PQC similar to gfat-1 gof. To this end, we measured the autophagic flux in 
a transgenic reporter strain expressing GFP-tagged LGG-1. LGG-1::GFP associates 
with inner and outer membrane of the forming phagophore. Upon membrane closure, 
the autophagosomes fuses with lysosomes to form the autolysosome. While the 
LGG-1::GFP in the outer membrane is recycled to the cytosol for further use, the 
LGG-1 attached to the inner membrane leaflet is quickly degraded by the lysosomal 
proteases. GFP is more resistant to proteolytic cleavage and is only degraded at a 
low pH (Figure 14A). Hence, it stays intact for an extended period before it is broken 
down as well. The ratio of free GFP (after cleavage and degradation of LGG-1) to the 
sum of total GFP (free GFP and LGG-1::GFP) can be assessed by Western Blot 
analysis and be considered to indicate the autophagic activity or the autophagic flux 
(Ni et al., 2011, Klionsky et al., 2016). When we used this method, we noted an 
increase in the intensity of the free GFP band in gfat-1 gof as well as gfat-1 OE 
worms compared to controls, suggesting an enhanced autophagic flux in the 
transgenic strains (Figure 14B). This trend was observed in multiple experiments and 
the boost of autophagic flux by gfat-1 gof was, in its extent, comparable to the one 
induced by neuronal as well as muscular gfat-1 OE (Figure 14C). These results 
suggest that modulating GFAT-1 activity and abundance might be separable 
processes: gfat-1 gof probably enhances PQC mechanisms through the overall 
enhanced production of UDP-GlcNAc, while the abundance of the GFAT-1 protein 
might serve a distinct function as no accumulation of the metabolite was measured in 
muscular gfat-1 OE animals under standard growth conditions. We set out to tackle 
the interesting question whether the presence of GFAT-1 protein itself could affect 
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PQC without inducing accumulation of the HP end product and to better understand 
the molecular mechanism underlying the elevation of PQC by gfat-1 OE.  
 
 
 
 
To identify genes that would mediate protein homeostasis downstream of 
GFAT-1, we aimed to establish an assay with a strong and very clear readout for the 
positive effect of gfat-1 OE on PQC. This would allow us to test the requirement of 
multiple candidate genes in the gfat-1 OE induced PQC improvement. A well-
 
Figure 14. Induction of autophagy by gfat-1 gof and OE. A. Scheme of autophagic degradation of 
LGG-1::GFP along with cargo (based on	 Djeddi et al., 2012). LGG-1::GFP binds to inner and outer 
membrane leaflet of the nascent phagophore, which closes to form an autophagosomes. After fusion 
with lysosomes, LGG-1::GFP attached to the outer membrane of the autolysosome is recycled for 
further use, while LGG-1::GFP linked to the inner membrane is degraded by lysosomal proteases. GFP 
is stable for a short period of time before it is degraded at low pH. B. Representative Western blot from 
young adult worms. C. Quantification of autophagic flux measured as free GFP/ total GFP	(LGG-1::GFP 
+ free GFP) in day 1 adults, normalized to control (indicated by dotted line at 100%), Box extends from 
25th to 75th percentile with the line indicating the median, whiskers extend from the minimal to maximal 
measured values, N=4, 1way ANOVA, Dunnett´s multiple comparisons test, **, p<0.01. 
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established model for proteotoxicity in C. elegans is the expression of a fluorophore 
fused to stretches of polyglutamine repeats (polyQ) of distinct length and in different 
tissues (Morley et al., 2002, Brignull et al., 2006, Mohri-Shiomi and Garsin, 2008). 
The abnormal extension of polyQ repeats within certain proteins was identified as 
cause of several severe human diseases, such as spinocerebellar ataxia and HD (La 
Spada et al., 1991, Di Prospero and Fischbeck, 2005). The C. elegans disease 
model strains reflect certain characteristics of the human protein folding diseases like 
accumulation of protein aggregates and progressive paralysis. We therefore 
analyzed the effect of gfat-1 OE on disease phenotypes in some of these model 
strains. 
When stretches of 44 glutamines fused to YFP were expressed in the 
nematode´s intestine, the signal was smoothly distributed in young worms but 
incrementally aggregated from mid-age onward. Surprisingly, we noted an 
appearance of polyQ aggregates already at an earlier stage in gfat-1 OE strains 
(Figure 15A). While the OE of gfat-1 under it´s endogenous promoter does not affect 
the polyQ aggregation in the intestine compared to controls, we detected a slight 
trend for enhanced polyQ aggregation in neuronal gfat-1 OE strains and significantly 
increased polyQ aggregation in muscular gfat-1 OE worms at day 8 of adulthood 
(Figure 15B). This might indicate that gfat-1 OE could, indeed, affect PQC 
mechanisms in a tissue-specific manner. While it might be overall positive and 
beneficial in certain tissues, it could be detrimental in other tissues. Alternatively, the 
formation of aggregates from disease proteins might be harmful in some tissues but 
could be protective under specific circumstances as well (Ross and Poirier, 2005, 
Carija et al., 2017). In any case, the observed induction of polyQ aggregate 
accumulation in the worm gut by OE of gfat-1 in muscle suggests cross-tissue 
communication and a potential compensatory mechanism. 
To investigate the influence of gfat-1 OE on the general health of worms with 
neuronal polyQ expression model we monitored the nematodes´ lifespan. 
Interestingly, the OE of gfat-1 also seems to be mildly harmful in this proteotoxicity 
model, both, in a cell autonomous manner as well as in a cell non-autonomous 
manner: The lifespan was equally shortened by gfat-1 OE under the gfat-1 
endogenous promoter, a muscle-specific and a pan-neuronal promoter (Figure 15C). 
Again, we must conclude that gfat-1 OE does not confer a general resistance to 
proteotoxic diseases and, to the contrary, can even exacerbate polyQ toxicity. 
These findings are in contrast with the expectation that gfat-1 OE, like gfat-1 
gof, would improve PQC and decrease the harmful effects of aggregation prone 
proteins. However, it was our goal to establish an assay, in which gfat-1 OE was 
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distinguishable from controls by a large margin to understand the downstream 
actions of gfat-1 OE leading to amelioration or deterioration of proteostasis. Hence, 
we did not further analyze the phenotype of these models but focused on the 
identification of a suitable model. 
 
 
 
 
2.4   Cell-autonomous benefit of muscle-specific gfat-1 OE on PQC 
 
Although we did not detect any benefit of tissue-specific gfat-1 OE on 
proteostasis and general health in models of protein folding stress and aggregation in 
intestine and neurons, we continued to investigate the role of gfat-1 in muscle 
integrity. Muscle polyQ expression leads to polyQ aggregation and progressive 
paralysis of worms with age (Morley et al., 2002). As this phenotype is specific for 
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Figure 15. Adverse effects of gfat-1 OE in models of intestinal and neuronal proteotoxicity. 
A. Representative images of intestinal polyQ model strain (vha-6P::Q44::YFP) at day 8 of adulthood in 
presence and absence of gfat-1 OE. B. Quantification of images (as in A.) taken of vha-6P::Q44::YFP 
strain at day 8 of adulthood, N≥2, 10 to 30 worms per experiment, 1way ANOVA, Dunnett´s multiple 
comparisons test, *, p<0.05. C. Lifespan analysis of neuronal polyQ model strain (F25B3.3P::Q86::YFP) 
in presence and absence of gfat-1 OE, 75 worms/ strain, N=1. 
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muscle function, easily measurable, and physiologically relevant, the model provides 
an ideal readout for polyQ toxicity. 
First, we studied the effect of gfat-1 OE on visible polyQ aggregation in a 
disease strain with a stretch of 40 glutamines fused to YFP expressed under the 
control of the muscle-specific unc-54 promoter. In this strain, the transgene rapidly 
formed aggregates already in larval stages. This process was slowed down 
considerably with concurrent muscular gfat-1 OE (Figure 16A). By contrast, the OE 
of gfat-1 under the gfat-1 or a neuronal promoter was not beneficial in this assay, 
leaving the load of polyQ aggregates unchanged compared to controls (Figure 16B). 
This observation could be corroborated by a biochemical approach. We extracted 
protein from day 1 adult worms and separated the polyQ::YFP fusion protein in SDS 
soluble and SDS insoluble fraction. It is commonly believed that the toxic form of 
many aggregation prone proteins like polyQ containing proteins and amyloid species 
is the SDS resistant oligomer (Walsh et al., 2002, Takahashi et al., 2008, Weiss et 
al., 2008, Wong et al., 2008). Indeed, we detected significantly less SDS resistant 
Q40::YFP when expression of GFAT-1 in muscle was high. The amount of non-toxic, 
SDS soluble monomers and small oligomers of Q40 was found to be much more 
abundant than the SDS insoluble fraction in all tested conditions. Additionally, gfat-1 
OE in general seemed to slightly increase the amount of soluble polyQ fusion protein 
(Figure 16C).  
As the toxicity of the transgene in the unc-54P::Q40::YFP strain set in already 
in C. elegans larval stages, we chose to use a model which expressed a shorter 
polyQ stretch in muscle tissue for further analysis. Using the unc-54P::Q35::YFP 
transgenic line, we expected a delayed onset and slowed down progression of 
toxicity, which would better reflect the hallmarks of actual polyQ diseases and would 
hopefully allow the observation of more subtle changes of aggregation and disease 
phenotype.  
Indeed, multiple and clear polyQ aggregates were observed in the 
unc-54P::Q35::YFP model starting only at day 4 of adulthood. Like in the Q40 model, 
the measurable benefit of gfat-1 OE was strictly cell autonomous: OE of gfat-1 in 
muscle massively decreased the load of aggregates, while OE of gfat-1 under its 
endogenous or a pan-neuronal promoter did not ameliorate polyQ aggregation 
(Figure 17A and 17B). 
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Importantly, we detected a clear mitigation of a further major disease 
characteristic by gfat-1 OE: While, in a swimming assay, Q35 expressing control 
animals were completely paralyzed at day 10 of adulthood, simultaneous gfat-1 OE 
in muscle greatly preserved the worms´ motility. Interestingly, also the gfat-1 OE 
under its endogenous promoter was mildly beneficial in this assay, although there 
was no significant influence on visible polyQ aggregation (Figure 17B and 17C). 
To rule out the possibility that the improved muscle function merely stems 
from a decreased disease transgene expression, we measured the total expression 
of Q35 in presence and absence of gfat-1 OE as important control. As we did not 
observe a reduction in overall Q35 expression by increasing GFAT-1 levels, we 
concluded that gfat-1 OE is indeed counteracting polyQ toxicity in muscle. This effect 
was particularly large when polyQ and gfat-1 were both expressed alongside in the 
Figure 16. Decreased polyQ protein aggregation in muscle by muscular gfat-1 OE. 
A. Representative images of late L4 larvae of the unc-54P::Q40::YFP strain. B. Quantification 
of Q40::YFP aggregates at late L4 stage in unc-54P::Q40::YFP background and gfat-1 OE 
under endogenous (gfat-1P), muscle-specific (myo-3P) (as in A.) and pan-neuronal promoter 
(rgef-1P), shown is the compiled mean +SEM of N=3 experiments, 10 worms per condition, 
1way ANOVA, ****, p<0.0001. C. Representative Western blot of SDS-soluble and SDS-
insoluble Q40::YFP fractions of day 1 adult unc-54P::Q40::YFP animals in presence and 
absence of tissue-specific gfat-1 OE, background, N=2. 
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body wall muscle and the amount of muscular GFAT-1 positively correlated with the 
extent of motility improvement (Figure 17D and 13C). 
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Figure 17. Cell-autonomous improvement of polyQ muscle toxicity by gfat-1 OE. 
A.	Representative images of unc-54P::Q35::YFP animals in presence and absence of muscular gfat-1 
OE at day 4 of adulthood. B. Quantification of Q35::YFP aggregates at day 4 of adulthood ( like in A.), 
shown is mean +SD of 10 worms per condition from representative experiment, , N≥3 for 
myo-3P::gfat-1 and control, N=1 for gfat-1P::gfat-1 and rgef-1P::gfat-1, 1way ANOVA, Dunnett´s 
multiple comparisons test, ****, p<0.0001. C. Motility of gfat-1 OE strains in unc-54P::Q35::YFP 
background at day 10 of adulthood as measured by swimming assay, 15 worms per condition, line and 
error bars indicate mean ± SD of one representative experiment, N≥3, only for rgef-1P::gfat-1, N=1, 
1way ANOVA, Tukey´s multiple comparisons test, *, p<0.05, ***, p<0.001. D. Representative Western 
blot of total Q35::YFP in day 1 adults, N=2. 
RESULTS 
70 
We, furthermore, wanted to exclude the possibility that the observed benefit 
on polyQ disease by gfat-1 OE is due to unspecific side effects of expressing any 
transgene in the worm muscle. To this end we knocked down gfat-1 expression by 
RNAi feeding levels in C. elegans with muscular gfat-1 OE and evaluated motility in a 
swimming assay. Reducing gfat-1 levels led to an apparent reduction in motility 
compared to controls treated with luciferase RNAi. Although gfat-1 RNAi did not 
reverse the improved swimming ability of gfat-1 OE worms to complete paralysis, it is 
safe to assume that PQC improvement is specific to gfat-1 OE and no experimental 
artifact (Figure 18A).  
Next, we wondered whether the benefit of gfat-1 OE on the health of polyQ 
expressing worms was dependent on activity of the HP and production of 
UDP-GlcNAc. To address this, we, in this assay, evaluated the consequences of 
RNAi against gna-2, the second enzyme of the HP. Similar to gfat-1 knock down, 
gna-2 knock down markedly reduced the motility of muscular gfat-1 OE strains 
(Figure 18B). To check the knock down efficiency and to clarify whether gna-2 knock 
down would directly impact on GFAT-1 levels and thereby show its strong effect, we 
measured gna-2 transcript levels and GFAT-1 protein amount in response to RNAi. 
Feeding of gna-2 RNAi dramatically lowered the mRNA level of gna-2 to about 20% 
of the luciferase RNAi reference in control and gfat-1 gof strain, whereas gfat-1 
mRNA levels were not affected. The second housekeeping gene cdc-42 was 
included as an additional control of the experiment (Figure 18C). We monitored the 
knock down efficiency of gfat-1 RNAi at the protein level as well by using our 
transgenic gfat-1 OE strains. Feeding of gfat-1 RNAi resulted in a mild reduction of 
GFAT-1 protein. The RNAi knock down of gna-2 did not decrease GFAT-1 protein 
(Figure 18D and 18E). In conclusion, gna-2 knock down does not seem to destabilize 
GFAT-1 protein, nor to induce a compensatory upregulation of GFAT-1. 
The observation that gfat-1 as well as gna-2 knock down led to a reduction of 
the gfat-1 OE induced motility improvement in polyQ transgenic worms indicates that 
the flux through the HP and the production of UDP-GlcNAc plays a central role in 
decreasing proteotoxicity. Hence, we measured the effect of luciferase, gfat-1 or 
gna-2 RNAi on the level of UDP-GlcNAc by LC-MS. We included control worms as 
well as gfat-1 gof worm strain in the analysis. UDP-HexNAc levels are elevated more 
than tenfold in gfat-1 gof (dh784) compared to controls, which is clearly above the 
concentrations essential for survival. Furthermore, the detection method was very 
sensitive in the range of UDP-HexNAc present in samples prepared from the gfat-1 
gof strain and consequently, we expected to even identify small changes in HP 
product levels. Surprisingly, neither gfat-1, nor gna-2 knock down decreased the 
RESULTS 
71 
steady-state concentration of UDP-HexNAc in wildtype controls or gfat-1 gof worms 
(Figure 18F). 
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These findings led us to believe that the mechanism through which gfat-1 OE 
amended polyQ toxicity in muscle was not only tracing back to altered UDP-GlcNAc 
levels but they suggested, again, that there might be a secondary function of GFAT-1 
protein affecting PQC. 
To test this hypothesis, we generated C. elegans strains that express an 
enzymatic dead version of GFAT-1 under a muscle-specific promoter (strains 
generated and experiments performed by Vignesh Karthikaisamy under my 
supervision). For this purpose we introduced a mutation in the isomerase domain of 
the protein, which transformed lysine (K) 720 of C. elegans gfat-1 to an arginine (R). 
It is known that the corresponding mutation of the conserved residue in E. coli and 
human gfat-1 leads to only negligible enzymatic activity (Mouilleron et al., 2011, 
Sabine Ruegenberg, personal communication) (Figure 19A). The intimate interaction 
of the lysine residue with the GFAT-1 substrate Fruc-6-P becomes obvious when 
studying the structure of the enzyme dimer with associated substrate. Even the 
conservative exchange of positively charged lysine (K) with equally charged, but 
bulkier arginine (R) seems likely to strongly interfere with Fruc-6-P binding, while 
simultaneously leaving the protein structure intact (Figure 19B). As the amounts of 
transgenic wildtype GFAT-1 and enzymatic dead GFAT-1 expressed in our different 
muscle-specific OE lines was very similar, we could directly compare these 
C. elegans lines in further experiments (Figure 19C). We analyzed the functionality of 
transgenic GFAT-1 in the gfat-1K720R strains by testing tunicamycin resistance, 
which can directly be correlated to UDP-GlcNAc production (Denzel et al., 2014). 
Figure 18. Improved motility in polyQ model by gfat-1 OE dependent on HP enzyme 
levels but not HP product. A. Motility of muscular gfat-1 OE in unc-54P::Q35::YFP 
background at day 10 of adulthood when grown on luciferase or gfat-1 RNAi from early L4 
stage onward, 15 worms per condition, line and error bars indicate mean ± SD, N=2, same 
trend was observed at day 8 of adulthood, 1way ANOVA, Bonferroni´s multiple comparisons 
test, **, p<0.01, ****, p<0.0001. B. as in (A.) but 20 worms per condition, line and error bars 
indicate mean ± SD of one representative experiment, N=2, same trend was observed at day 
8 of adulthood), 1way ANOVA, Bonferroni´s multiple comparisons test, **, p<0.01, 
****,	p<0.0001. C. Relative mRNA amount in day 1 adult worms, grown on RNAi from egg 
onwards as measured by qRT-PCR, shown is mean +SEM, values normalized to ama-1, 
N=3, 2way ANOVA, Tukey´s multiple comparisons test, ****, p<0.0001. D. Representative 
Western blot of GFAT-1::CFP and actin loading control in day 1 adult gfat-1 OE strains after 
RNAi treatment from egg onward. E. Quantification of GFAT-1::CFP expression in day 1 adult 
gfat-1 OE strains after gfat-1 or gna-2 RNAi treatment (as in D.), shown is mean +SEM, N=3, 
2way ANOVA, Tukey´s multiple comparisons test, *, p<0.05. F. LC-MS analysis of 
UDP-HexNAc levels in day 1 adult gfat-1 gof and control animals after gfat-1 or gna-2 RNAi 
treatment from egg onward, shown is mean +SEM, N=4, 2way ANOVA, Tukey´s multiple 
comparisons test, **, p<0.01. 
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Control animals were included as sensitive reference and animals with gfat-1 OE 
under the endogenous promoter as resistant reference. While muscle-specific OE of 
wildtype gfat-1 rendered animals mildly resistant to low levels of tunicamycin, 
C. elegans overexpressing enzymatic dead gfat-1 in muscle were undistinguishable 
from sensitive controls (Figure 19D). This observation confirmed the 
myo-3P::gfat-1K720R strains to be unable to produce higher UDP-GlcNAc levels as 
controls and consequently proved GFAT-1K720R as catalytically inactive enzyme. 
Strikingly, C. elegans strains that overexpress this enzymatic dead version of 
GFAT-1 under a muscle-specific promoter are still somewhat protected from the 
detrimental effects of polyQ aggregation. When we tested the motility of aged 
animals in a swimming assay, myo-3P::gfat-1K720R worms performed significantly 
better than controls. Although animals with OE of functional GFAT-1 enzyme in 
muscle were still clearly healthier and more motile, with about three times more 
swimming motions observed, we conclude that GFAT-1 protein itself counteracts 
polyQ toxicity in muscle (Figure 19E). And while the enzymatic function of GFAT-1 is 
definitively involved in improving PQC, GFAT-1 seems to, indeed, fulfill a dual role in 
this context.  
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Figure 19. Mildly improved motility in polyQ model by OE of enzymatic dead gfat-1. A. Alignment 
of the gfat-1 C-terminus from different species with conserved catalytic lysine residue E. coli K603, 
corresponding to C. elegans K720, alignment produced using ENDscript 2 {Robert:2014fy}. B. 
Molecular structure of E. coli GFAT-1 homodimer (monomers in grey and blue) with bound substrate 
Fruc-6-P (pink), highlighted is lysine 603 (green), figure constructed with PyMOL using pdb code 4AMV. 
C. Representative Western blot of day 1 adult controls and worms expressing functional and enzymatic 
dead GFAT-1 (gfat-1K720R) under a muscle-specific promoter, N=3 D. Development of C. elegans 
strains on 0, 4, or 6 µg/ml Tunicamycin, animals that reach L4 larval or adult stage from egg after 4 
days were designated the resistant fraction, Control animals were included as sensitive strain and 
gfat-1P::gfat-1 as resistant control, shown is mean +SEM, N=3, 2way ANOVA, Dunnett´s multiple 
comparisons test, ****, p<0.0001. E. Motility of muscular gfat-1 and gfat-1K720R OE strains in 
unc-54P::Q35::YFP background at day 8 of adulthood as measured by swimming assay, 10 worms per 
condition, line and error bars indicate mean ± SD of one representative experiment, N=3, 1way 
ANOVA, Tukey´s multiple comparisons test, ****, p<0.0001. All experiments for Figure 19 C, 19 D and 
19 E were performed by Vignesh Karthikaisamy under my supervision. 
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2.5   Physical interaction partners of GFAT-1 
 
GFAT-1 functions as an enzyme in the HP to generate the essential molecule 
UDP-GlcNAc. However, our results suggest that, additionally, GFAT-1 can 
ameliorate proteotoxicity in muscle independently of UDP-GlcNAc production. To 
gain a full picture of the possible mode of action by which gfat-1 OE leads to 
improved PQC, we set out to identify physical interaction partners of GFAT-1 in 
C. elegans. We generated all gfat-1 OE strains with Flag and HA peptide as well as 
CFP at the protein´s N-terminus. This allowed co-immunoprecipitation (IP) of GFAT-1 
with associated proteins from worm lysates. To minimize false positive interaction 
partners, we included the gfat-1P::Flag::HA::CFP strain lacking the gfat-1 ORF as 
reference. Both transgenic proteins were strongly bound by Flag antibody and only a 
very small fraction of the apparently less firmly associated Flag::HA::CFP control 
protein was detected in the flow-trough (FT) fraction. Incubation with Flag peptide 
effectively replaced GFAT-1 fusion protein control protein in antibody binding and 
there was a high abundance of both proteins in the eluate fraction, while no 
contamination with tubulin was observed (Figure 20A). The unspecific identification 
of proteins in the different IP fractions by silver staining confirmed the feasibility of 
the GFAT-1 co-IP: the majority of proteins was successfully depleted after the IP and 
only a limited number of bands was visible in the eluate fraction from lysate of gfat-1 
OE and control worms. As this number was higher after pull down with GFAT-1 
fusion protein, it suggested that specific interaction partners of GFAT-1 could be 
identified by our approach (Figure 20B).  
MS analysis of the eluate and comparison between both strains could, 
indeed, determine a set of GFAT-1 binding partners with false discovery rates 
(FDRs) of 0.001 or 0.01. Although GFAT-1 itself was clearly enriched in the IP eluate 
from the gfat-1 OE strain, it was also present and relatively abundant in the eluate 
from the control strain, which rendered its enrichment not significant (Figure 20C). 
Study of the complete list of GFAT-1 binding partners did not reveal a clustering of 
the interacting proteins within a biological pathway or process. Of note, however, was 
the identification of multiple heat shock proteins (F44E5.4, HSP-16.1, HSP-16.41, 
HSP-1, HSP-16.48) and proteins involved in mRNA translation like ribosomal 
subunits (RLA-2, RPL-31, RLA-1, RPL-23, RPL-8, RPS-14, RPS-27, RPS-3, 
RPS-30), tRNA synthetases (MRS-1, EARS-1, ERS-1;QARS-1, KARS-1;KRS-1, 
RARS-1;RRT-1) and translation initiation and elongation factors (EEF-1B.2, EEF-1G, 
EGL-45, EIF-3.B, EIF-3.I, Y39G10AR.8) (Figure 20D). 
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Figure 20. Identification of physical interaction partners of GFAT-1. A. Representative Western blot of 
Flag IP fractions from lysates of mixed population of gfat-1P::Flag::HA::CFP::gfat-1 and 
gfat-1P::Flag::HA::CFP as control, elution with Flag peptide, N=3, FT=low-trough. B. Representative silver 
gel, samples as in (A.), Elute=beads before trypsin digest, Beads=beads after 24 h trypsin digest, arrow 
head indicates Flag::HA::CFP, filled arrowhead indicates Flag::HA::CFP::GFAT-1, N=2. C. Volcano plot of 
GFAT-1 interaction partners identified by Flag IP with lysates of mixed population of 
gfat-1P::Flag::HA::CFP::gfat-1 and gfat-1P::Flag::HA::CFP as control, only select binding partners of 
GFAT-1 with FDR≤0.01 and GFAT-1 itself are labeled, peptide digest from beads with trypsin, peptide 
purification and MS-analysis, N=4, FDR, false discovery rate. D. List of all physical interaction partners of 
GFAT-1 with FDR of 0.001 or 0.01 (as in C.). 
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2.6   Screen for essential factors in gfat-1 OE induced PQC improvement 
 
It was one of my overarching aims to identify the molecular mechanism 
underlying the gfat-1 OE induced improvement of PQC mechanisms. To narrow 
down the list of potential candidates and processes, we used our muscular gfat-1 
OE, polyQ model to set up a selective, multi-step RNAi based suppressor screen for 
motility (Figure 21A). We generated a set of 227 RNAi clones targeting identified 
physical interactors of GFAT-1, PMK-1, factors involved in glycosylation and PQC 
mechanisms, amongst others. In a first screening round we roughly determined the 
effect of each RNAi clone on the motility of unc-54P::Q35, myo-3P::gfat-1 worms. For 
this purpose we visually assessed the ability of aged worms to leave a marked area 
on culture plates within one minute. Nematodes exclusively overexpressing polyQ in 
muscle and grown on luciferase control RNAi were completely paralyzed at day 12 of 
adulthood and not a single animal was able to leave the marked area within our set 
time interval and even longer time periods. By contrast, polyQ expressing worms 
grown on luciferase RNAi with additional muscular gfat-1 OE were still very motile 
and all worms left the marked spot within one minute. Feeding gfat-1 and gna-2 RNAi 
in this background served as our reference for hits in this assay, as it led to an 
intermediate phenotype. The nematodes could still move sluggishly but most of them 
were not able to crawl out of the marked area within one minute (Figure 21B). All 
RNAi clones that caused a comparable phenotype were considered primary hits and 
taken to the second screening round in which three to five worms per condition were 
subjected to a quantitative motility assay in liquid (Figure 21A). We quantified 
swimming motions within an interval of 30 seconds. If the mean motility of the 
nematodes on specific candidate RNAi clones was below the standard error of the 
luciferase RNAi control and comparable to the performance of worms on gna-2 
RNAi, they were taken to the next step of the screening process (Figure 21C). This 
step was designed to exclude RNAi clones that aggravate the polyQ phenotype and 
decrease the worms´ motility independently of gfat-1 OE. To address this, we 
performed a counter screen in polyQ background without gfat-1 OE. As complete 
paralysis sets in very early in this model, the quantitative motility assay in liquid had 
to be performed at a younger age (Figure 21A). In this case, the cut off for 
candidates was set within the range of the standard error of polyQ worms grown on 
luciferase RNAi or gna-2 RNAi, which had no detrimental effects in this setup. If the 
mean swimming ability of animals grown on specific RNAi clones was below the cut 
off value, the decreased motility was considered a sign of toxicity in polyQ animals 
and independent of gfat-1 OE. These clones were excluded from further analyses 
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(Figure 21D). After the first three steps of the screening process, the remaining 
candidates were confirmed with a more extensive swimming assay, comprising a 
higher number of worms for each condition. For this assay, unc-54P::Q35, 
myo-3P::gfat-1 worms were cultured without Fluorodeoxyuridine (FUDR), a DNA 
synthesis inhibitor, and motility was evaluated already at day 10 of adulthood to allow 
the detection of subtle differences (Figure 21A and 22A) . The cut off for candidates 
was, as before, determined by the motility of unc-54P::Q35, myo-3P::gfat-1 animals 
on luciferase RNAi as negative control. Every RNAi clone that caused a decrease of 
mean motility below the standard error of this control and that was well in the range 
of unc-54P::Q35, myo-3P::gfat-1 animals on gna-2 RNAi as positive control was 
classified a true hit (Figure 22A). Again, a counter screen was carried out to 
determine whether single RNAi hits reduced motility in polyQ background, 
independently of gfat-1 OE. Here, RNAi treatment that led to a swimming capacity 
within the standard error of polyQ worms on luciferase, gfat-1 and gna-2 RNAi as 
controls was considered a true hit and was included in our shortlist of potential gfat-1 
downstream effectors (Figure 22B and 22D).  
180 out of the 227 tested RNAi clones could already be excluded from further 
analyses in the initial motility screen on plates and consecutive small swimming 
assay in liquid. Another 11.5% were censored after the first counter screen in polyQ 
background. Further 2.6% of candidates could not be confirmed in the more 
extensive fourth step of our screen, which left us with 6.6% true hits corresponding 
to15 candidate genes (Figure 22C). These genes do not cluster in a single pathway 
or biological process and most genes are not associated to PQC mechanisms. 
However, we realized that three of the candidates were involved in protein 
translation: abcf-3, the ortholog of S. cervisiae gcn20, works in a complex to 
modulate phosphorylation of eIF2α and is thereby implicated in translation initiation 
and regulation of atf-5 transcription (Vazquez de Aldana et al., 1995, Marton et al., 
1997, Garcia-Barrio et al., 2000, Hirose and Horvitz, 2014); rars-1 codes for the 
arginyl-tRNA synthetase and is, as such, necessary for protein translation (Ibba and 
Soll, 2000); rla-2 is encoding an acidic protein in the 60S ribosomal subunit that is 
essential for protein synthesis (Rich and Steitz, 1987) (Figure 22D). We found this 
novel link between the energy sensor GFAT-1 and protein synthesis highly intriguing 
and decided to further investigate along these lines. 
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1
Figure 21. Screen for downstream effectors of gfat-1 OE induced motility improvement in polyQ 
background. A. Outline of multi-step RNAi based suppressor screen. B. Representative image of 
control animals in first screening round (motility on plates), ability to leave marked area on culture 
plates within one minute. C. and D. Only a subset of screened genes is shown, red box indicates cut off 
for potential candidates, filled red area shows controls, RNAi clones with mean motility within red box 
are considered hits, red background signifies controls, line and error bars indicate mean ±SEM. 
C. Small quantitative assay in liquid in unc-54P::Q35::YFP, myo-3P::Flag::HA::cfp::gfat-1 background 
at day 12 of adulthood, in the depicted subset all candidates were taken to next screening step. 
D. Counter-screen in unc-54P::Q40::YFP background at day 5 of adulthood, in the depicted subset 
5 genes were excluded from further analyses. FUDR, Fluorodeoxyuridine. 
2
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Figure 22. Confirmation of gfat-1 downstream effectors causing motility improvement in polyQ 
background. A. and B. Only a subset of screened genes is shown, red box indicates cut off for 
potential candidates, filled red area shows controls, RNAi clones with mean motility within red box are 
considered hits, red background signifies controls, line and error bars indicate mean ±SEM. 
A. Confirmation of candidates in quantitative swimming assay in unc-54P::Q40::YFP, 
myo-3P::Flag::HA::cfp::gfat-1 (2) background at day 10 of adulthood. B. Confirmation of candidates in 
counter screen, quantitative swimming assay in unc-54P::Q40::YFP background at day 5 of adulthood. 
C. Pie chart of RNAi clone distribution within screen categories; 180 out of 227 (79.3%) screened RNAi 
clones were no primary hits, 11.5% aggravated the polyQ phenotype independent of gfat-1 OE and 
were censored after counter screening, 2.6% of the remaining candidates were not confirmed in more 
extensive second screening round, 6.6% of screened RNAi clones remained as true hits. D. List of 
confirmed candidates from completed RNAi based suppressor screen to identify effectors of gfat-1 OE 
induced PQC improvement (15 hits out of 227 screened genes), GFAT-1 interacting partners are 
marked by blue boxes. 
RESULTS 
81 
2.7   Effects of gfat-1 OE on protein translation 
 
Protein synthesis is one of the most energy intensive processes in the cell 
and is, therefore, tightly controlled. Activation of the integrated stress response (ISR) 
is one method to stall global translation in response to various insults. Four widely 
conserved serine/threonine kinases are known in mammals to target the key protein 
of the ISR, the translation initiation factor eIF2. The kinases sense stress conditions, 
namely viral infection, heme depletion, amino acid deprivation or protein folding 
stress in the ER and, as a response, phosphorylate and thereby inactivate the α 
subunit of eIF2 (Berry et al., 1985, Chen and London, 1995, Harding et al., 1999, 
Hao et al., 2005). This, in turn, reduces global mRNA translation but simultaneously 
leads to the expression of the ATF4 (yeast GCN4, C. elegans ATF-5) transcription 
factor, which is usually repressed by translation initiation at upstream open reading 
frames (uORFs) (Mueller and Hinnebusch, 1986, Hershey, 1991, Hinnebusch, 1994, 
Vattem and Wek, 2004, Castilho et al., 2014). ATF4 downstream targets comprise 
genes involved in amino acid synthesis and transport, metabolism, the UPRER and 
induction of apoptosis, to name few processes. Thereby, ATF4 signaling assists in 
opposing the cellular stress that caused the attenuation of protein translation in the 
first place	 (Hai et al., 1989, Ron, 2002, Harding et al., 2003, Pakos-Zebrucka et al., 
2016) (Figure 23A). 
To gain first insights into whether protein synthesis might be affected by 
gfat-1 OE we determined the amount of phosphorylated eIF2α by Western blot 
analysis. As negative control we included a strain that lacks the only two known 
eIF2α kinases in C. elegans, gcn-2 (GCN2) and pek-1 (PERK) (Baker et al., 2012). 
Indeed, no P-eIF2α could be detected in lysates of these worms. As positive control 
we induced protein folding stress in wildtype worms by exposure to tunicamycin. This 
intervention resulted in a roughly twofold increase in P-eIF2α level compared to the 
untreated controls. Interestingly, we noted an elevation of P-eIF2α of about 1.5 fold in 
the gfat-1P::gfat-1 strain relative to Histone H3 compared to controls. A tendency for 
elevated P-eIF2α is additionally present in the muscular gfat-1 OE strain with high 
levels for transgenic GFAT-1. C. elegans lines with comparably low GFAT-1 
expression, myo-3P::gfat-1 (1) and neuronal gfat-1 OE worms, showed no 
measurable increase in P-eIF2α (Figure 23B and 23C).  
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Figure 23. Mild induction of the ISR by gfat-1 OE. A. Schematic view of the integrated stress 
response in mammals. Upon sensing distinct stress conditions committed kinases phosphorylate eIF2α, 
which causes stalling of global protein synthesis with concomitant induction of ATF4 transcription factor 
(ATF-5 in C. elegans) expression. ATF4 targets are upregulated to counteract cellular stress conditions 
or induce apoptosis. B. Representative Western blot of gfat-1P::gfat-1 OE line at day 1 adult stage. TM, 
4h Tunicamycin 10 µg/ml C. Quantification of Western blots (like in B.), N=3 (but N2+TM N=2 and 
gfat-1P::gfat-1+TM N=1), line and error bars indicate mean ± SEM, multiple t-tests, **, p<0.01, 
****, p<0.0001. D. Representative images of atf-5P::GFP with and without additional gfat-1 OE reporter 
strain at day 1 adult stage. Area marked by red, dashed line indicates quantified worm area, excluded is 
signal from pharyngeal co-injection marker myo-2::mcherry. E. Quantification of microscopy pictures of 
atf-5P::GFP reporter strain at day 1 adult stage (like in D.), worms grown at 20°C for entire experiment 
or shifted to 25°C at late L4 stage to cause mild heat stress, N=3, 10 worms per condition, line and 
error bars indicate mean ± SEM, multiple t-tests, * p<0.05.  
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Furthermore, we used a reporter line to assess the effect of GFAT-1 OE on 
atf-5 expression downstream of P-eIF2α. We chose the gfat-1P::gfat-1 strain for this 
experiment, as it shows the highest expression of transgenic GFAT-1 and P-eIF2α. 
Under growth conditions, we noticed a slight upregulation of GFP controlled by the 
atf-5 promoter in gfat-1 OE worms The increase in signal was mainly restricted to the 
hindgut of the animals (Figure 23D and 23E). To include a positive control in the 
assay, we shifted C. elegans to 25°C to provoke protein misfolding. This intervention 
doubled atf-5 expression compared to unstressed controls. Under this mild heat 
stress, we still observed a tendency of elevated atf-5 in the gfat-1 OE strain 
(Figure 23E). 
Taken together, we propose that OE of gfat-1 might promote phosphorylation 
of eIF2α under standard conditions to decreased global protein synthesis and 
simultaneously increase ATF-5. This mild but sustained activation of the ISR might 
explain the improved proteostasis of gfat-1 OE lines. 
 
 
2.8   Requirement of abcf-3 for gfat-1 OE induced PQC improvement 
 
After we obtained first evidence that gfat-1 OE might act on protein translation 
through modulation of P-eIF2α, we, for further analysis, focused on one candidate 
from the RNAi suppressor screen, which had been implicated in translational 
regulation before. ABCF-3 (yeast GCN20) was described to work in a complex with 
GCN-1 to regulate phosphorylation of eIF2α (Vazquez de Aldana et al., 1995, Marton 
et al., 1997, Garcia-Barrio et al., 2000). This function of ABCF-3 fits in well with the 
observed modulation of P-eIF2α and ATF-5 expression in gfat-1 OE mutants. Hence, 
we analyzed the role of ABCF-3 and its binding partner GCN-1, both of which we 
identified to be a physical interaction partners of GFAT-1 (Figure 19D), in gfat-1 OE 
induced PQC improvement. To this end we generated lines with complete abcf-3 or 
gnc-1 deletions in the muscular gfat-1 OE, polyQ background and studied protein 
aggregation and proteotoxicity. 
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In the absence of gfat-1 OE neither abcf-3 nor gcn-1 deletion aggravated the 
accumulation of polyQ aggregates in the nematodes´ body wall muscle (Figure 24A 
and 24B). As observed before, overexpression of gfat-1 in muscle was beneficial and 
decreased the load of protein aggregates. The deletion of abcf-3 in gfat-1 OE 
 
 
Figure 24. Requirement of abcf-3, but not gcn-1 for gfat-1 OE induced motility improvement. 
A. Representative images of polyQ aggregates in day 4 adults with and without muscular gfat-1 OE 
and effects of abcf-3 and gcn-1 deletion. B. Quantification of Q35::YFP aggregates at day 4 adult stage 
in unc-54P::Q35::YFP background (as in A.), representative experiment of N≥3, 10 worms per 
condition, shown is mean +SD, statistical test 2way ANOVA, Tukey´s multiple comparisons test, 
****, p<0.0001. C. Effect of muscular gfat-1 OE and of abcf-3 deletion on motility in unc-54P::Q35::YFP 
background at day 8 of adulthood as measured by swimming assay, 15 worms per condition, N≥2, line 
and error bars indicate mean ± SD of representative experiment, 1way ANOVA, Tukey´s multiple 
comparisons test, ****, p<0.0001. D. Effect of muscular gfat-1 OE and of gcn-1 deletion on motility in 
unc-54P::Q35::YFP background at day 8 of adulthood as measured by swimming assay, 15 worms per 
condition, N=2, line and error bars indicate mean ±SD of representative experiment, 1way ANOVA, 
Tukey´s multiple comparisons test, ****, p<0.0001, ns, not significant. 
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background led to a complete reversal of the gfat-1 induced benefits and leveled the 
number of polyQ aggregates in the gfat-1 OE strain and the control strain. Deletion of 
gcn-1 on the other hand did not counteract the PQC benefits induced by gfat-1 OE 
and the amount of polyQ aggregates remained low (Figure 24A und 24B). To confirm 
these results in an independent assay, we performed a quantitative motility assay in 
aged worms. The swimming capacity of polyQ worms was not altered by abcf-3 
deletion. However, the improvement in motility seen in muscular gfat-1 OE was 
completely dependent on abcf-3 and reverted to the state of paralysis typical of the 
polyQ controls upon abcf-3 deletion (Figure 24C). Although GCN-1 and ABCF-3 
were shown to work in a complex to facilitate eIF2α phosphorylation, GCN-1 does 
not seem to be essential for the improved PQC caused by gfat-1 OE. In the polyQ as 
well as the polyQ, gfat-1 OE worms the deletion of gcn-1 had no effect on motility 
(Figure 24D). 
To conclude, we generated evidence supporting the hypothesis of a novel 
mode of action for the HP enzyme GFAT-1: Together with its binding partner 
ABCF-3, GFAT-1 protein modulates the ISR independent of unfavorable 
environmental conditions and thereby counters proteotoxicity. The enzymatic activity 
of GFAT-1 is only partially required for its newly identified function. 
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3.   DISCUSSION 
 
 
3.1.   Implication of GFAT-1 regulation in the ER stress response 	
The production of the HP end product UDP-GlcNAc and its isomer 
UDP-GalNAc is essential for cell survival. Given the interlinking of the HP with 
several other metabolic pathways and the high energy expense necessary to 
produce these aminosugars, it is conceivable that the HP is tightly regulated. This 
regulation focuses on GFAT-1 as it is the rate-limiting enzyme in UDP-GlcNAc 
biosynthesis. Increasing the abundance of gfat-1 transcript and consequently 
GFAT-1 protein could be one mechanism to boost HP activity. And while this method 
is widely used to enhance the capacity of innumerable biological processes and can 
be especially useful to induce rather persistent changes, it is a comparatively slow 
adaption. While gene transcription, mRNA translation and protein folding will at least 
require several minutes, the activation of proteins by PTMs like phosphorylation is 
only a matter of seconds (Anfinsen, 1973, Milo and Phillips, 2015, Blazek et al., 
2015). In any case, it was described that, in tissue culture and in a mouse model, 
gfat-1 transcription is target of distinct signaling cascades and is elevated under 
specific conditions, such as disruption of the ER homeostasis or nutrient shortage 
(Wang et al., 2014, Chaveroux et al., 2016, Moloughney et al., 2016).  
When we challenged C. elegans with stressful environmental conditions, we 
expected to recapitulate these results. Interestingly, we observed a surprising 
stability of gfat-1 transcript levels between diverse treatments. Neither nutrient 
deprivation, nor glucose supplementation or ER stress altered the amount of gfat-1 
mRNA (Figure 8A and 8B). This lack of transcriptional induction of gfat-1 could have 
diverse reasons. Although gfat-1 structure and function are highly conserved 
between species, it is possible, that in C. elegans unlike in tissue culture and mice, 
gfat-1 transcription is not increased in response to stress. Alternatively, gfat-1 mRNA 
might be regulated differentially in distinct tissues or might be elevated only in select 
cells. In this case, it is very likely that changes would not be picked up by qRT-PCR 
on extracts of whole worms as the increased expression in certain cells could be 
diluted too strongly by unaffected cells or be canceled out by other cells, which 
reduce gfat-1 expression. Also, it is conceivable, that merely raising the amount of 
GFAT-1 might not boost HP activity. We know that introducing the gfat-1 gof 
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mutations identified in C. elegans into murine cells, does not increase the amount of 
GFAT-1 protein, but still confers TM resistance (Moritz Horn and Martin Denzel, 
personal communication). This argues, that elevation of GFAT-1 level is not 
necessary to activate the HP and promote UDP-GlcNAc production. Furthermore, 
this observation indicates that wildtype GFAT-1 is constantly feedback inhibited 
because it fails to amass UDP-GlcNAc even under TM challenge although its 
physical protein amount would be sufficient for it. 
In contrast to our qRT-PCR results, we found an induction of GFAT-1 protein 
under various stress conditions (Figure 8D). This difference could either originate 
from shortcomings in detecting according changes on mRNA level by qRT-PCR or 
reflect the real picture. Triggered by stress, GFAT-1 protein might be stabilized by 
PTMs, its translation enhanced or proteolytic mechanisms inhibited, leading to its 
protein accumulation while transcript levels would remain unaltered. Using a 
translational reporter line allowed us to study tissue distribution and expression 
pattern beyond changes in GFAT-1 protein amount. Interestingly, high temperature, 
oxidative stress and elevated glucose all triggered the formation of foci with high 
GFAT-1 expression in seam cells and pharynx (Figure 8C). It is not clear, whether 
these structures fulfill any functions or whether they are a byproduct of failing 
homeostasis mechanisms under conditions that were, judging by the small body size 
of the worms, severely challenging. At any rate, boosting HP flux by gof mutations in 
gfat-1 did not influence C. elegans´ sensitivity to heat and oxidative stress.  
The observed changes following exposure to the ER stress inducing drugs 
TM and thapsigargin seem physiologically more relevant: The distribution of GFAT-1 
remains smooth as in the controls kept under standard growth conditions but there 
was a remarkable induction of GFAT-1 in the intestine. As this tissue is usually one 
of the first ones to come in contact with environmental toxins and the expression of 
many detoxification genes is restricted to the intestine, it suggests a specific role for 
GFAT-1 in countering the effect of the administered drugs (McGhee, 2007). Indeed, 
we know that TM resistance can be induced by simple overexpression of gfat-1 and 
no circumvention of feedback inhibition is required (Figure 13E). The compound TM 
is naturally produced by soil bacteria, mainly by Streptomyces strains, and the soil 
nematode C. elegans, which feeds on bacteria is not unlikely to come in contact with 
the toxin (Takatsuki et al., 1971). Hence, GFAT-1 induction in the intestine could be a 
physiological TM detoxification mechanism. Thapsigargin on the other hand is of 
plant origin and therefore less likely to pose a challenge in the natural environment of 
C. elegans (Thastrup et al., 1989). In this case, GFAT-1 induction is probably only a 
consequence of the disturbed ER homeostasis and does not constitute a remedy as 
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gfat-1 gof mutations failed to boost thapsigargin resistance (Martin Denzel, personal 
communication). We concluded that although GFAT-1 protein level and tissue 
distribution are responsive to diverse challenges and culture conditions, it is unlikely 
that GFAT-1 fulfills an important function in directly counteracting unfavorable 
environmental conditions in general beyond its clear requirement for detoxification of 
TM (Figure 10). However, an increase in GFAT-1 expression, albeit not per se 
protective, might still be relevant in assisting to maintain physiological processes like 
protein glycosylation and folding under stressful conditions. This is supported by the 
observation that UPRER activation in a single tissue measurably elevated the amount 
of UDP-GlcNAc in whole worm lysates (Figure 9C). Especially under stress, it is 
essential to reasonably allocate available resources and stimulation of the cost-
intensive HP would be strongly contraindicated, if it was not relieving the situation in 
any way. 
 
 
3.2.   Unaltered Transcriptome and Proteome by gfat-1 gof mutations 
 
The identification of concrete downstream effects of gfat-1 gof mutations at 
the basis of improved PQC mechanisms proved to be very challenging. Analyzing 
transcriptome and proteome of the mutants did not reveal evident regulation of 
specific pathways and processes (Figure 11). Considering that genetic mutations or 
interventions that cause longevity typically show differential expression of tens to 
hundreds of genes, this finding was surprising (Murphy et al., 2003, Halaschek-
Wiener et al., 2005, Ruzanov et al., 2007, Depuydt et al., 2014). As UDP-GlcNAc is 
essential for protein glycosylation, which can directly affect protein stability, 
significant changes in the abundance of at least glycoproteins in gfat-1 gof lines 
compared to wildtype controls would have been plausible (Vegarud and Christnsen, 
1975, Wang et al., 1996, Kozarsky et al., 1988, Garner et al., 2001). We do, 
however, not know whether the modulation of accessible UDP-GlcNAc within a 
C. elegans cell alters the pool of glycosylated proteins or the glycosylation state of 
proteins. Thus, it is possible that UDP-GlcNAc is not the limiting resource for 
glycosylation reactions and increasing its amount does not entail changes in the 
glycoproteome. Alternatively, if UDP-GlcNAc availability does affect protein 
glycosylation, it might well influence protein properties other than stability, like other 
PTMs and phosphorylation state or association with interaction partners. These 
possible consequences of UDP-GlcNAc accumulation would have not been picked 
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up by proteome analysis. Unfortunately, our approaches to gain a comprehensive 
picture of the C. elegans gfat-1 gof glycoproteome did not succeed. To date, the 
global analysis of the exceptionally diverse classes of glycoproteins remains 
challenging (Xiao et al., 2018, You et al., 2018). In the C. elegans system, we were 
able to identify only a very limited number of glycoproteins (data not shown), which 
did not advance our understanding of molecular changes evoked by gfat-1 gof 
mutations. 
 
 
3.3.   Cell autonomous PQC improvement by muscle-specific GFAT-1 OE 
 
As the attempt to generate candidates for downstream effectors of gfat-1 gof 
by transcriptomic, proteomic and glycoproteomic analyses was not successful we set 
out to dissect consequences of HP activation in a tissue-specific manner. The 
C. elegans strains we generated overexpressed gfat-1 either under its endogenous 
promoter, a body wall muscle-specific, a pan neuronal or an intestine-specific 
promoter.  
The OE of gfat-1 in the worm gut was of interest, because of the observed 
local induction of GFAT-1 in this tissue after experiencing ER stress and its potential 
role in detoxification. Furthermore, one can hypothesize that the intestine as major 
metabolic tissue might be especially sensitive to boosting the HP. This, in fact, 
seemed to be true, despite not in regards to the benefits caused by gfat-1 gof. Even 
after repeated attempts no stable transgenic line with intestinal overexpression of 
gfat-1 could be generated. The slow development and small body size as signs of 
poor health as well as the low plasmid transmission rate and very restricted and 
patchy transgene expression observed in the obtained worms argued for toxicity of 
elevated GFAT-1 in the worm intestine. Possibly, the transgenic elevation of GFAT-1 
leads to detrimental metabolic imbalances or, as part of the ER stress response, it 
might signal the presence of environmental stress or unfolded proteins. This, in turn, 
could trigger a maladaptive stress response, which could be causal for the 
transgene´s deleterious effects (Roth et al., 2014).  
We, beyond that, chose neurons as tissue for GFAT-1 OE for two main 
reasons. First, neurodegeneration is arguably the severest consequence of age-
associated protein aggregation. Here, the broad PQC benefit of gfat-1 gof mutations 
could be of particular physiological relevance. Second, we were very interested in the 
question whether the activation of the HP boosts proteostasis directly and cell 
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autonomously or whether it worked cell non-autonomously by cross tissue signaling. 
Neurons are classically responsible to integrate stimuli and signals and based on this 
information induce responses in distal tissues or even raise systemic responses. 
Furthermore, it was already reported that neuron-specific activation of the IRE-1 
branch of the UPRER by OE of XBP-1s can systemically improve ER stress 
resistance and prolongs life (Taylor and Dillin, 2013). GFAT-1 is a described UPRER 
target and gfat-1 gof mutations have comparable effects as neuronal XBP-1s OE. 
Hence, we wondered whether GFAT-1 would also play a special role in nervous 
tissue and whether a similar mechanism was responsible for the phenotype of the 
distinct transgenic lines. Interestingly, neuronal GFAT-1 OE could not confer 
systemic ER stress resistance and the worms remained sensitive to TM 
(Figure 13E), while at the same time it did promote autophagy if not significantly, due 
to the high variability of the assay (Figure 14C). It is difficult to sensibly monitor 
autophagy in C. elegans and from our experiments we cannot deduce if the 
autophagic flux was elevated exclusively in a cell autonomous manner or if it was 
additionally increased in distal tissues. However, because the globally assessed 
autophagic flux is more than 150% of controls, we believe neuronal GFAT-1 OE to 
act cell non-autonomously in promoting autophagy. It is quite surprising that the 
induction of autophagy lacked any positive effect on protein aggregation models in 
the worm gut, in muscle and even in neurons itself (Figure 15, 16B, 17B and 17C).  
Finally, we were particularly interested in the effects of GFAT-1 OE in muscle 
tissue because recessive mutations in human GFAT-1 (GFPT1) cause congenital 
myasthenic syndrome, also called limb-girdle myasthenia with tubular aggregates. 
Major clinical manifestations of this disease include early onset limb muscle 
weakness, disruptions of neuromuscular junction transmission and abnormal muscle 
morphology (Senderek et al., 2011, Guergueltcheva et al. 2012, Selcen et al., 2013). 
Decreased GFAT-1 expression levels rather than a decline in enzymatic function 
seemed to be responsible for the severe muscular and neuro-muscular phenotype 
(Senderek et al., 2011, Willems et al., 2016). In one severely affected patient, which 
exhibited myopathy already in utero, an intronic mutation could be identified that 
disrupted the muscle-specific GFAT-1 isoform (Selcen et al., 2013).  
These findings indicate an increased importance for GFAT-1 in nervous and 
especially muscle tissue and raised the questions: Is the OE of GFAT-1 protein in 
muscle particularly beneficial for C. elegans and does it have exclusively cell 
autonomous benefits or does it work across tissues to improve PQC? Like with 
neuronal GFAT-1 OE, we observed an increased autophagic flux in C. elegans with 
muscle-specific GFAT-1 OE. Again, the extent of induction is relatively large, 
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especially in the transgenic line with high GFAT-1 expression levels. Here, the 
autophagic flux is at about 200% relative to wildtype controls (Figure 13C, 14B and 
14C). We would argue, therefore, that muscular GFAT-1 OE systemically boosts 
autophagy and that the size of the effect depends on GFAT-1 protein levels. What is 
more, we could measure a marginally elevated resistance to low doses of TM at high 
muscular GFAT-1 expression levels in one set of experiments (Figure 19D and 13E).  
Another piece of evidence in support of cell non-autonomous consequences 
of muscular GFAT-1 OE was gained by studying intestinal and neuronal polyQ 
models. We were surprised to learn that GFAT-1 OE in muscle apparently disturbed 
the intestinal proteostasis network seeing that it potently accelerated polyQ 
aggregate formation in the gut (Figure 15A and 15B). Furthermore, muscle-specific 
GFAT-1 OE decreased the lifespan of worms expressing polyQ repeats under a 
neuronal promoter. All of these observations indicate a cross-tissue effect of 
muscular GFAT-1 OE, although not necessarily improving PQC as we had expected. 
The strongest phenotype of muscular GFAT-1 OE was, however, cell 
autonomous and beneficial: in muscle-specific protein aggregation models, 
transgenic GFAT-1 expression strongly decreased the load of polyQ aggregates and 
sustained their solubility and, most importantly, maintained the worms´ motility into 
old age (Figure 16 and 17). This finding could be of physiological significance as 
there are numerous diseases of muscle tissue with concurring protein aggregation 
even if the most famous protein folding diseases like AD, PD and HD are all signified 
by accumulation of aggregated proteins in the central nervous system. Protein 
aggregate myopathies (PAMs), also including congenital myasthenic syndrome, 
reportedly share advanced age as the main risk factor but are, beyond that, a highly 
diverse group of hereditary and sporadic diseases. They show a large heterogeneity 
regarding onset of symptoms, clinical manifestations and species of aggregating 
proteins. Many characteristics of these diseases like their underlying causes are 
often still poorly understood, hence there is, in many cases, no effective therapy 
available (Sharma and Goebel, 2005, Goebel and Müller, 2006, Naddaf et al., 2018). 
Only recently, it was described that the age dependent accumulation of aggregated 
proteins in muscle is not only an accompanying symptom of disturbed processes 
leading to PAMs but is itself a contributor to declining muscle function and loss of 
muscle mass (Ayyadevara et al., 2016). It could be really interesting to model some 
of these diseases in C. elegans and assess whether muscular GFAT-1 OE can 
alleviate symptoms. 
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3.4   Dual Role of GFAT-1 
 
It was the major focus of my work to elucidate the downstream effects of 
GFAT-1 OE and HP activation leading to improved proteostasis. As transcriptomic 
and proteomic analyses could not generate a set of candidates, we approached the 
question from a different angle and set out to identify physical interaction partners of 
GFAT-1. We speculated that GFAT-1 might fulfill another role within cells beyond 
producing UDP-GlcNAc as part of the HP and that it might do so by binding to other 
proteins. By forming connections with other proteins GFAT-1 might increase their 
stability, trigger conformational changes, which might be activating or deactivating, it 
could block or foster interactions with additional factors or it might influence 
subcellular distribution or concentration of its binding partners. The rationale behind 
the hypothesis of a dual role of GFAT-1 as enzyme in the HP and as protein in a 
complex was mainly based on two of our findings: First, some of the observed effects 
present in GFAT-1 OE lines were not recapitulated in gfat-1 gof lines. While 
C. elegans with GFAT-1 OE under its endogenous promoter for example showed 
mildly improved motility in the polyQ strain, gfat-1 gof mutants were completely 
paralyzed like controls (Figure 17C and data not shown). In my opinion, this can only 
be explained if a possibility to regulate GFAT-1 enzymatic activity is crucial for this 
phenotype or if GFAT-1 protein is improving PQC by an additional mechanism 
distinct from UDP-GlcNAc production. Second, muscular OE even of enzymatic dead 
GFAT-1K720R in polyQ background could moderately improve the worms´ motility in 
a swimming assay (Figure 19 E). This experiment clearly argued for a function of 
GFAT-1 protein in PQC independent of its enzymatic activity.  
We presumed that the identification of GFAT-1 binding partners might help us 
to better understand this intriguing finding. Using co-IP of GFAT-1 and consecutive 
MS analysis we were able to describe 119 GFAT-1 interacting proteins with a FDR of 
0.01 or lower (Figure 20D). Unfortunately, the group of physical GFAT-1 interactors 
we identified did not strongly cluster into specific biological processes and we could 
not gain conclusive evidence to which pathways might be regulated through 
interaction with GFAT-1. Thus, we considered all of these proteins potential 
downstream effectors of GFAT-1 OE. We further tested their role in muscle PQC 
besides many other genes implicated in proteostasis, longevity regulation and 
glycosylation reactions, in a selective RNAi suppressor screen. Indeed, knock down 
of several binding partners of GFAT-1 could revert the improved motility of muscle 
GFAT-1 OE to controls while simultaneously they did not aggravate the polyQ 
phenotype itself. 
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3.5   Cross-talk of GFAT-1 and the ISR 
 
It was reported before that the HP can sense the metabolic status of cells 
and, as way of downstream signaling and adapting, alter the O-GlcNAcylation pattern 
of proteins accordingly (Lubas et al., 1997, Yang et al., 2002, Hanover et al., 2012, 
Ruan et al., 2013, Berrabah et al., 2014). One process, which is controlled by 
O-GlcNAcylation and thereby the HP and OGT, is protein synthesis. Jang and 
coworkers described that eIF2α has three O-GlcNAcylation sites. At high occupancy 
of these sites eIF2α phosphorylation can be impeded and thereby O-GlcNAc 
modification of eIF2α can support normal protein translation even under ER stress 
conditions (Jang et al., 2015). Another study determined the dynamic O-GlcNAc 
modification of translation initiation factor eIF4GI as an underlying mechanism for 
stress granule dissolution and selective translation of stress-related mRNAs upon 
heat shock (Zhang et al., 2018). The work of both research groups illustrates the 
regulatory role of UDP-GlcNAc availability and O-GlcNAcylation status in selective 
translation. 
Here, we demonstrate for the first time an additional role for GFAT-1 protein 
levels in proteostasis. We propose cross-talk and control between the ISR and 
GFAT-1 to be responsible for the GFAT-1 OE induced PQC benefits, which were, at 
least partially, independent of steady-state UDP-GlcNAc availability (Figure 25). 
With this work we could identify previously unknown physical interaction 
partners of GFAT-1 (Figure 20). Interestingly, the group of GFAT-1 binding partners 
was enriched for factors involved in protein synthesis, namely tRNA synthetases, 
ribosomal proteins and translation initiation and elongation factors. The list 
furthermore contained, two known modulators of GCN-2 activity (Vazquez de Aldana 
et al., 1995, Marton et al., 1997). The deletion of either ABCF-3 or GCN-1 did not 
aggravate polyQ toxicity, but ABCF-3 was absolutely essential for the improved 
motility and decreased aggregation caused by GFAT-1 OE in polyQ background 
(Figure 24). Our study showed that GFAT-1 OE mildly induced the phosphorylation 
of eIF2α and increase ATF-5 expression and this could plausibly be achieved 
through interaction with ABCF-3 (Figure 23 and 25). Previous studies demonstrated 
the physical binding of GCN-1 to GCN-2 to be absolutely critical for activation of 
GCN-2 by uncharged tRNA (Marton et al., 1993, Kubota et al., 2000). It was, 
however, also suggested that GCN-1 merely fulfills a scaffolding function causing the 
required proximity between GCN-2 and, for example, uncharged tRNA molecules at 
the translating ribosome (Castilho et al., 2014). Observations that support this notion 
showed that the requirement for GCN-1 in GCN-2 activation can be circumvented by 
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OE of tRNAs, generating a surplus of the activating agent, or by gof mutations in 
GCN-2, which abolish tRNA binding necessity (Garcia-Barrio et al., 2000, Qiu et al., 
2002). As GCN-1 is not essential for GFAT-1 OE induced PQC benefits, we propose 
that the complex formed by GFAT-1 and ABCF-3 can by itself promote GCN-2 
activation and eIF2α phosphorylation. This could be achieved by several 
mechanisms: First, it is possible that GFAT-1 can assume GCN-1 function in forming 
a hub for essential factors in GCN-2 activation. By binding to ribosomes, tRNA 
synthetases and the GCN-2 modulator ABCF-3 it could generate an environment that 
facilitates the induction of the ISR (Figure 20). Alternatively, GFAT-1 could act 
through stabilizing ABCF-3 protein. It was proposed that ABCF-3 is quickly degraded 
if it does not form a complex with GCN-1 (Vazquez de Aldana et al., 1995). GFAT-1 
could, through its binding to ABCF-3, have a comparable effect and GFAT-1 OE 
might lead to stabilization of higher amounts of ABCF-3, supporting GCN-2 
activation. Another possibility is a change in ABCF-3 ability to activate GCN-2 by 
increased GFAT-1 binding under GFAT-1 OE conditions. Of course, the 
ABCF-3/GFAT-1 complex could potentially also hinder eIF2α dephosphorylation by a 
distinct and unknown mechanism independent of GCN-2, ribosome and uncharged 
tRNAs, for example by promoting GADD34 function (Novoa et al., 2001).  
The mild induction of the ISR resulting from GFAT-1 OE could explain the 
observed boost in PQC and ameliorated proteotoxicity. A slight decrease in protein 
synthesis can improve protein folding in the ER by a lower load of erroneously 
produced proteins and better accessibility to chaperones and the proteolytic 
pathway, which can counteract protein aggregation (Syntichaki et al., 2007, Hansen 
et al., 2007,	 Pan et al., 2007, Hipkiss, 2007, Tsaytler et al., 2011, Das et al., 2015, 
Schneider and Bertolotti, 2015). Additionally, activation of the ISR promotes the 
expression of ATF4 (ATF-5) and few other transcription factors and induces specific 
transcriptional programs that tune proteostasis mechanisms like autophagy (B'chir et 
al., 2013, Pakos-Zebrucka et al., 2016). Furthermore, ISR downstream changes in 
metabolism and amino acid uptake could be beneficial under conditions of protein 
aggregation (Harding et al., 2003, Seo et al., 2009, Wang et al., 2010a, Quirós et al., 
2017). Besides entrapping components of the PQC machinery, non-degradable 
protein aggregates might also restrict critical resources like the pool of cycling amino 
acids (Cummings et al., 1998, Chai et al., 1999). A shift in metabolism and elevation 
of amino acid biosynthesis might help to overcome this restriction of resources 
trough protein aggregation. Beyond that, it was already reported that ATF4 fulfills a 
special role in modulating toxicity of protein aggregation diseases and tissue 
maintenance. While ATF4 expression slowed down accumulation of prion and polyQ 
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aggregates, it, at the same time, contributed to age related muscle atrophy (Hetz et 
al., 2007, Sayers et al., 2013, Hernández et al., 2017). It is established that the 
extent and duration of eIF2α phosphorylation, ISR activation and ATF4 induction are 
crucial for the downstream programs and the mild induction by GFAT-1 OE seems to 
have decidedly positive effects on PQC (Pakos-Zebrucka et al., 2016).  
 
 
 
 
 
 
Chaveroux and colleagues recently identified GFAT-1 as target of activated 
GCN-2 and thereby suggested for the first time a connection between GFAT-1 and 
the ISR (Chaveroux et al., 2016). We supported this finding by data establishing that 
GFAT-1 OE, in turn, can tune the ISR. We propose that physical interaction of 
GFAT-1 and its binding partner ABCF-3 is essential to connect the HP to the ISR and 
cause the GFAT-1 OE induced PQC improvement and decrease in proteotoxicity. 
Future work on the interconnection and cross-regulation of both pathways will be 
highly interesting and could be relevant in the context of protein aggregation disease 
Figure 25. Model for the dual role of GFAT-1 in UDP-GlcNAc production and ISR modulation. 
GFAT-1 gof mutations potently increase UDP-GlcNAc production to activate PQC and decrease 
proteotoxicity via an unidentified mechanism. By contrast, OE of GFAT-1 does not elevate steady-state 
UDP-GlcNAc levels but still boosts PQC and reduces proteotoxicity by modulation of the ISR. GFAT-1 
activates GCN-2 through its binding partners ABCF-3 and GCN-1. The resulting increase in P-eIF2α  
leads to a mild induction of ATF-5, responsible for the improved proteostasis. Activation of the ISR in 
turn induces GFAT-1 expression leading to cross-talk between the HP and the ISR via a positive 
feedback loop (Chaveroux et al., 2016). PGM3, Phosphoacetylglucosamine mutase; UAP1, 
UDP-N-acetylglucosamine pyrophosphorylase 
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interventions or in the maintenance of healthy and functional skeletal muscle tissue 
during the aging process. 
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4.   Future perspectives 
 
My results presented in this thesis open up a number of important questions, 
which could initiate interesting follow-up studies. Some possible future directions are 
described in this final section. 
 
 
4.1   Analyzing an implication of GFAT-1 in ER stress resistance 
 
Our study showed that gfat-1 gof mutations do not confer a general stress 
resistance. A special role for GFAT-1 under stress conditions is, however, still likely 
as its expression is significantly upregulated upon stress. This effect was particularly 
pronounced under ER stress and we propose to further study the role for GFAT-1 in 
this context. We should also consider that GFAT-1 OE and gfat-1 gof might have 
distinct effects under ER stress conditions and therefore compare and contrast the 
different transgenic lines. 
First, one should assess the resistance of GFAT-1 OE and gfat-1 gof 
C. elegans strains in diverse ER stress conditions, such as treatment with 
thapsigargin, dithiothreitol or RNAi against factors of the ERAD machinery. With 
these experiments we can elucidate whether GFAT-1 protein levels are critical in a 
challenging environment or whether its enzymatic activity and the amount of 
UDP-GlcNAc produced also play a major role.  
Second, it could be quite informative to study the role of gfat-1 in modulating 
stress signaling pathways. To this end, one would analyze the induction of diverse 
stress-responsive pathways in GFAT-1 OE and gfat-1 gof strains in comparison to 
controls and gfat-1 RNAi treated worms. Tunicamycin, to which GFAT-1 OE and 
gfat-1 gof strains are highly resistant, as well as the previously mentioned agents 
should be used to trigger ER stress. The induction of the different branches of the 
UPR and several compartment specific chaperones as well as accumulation of 
ERAD substrate within the ER lumen could be either measured by qRT-PCR or by 
using available reporter lines. Addressing the effectiveness of autophagic and 
proteasomal protein degradation would be much more challenging but the suggested 
experiments could generate first evidence of GFAT-1 being involved in coordination 
or tuning of distinct stress pathways. 
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4.2   Investigating the role of GFAT-1 in normal muscle aging 
 
Muscular GFAT-1 OE was highly beneficial in a muscle-specific polyQ 
proteotoxicity model. Not only was the load of aggregates significantly decreased but 
also the worms´ motility could be maintained into high age when polyQ controls were 
completely paralyzed. But aggregating proteins are only one of the many causes for 
loss of muscle mass, strength and function. Especially sarcopenia is a very prevalent 
conditions and poses a public health problem as it is one of the major causes of 
disability in the elderly and a contributor to their morbidity (Baumgartner et al., 1998, 
Janssen et al., 2002, Lauretani et al., 2003, Candow and Chilibeck, 2005, Pérez-
Zepeda et al., 2017). We were wondering whether the upregulation of GFAT-1 was 
generally improving muscle tissue maintenance beyond its role in counteracting 
proteotoxicity. If GFAT-1 OE would be effective against the age-associated loss of 
muscle integrity it could open up new possibilities of sarcopenia treatment and help 
preserve the quality of life in older people. Hence, it could be highly relevant to 
compare muscle function in C. elegans controls and muscle-specific GFAT-1 OE 
strains at different age. The rather recent development of several new tools and 
techniques allows to reliably monitor many parameters of muscle function, like force 
production, speed, range of motion and an activity index in nematodes besides 
roughly assessing motility and muscle fiber architecture (Restif et al., 2014, Beron et 
al., 2015, Rahman et al., 2018). We propose that these techniques could be adapted 
to develop a comprehensive picture of the role of GFAT-1 in muscle aging. If, indeed, 
GFAT-1 OE can delay the age-associated loss of muscle function, it would be 
interesting to test whether the same downstream effectors are required as in the 
GFAT-1 OE induced polyQ resistance. 
 
 
4.3   Understanding the link between GFAT-1 and the ISR 
 
Our data indicate that tuning of the ISR by physical interaction of GFAT-1 with 
ABCF-3 is required for the GFAT-1 OE induced reduction of proteotoxicity. 
Therefore, our study supports a previous report on a connection between the HP and 
activation of GCN-2 (Chaveroux et al., 2016). However, the crosstalk between the 
metabolic HP and the ISR remains poorly understood.  
First, a pharmacological approach is possible to specifically address the need 
for increased P-eIF2α levels in transmitting GFAT-1 OE into boosting PQC. ISRIB is 
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a commercially available compound that was shown to decrease the phosphorylation 
state of eIF2α by activating its GEF eIF2B (Sidrauski et al., 2015b). Thereby, ISRIB 
prohibits the induction of the ISR with its downstream effects like the expression of 
ATF4 (ATF-5) and the set of its target genes (Sidrauski et al., 2013, Sidrauski et al., 
2015a). It would be straightforward to test whether muscle-specific GFAT-1 OE can 
still ameliorate polyQ toxicity when the ISR is blocked by ISRIB supplementation. 
This experiment can confirm or refute our current hypothesis that GFAT-1 OE 
modulates the ISR to exert its positive effects on PQC. 
Second, it is important to understand how the GFAT-1/ABCF-3 interaction 
modulates the ISR. To answer this question, one should determine the dependence 
of the PQC benefits by GFAT-1 OE on further factors of the ISR like GCN-2, PEK-1 
and ATF-5 by RNAi knock down or genetic deletions. This could generate first 
evidence of the target of the GFAT-1/ABCF-3 complex. 
Third, the generation of a C. elegans line with endogenously tagged ABCF-3 
protein by CRISPR/Cas technology would allow us to detect changes in protein 
abundance or subcellular localization caused by GFAT-1 OE, which could be 
responsible for tweaking ISR signaling. 
Finally, by performing polysome profiling, we could begin to understand 
whether GFAT-1 OE alters overall protein synthesis and specifically identify the 
subset of genes with differential active expression between GFAT-1 OE mutants and 
controls under standard conditions and under stress. It would even allow us to probe 
whether GFAT-1 is binding to translating ribosomes and whether this association is 
influenced by ABCF-3 (del Prete et al., 2007, Chassé et al., 2017, Pringle et al., 
2018). 
 
 
4.4   Further evaluation of candidates from motility screen 
 
By performing a selective RNAi suppressor screen for the GFAT-1 OE 
induced motility benefits in polyQ background we generated a list of 15 potential 
downstream effectors of GFAT-1 OE. While the deletion of the GCN-2 modulator 
ABCF-3 was shown to completely revert polyQ aggregation and progressive 
paralysis to the levels observed in controls, the other candidates were, up to now, not 
studied in more detail. Interestingly, the arginyl tRNA-synthetase rars-1 and the 
ribosomal protein lateral stalk subunit P1 rla-2 are included in the candidate list as 
well. This particular ribosomal subunit is known to interact with translation initiation 
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and elongation factors to promote translation initiation (Ito et al., 2014, Murakami et 
al., 2018, Tanzawa et al., 2018). Furthermore, the ribosomal p stalk is in close 
proximity of the ribosomal tRNA acceptor site (A site), which is the proposed site of 
action of the GCN-1/ABCF-3/GNC-2 complex (Sattlegger and Hinnebusch, 2000, 
Visweswaraiah et al., 2012, Graifer and Karpova, 2015). It could be exciting to study 
the role of GFAT-1, which we identified as binding partner of ABCF-3, RLA-2 and 
RARS-1, in this complex of translating ribosome, tRNA-synthetases, GCN-2 and 
modulators and translation initiation and elongation factor. I can imagine that its 
presence in the complex could modify its composition and the affinity of different 
molecules. Again, this could be addressed by polysome profiling as suggested 
previously. First, however, it is important to study the dependence of the GFAT-1 
downstream effects on these factors in more detail. 
Of the remaining candidates, the proteasomal subunit rpn-1, the 
mitochondrial chaperone hsp-60 and the lysosomal proton ATPase subunit vha-1 
and vacuolar protein sorting factor vps-33.1 are the only ones that provide a direct 
link to proteostasis and could therefore be considered the most promising. Beyond 
that, it is compelling to analyze the relevance of the GlcNAc-transferring tumor 
suppressor EXT gene rib-1, involved in heparin sulfate proteoglycan synthesis, in 
GFAT-1 mediated PQC changes. It is possible that GFAT-1 OE might impact on 
ECM composition trough RIB-1 and might hereby influence cell-cell interactions, 
cellular transport and multiple signaling pathways (Sarrazin et al., 2011). The study 
of these processes might, however, be challenging in C. elegans. 
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5.   MATERIALS & METHODS 
 
 
5.1   Genetics and C. elegans handling 
 
 
5.1.1   Maintenance and culture of C. elegans strains 
 
As standard all C. elegans strains were grown at 20°C on nematode growth medium 
(NGM: 2.5% bacto-agar, 0.225% bacto-peptone, 0.3% NaCl (all w/v), 1 mM CaCl2, 1 
mM MgSO4, 25 mM KPO4, 5 µg/ml cholesterol) seeded with the OP50 strain of E. 
coli bacteria unless mentioned otherwise (Brenner, 1974). The strains used in 
experiments were outcrossed at least 4 times to the N2 Bristol control strain, which 
simultaneously served as wild type reference strain. 
Generally, worms were maintained by transferring L4 larvae to fresh culture plates 
twice a week. 
In case of bacterial contaminations on culture plates, worms were collected in M9 
buffer (0.6% Na2HPO4, 0.3% KH2PO4, 0.5% NaCl (all w/v), 1 mM MgSO4) and spun 
down at 2000 x g for 2 min. Bleach solution (0.5 M KOH, 20% (v/v) NaClO) was 
added to the worm pellet. After the worms were completely dissolved and only eggs 
remained, usually after 8 to 10 min, the reaction was stopped by adding M9 buffer. 
Then the eggs were spun at 2500 x g for 2 min down, the liquid removed and after at 
least two washing steps in M9 transferred to fresh culture plates. 
 
 
5.1.2   Synchronization of worm population 
 
For all experiments with exception of the GFAT-1 IP worms were synchronized by 
short egg-lays. For that purpose gravid adults were transferred to culture plates and 
completely removed again after a period of 4 hours at the most. The eggs were 
allowed to develop and the animals collected for experiments as indicated, usually at 
late L4 larval stage or day 1 adult stage. 
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5.1.3   List of C. elegans strains 
 
N2 Bristol (wildtype),  
AA4135 dhls941[gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1 3'UTR; myo-2::mCherry] 
AGD927 uthIs270[rab-3p::xbp-1s (constitutively active); myo-2p::tdTomato] 
{Taylor:2013kw} 
AA3105 gfat-1 gof(dh468) II 
AA3106 gfat-1 gof(dh784) II 
AA3104 gfat-1 gof(dh785) II 
CB1370 daf-2(e1370) III 
KU25 pmk-1(km25) IV 
AA3589 pmk-1(km25) IV;  gfat-1(dh468) II 
PRJ112 mutEx70[pmk-1P::pmk-1::GFP; rol-6(su1006)] 
AA3882 gfat-1 gof(dh468) II; mutEx70[pmk-1P::pmk-1::GFP; rol-6(su1006)] 
AA3741 gfat-1 gof(dh784) II; mutEx70[pmk-1P::pmk-1::GFP; rol-6(su1006)] 
AA3861 gfat-1 gof(dh785) II; mutEx70[pmk-1P::pmk-1::GFP; rol-6(su1006)], 
AA4136 dhls1042[(myo-3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] 
(1)  
AA4137 dhls1042[(myo-3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] 
(2) 
AA3735 dhEx1017[(rgef-1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] 
(1) 
AA3736 dhEx1017[(rgef-1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] 
(2)  
AA4339 dhEx1095[(ges-1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry]  
AA4406 dhIs1095[(ges-1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] 
DA2123 adIs2122[(lgg-1::GFP; rol-6(su1006)] 
AA3131 gfat-1 gof (dh785) II; adIs2122[(lgg-1::GFP; rol-6(su1006)] 
AA3951 adIs2122[(lgg-1::GFP; rol-6(su1006)]; dhEx1041[pDC28; myo-2::mCherry 
(line E8)] 
AA3953 adIs2122[(lgg-1::GFP; rol-6(su1006)]; dhEx1041[pDC28; myo-2::mCherry 
(line F8)] 
AA3942 adIs2122[(lgg-1::GFP; rol-6(su1006)]; dhEx1017[(rgef-
1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA3943 adIs2122[(lgg-1::GFP; rol-6(su1006)]; dhEx1017[(rgef-
1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (2) 
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OG412 drIs20 [vha-6p::Q44::YFP+rol-6(su1006)+pBluescript II] 
AA4290 drIs20[vha-6p::Q44::YFP+rol-6(su1006) +pBluescript II]; dhls941[(gfat-
1P::FLAG-HA::cfp::gfat-1::gfat-1 3'UTR); myo-2::mCherry] 
AA4288 drIs20[vha-6p::Q44::YFP+rol-6(su1006)+pBluescript II]; dhls1042[(myo-
3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4289 drIs20[vha-6p::Q44::YFP+rol-6(su1006)+pBluescript II]; dhls1042[(myo-
3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (2) 
AA4324 drIs20[vha-6p::Q44::YFP+rol-6(su1006)+pBluescript II]; dhEx1017[(rgef-
1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4325 drIs20[vha-6p::Q44::YFP+rol-6(su1006)+pBluescript II]; dhEx1017[(rgef-
1P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (2) 
AM322 N2; rmEx135(F25B3.3p::Q86::YFP) 
AA4473 rmEx135(F25B3.3p::Q86::YFP); dhls941[(gfat-1P::FLAG-HA::cfp::gfat-
1::gfat-1 3'UTR); myo-2::mCherry] 
AA4471 rmEx135(F25B3.3p::Q86::YFP); dhls1042[(myo-3P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4478 rmEx135(F25B3.3p::Q86::YFP); dhls1042[(myo-3P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (2) 
AA4472 rmEx135(F25B3.3p::Q86::YFP); dhEx1017[(rgef-1P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AM141 rmIs133[unc-54P::Q40::YFP] 
AA4192 rmIs133[unc-54P::Q40::YFP]; dhls941[(gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1 
3'UTR); myo-2::mCherry] 
AA4190 rmIs133[unc-54P::Q40::YFP]; dhls1042[(myo-3P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4191 rmIs133[unc-54P::Q40::YFP]; dhls1042[(myo-3P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (2) 
AA4223 rmIs133[P(unc-54) Q40::YFP]; dhIs1017[(rgef-1P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AM140 rmIs132[unc-54P::Q35::YFP] 
AA4234 rmIs132[unc-54P::Q35::YFP]; dhls941[(gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1 
3'UTR); myo-2::mCherry] 
AA4230 rmIs132[unc-54P::Q35::YFP]; dhls1042[(myo-3P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4233 rmIs132[unc-54P::Q35::YFP]; dhls1042[(myo-3P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (2) 
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AA4296 rmIs132[unc-54P::Q35::YFP]; dhEx1017[(rgef-1P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4297 rmIs132[unc-54P::Q35::YFP]; dhEx1017[(rgef-1P::HA::FLAG::CFP::gfat-
1::gfat-1 3´UTR); myo-2::mCherry] (2) 
AA3173 N2; dhEx940[(gfat-1P::FLAG-HA::CFP::gfat-1 3'UTR); myo-2::mCherry] 
AA4200 gcn-2(ok871) II; pek-1(ok275) X 
AA4423 ldIs[atf-5P::GFP::unc-54 3'UTR] (kindly provided by Dr. Keith Blackwell) 
AA4474 ldIs[atf-5P::GFP::unc-54 3'UTR]; dhls941[(gfat-1P::FLAG-HA::cfp::gfat-
1::gfat-1 3'UTR); myo-2::mCherry] 
AA4479 abcf-3(ok2237) III; rmIs132[unc-54P::Q35::YFP] 
AA4554 abcf-3(ok2237) III; rmIs132[unc-54P::Q35::YFP]; dhls1042[(myo-
3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4493 abcf-3(ok2237) III; rmIs132[unc-54P::Q35::YFP]; dhls1042[(myo-
3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (2) 
AA4561 gcn-1(n4827) III; rmIs132[unc-54P::Q35::YFP] 
AA4560 gcn-1(n4827) III; rmIs132[unc-54P::Q35::YFP]; dhls1042[(myo-
3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (1) 
AA4559 gcn-1(n4827) III; rmIs132[unc-54P::Q35::YFP]; dhls1042[(myo-
3P::HA::FLAG::CFP::gfat-1::gfat-1 3´UTR); myo-2::mCherry] (2)	
 
All underlined strains were generated in this work by molecular cloning and 
microinjections, crossing or UV integration. 
 
 
5.1.4   Genotyping by PCR and TagMan SNP analysis 
 
In case genotyping was not possible by phenotypic assessment, Taq polymerase 
chain reaction (PCR) and agarose gel electrophoresis or SNP analysis by TaqMan 
were conducted. As template served the lysate obtained from incubating a single 
worm in 10 µl (for PCR) or 5 µl (for TaqMan SNP mapping) single worm lysis buffer 
(10mM Tris pH 8.3, 50mM KCl, 2.5 mM MgCl2, 0.45% Tween 20, 0.45% Triton X-100 
(all v/v), 1mg/ml proteinase K (NEB)) for 60 min at 65°C and subsequently 15 min at 
95°C. 
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PCR reaction composition 
 
PCR program 
      H2O 9.49  µl 
 
  95°C   5 min 
 Taq Buffer 1.50  µl 
    50mM MgCl 0.45  µl 
 
  95°C   45 sec 
 10mM dNTPs 0.15  µl 
 
≈ 60°C    30 sec 30 x 
DMSO 0.35  µl 
 
   72°C ~ 60 sec/kb 
 Taq Polymerase 0.06  µl 
    Primer FW 0.75  µl 
 
  72°C   10 min 
 Primer RV 0.75  µl 
    single worm lysate 1.50  µl 
     
Genotyp
e PCR primer Tanneal telong PCR product 
     
pmk-1 
(km25) 
FW 
GTTTCCACAGACAACAATGGATC  
RV   
CGTATCCAGTCATTTCAGAATCAG 
65°C 45 sec 
WT: 
622bp                  
mutant: - 
     
abcf-3 
(ok2237) 
FW    
GTGGACGAGCTAACAGCTTC 
RV    
CCACGGAAGCTTGAAGATG 
RV2  
CAACGGTAGTTGGAGTATCTC 
58°C 35 sec 
WT:  
354bp 
+561bp 
mutant: 
354bp 
 
For TaqMan SNP mapping of gcn-1(n4827) specific primers were designed by and 
purchased from Applied Biosystems. The reaction was run according to 
manufacturer´s instructions on a ViiA 7 Real-Time PCR system with corresponding 
software. Each sample was run in technical duplicates and wildtype and mutant 
animals were included as controls in every reaction. 
 
TaqMan reaction composition 
  TaqMan Universal Master Mix II (2x), with UNG 5  µl 
Primers Master Mix (40x) 0.25  µl 
H20 2  µl 
single worm lysate 2.75  µl 
 
 
5.1.5   Gene knockdown by RNAi 
 
For RNAi-mediated knockdown of a specific gene worms were cultured from egg or 
L4 stage onward on E. coli HT115 (DE3) bacteria expressing dsRNA of the target 
gene under the control of an IPTG-inducible promoter (Timmons and Fire, 1998, 
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Kamath et al., 2001). NGM plates for RNAi experiments contained a final 
concentration of 100 µg/µl ampicillin and 1mM IPTG to select for vector carrying 
HT115 bacteria and induce dsRNA expression. All RNAi clones used in this study 
were obtained from either the Ahringer or Vidal library (Kamath and Ahringer, 2003, 
Rual et al., 2004). All clones, despite excluded candidates from the RNAi suppressor 
screen, were confirmed by plasmid purification (MiniPrep, Qiagen) and sequencing 
with the L4440 seq RV primer. 
 
 
5.1.6   UV integration of extrachromosomal arrays 
 
L4 larvae and young adults expressing a plasmid as extrachromosomal array were 
UV irradiated (0.03 Joule/cm2 on Viber Lourmat BLX-254 crosslinker) to achieve 
stable integration of the transgene in the genome. The at least 100 irradiated P0 
worms were kept in the dark for at least 24h to prevent further light induced DNA 
damage. At least 4 F1 animals of every surviving P0 worm were singled out and the 
F2 and F3 generation were scanned for stable integrands, which were then 
outcrossed to controls at least 4 times. 
 
 
5.1.7   Worm imaging  
 
General handling of C. elegans was done on a Leica M80 stereomicroscope. 
Worm stacks were arranged on unseeded NGM plates on ice and images were taken 
on a Leica M165FC fluorescence microscope using a Leica DFC 3000G camera and 
Leica Application Suite. The worm area was determined and the mean pixel 
intensity/worm area calculated using Photoshop (Microsoft office).  
Images of single worms at higher magnification were obtained on a Carl Zeiss Axio 
Imager Z1 connected to a Zeiss Axiocam 506 mono camera using AxioVision 
software. Pictures were processed and fluorescence intensity was determined using 
Adobe Photoshop CS5. 
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5.1.8   PolyQ aggregate quantification 
 
Quantification of polyQ aggregates in C. elegans intestine and muscle was done 
from images of aligned worms taken on a Leica M165FC fluorescence microscope 
(see 5.1.7) at magnification of about 8 fold. The worms were synchronized to a 4 
hours time window and were grown until analysis at late L4 larval stage in 
unc-54P::Q40 background, at day 4 adult stage in unc-54P::Q35 background and in 
day 8 adult stage in vha-6P::Q44 background. Images of 10 worms were taken for 
each biological replicate, the colors were inverted in Photoshop for easier aggregate 
distinction and aggregates were counted by eye. To avoid bias worms were selected 
and arranged for analysis on a Leica M80 light microscope and aggregate 
quantification was performed blinded. 
 
 
5.1.9   Motility assay 
 
To assess motility in a swimming assay worms were synchronized to a 4 hours time 
window and were cultured at standard conditions to day 5, day 8, day 10 or day 12 of 
adulthood as indicated in individual experiments. Worms that were able to move at 
least slightly after touch stimulus on culture plates were transferred to M9 buffer on 
unseeded NGM plates and were allowed to adjust to new conditions for about 30 
sec. Afterwards full body bends within a 30 sec interval were recorded by counting. 
Except for the RNAi suppressor screen 15 worms per genotype and condition were 
analyzed for each biological replicate. To avoid bias all experiments were carried out 
blinded. 
 
 
5.1.10   Selective RNAi screen for gfat-1 mediators 
 
Eggs of the muscular gfat-1 OE strain AA4137 were collected in M9 after bleaching 
and roughly 50 eggs were transferred to NGM plates containing 40 µM 5-Fluoro-2′-
deoxyuridine (FUDR, Sigma), seeded with HT115 bacteria expressing select RNAi 
clones. If animals showed a strong developmental delay or appeared sick, RNAi 
knockdown of the specific genes was only started at late L4 larval stage. At day 4 of 
adulthood worms were transferred to fresh culture plates and at day 12 motility was 
assessed on plates by comparing to luciferase, gfat-1 and gna-2 RNAi as well as the 
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polyQ strain without gfat-1 OE as controls. Therefore worms were picked to a 
marked small circle on culture plate and their ability to leave the circle within 1 minute 
was scored. Worms that performed similar to gfat-1 and gna-2 RNAi or the polyQ 
strain on luciferase RNAi were evaluated in a motility assay as described in 5.1.9 
with only 3 worms per test condition and 5 worms per control condition. RNAi clones 
causing motility within the range of error of gfat-1 and gna-2 RNAi controls or the 
polyQ strain on luciferase RNAi were defined as primary hits. The effect of these 
candidate RNAi clones was next measured in the polyQ background without gfat-1 
OE (AM140) as counter screen. The worms were grown to day 5 of adulthood and a 
motility assay performed as described above. If the motility on specific RNAi clones 
was below the range of error of luciferase, gfat-1 and gna-2 RNAi as controls the 
candidates were not considered secondary hits and excluded from further analysis. 
The remaining candidates were confirmed in another round of screening at day 10 
and counter screening at day 5 and without FUDR in culture plates. The same 
criteria as previously described were applied to exclude candidates and determine 
true hits. 
 
 
5.1.11   Stress assays 
 
To analyze the effect of stress on gfat-1 mRNA expression wildtype N2 Bristol worms 
were cultured to late L4 larval stage under standard condition. Subsequently they 
were exposed to stress conditions for 8h, harvested, RNA was extracted and mRNA 
levels compared. To check the effect of stress on GFAT-1 protein expression 
gfat-1P::CFP::gfat-1 worms were, likewise, grown to late L4 larval stage under 
standard condition and images were taken after 14 h exposure to stress conditions. 
C. elegans was shifted to 30°C to induce heat stress or transferred to culture plates 
containing 10 µg/ml Tunicamycin. Worms kept on standard NGM/OP50 plates served 
as reference.  
Worms were exposed to 100 mM Paraquat, 5 µM Thapsigargin or 2% Glucose in 
liquid medium (100 mM NaCl, 0.1% K2HPO4, 0.6% KH2PO4 (all w/v), 5 µg/ml 
cholesterol) containing OP50 bacteria, or exposed to starvation in M9 buffer. As 
control for these conditions worms were grown in liquid medium containing OP50 
bacteria. All nematodes kept in liquid medium were slowly shaken at 20°C. 
Tunicamycin resistance of transgenic C. elegans strains was tested on NGM plates 
containing 0, 4, 6, 8 or 10 µg/ml Tunicamycin as described previously (Denzel et al., 
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2014). At least 75 eggs per strain and concentration were transferred to Tunicamycin 
plates. All animals that developed to L4 larval stage or adulthood after 4 days were 
scored as resistant. Paraquat resistance was tested by transferring 60 late L4 C. 
elegans larvae to NGM plates containing 50mM Paraquat. The survival was scored 
after 24 h. 
 
 
5.1.12   Lifespan analysis 
 
Worms were synchronized by egglay and adult lifespan analysis was performed with 
180 animals per genotype at 20°C on E. coli OP50. The young adult stage was 
defined as day 0 and survival was scored every day or every second day. 
Worms with internal hatching or bursting vulva as well as worms that crawled off the 
agar were censored. 
 
 
5.2   Molecular biology 
 
 
5.2.1   Molecular cloning 
 
Plasmids for tissue-specific overexpression of gfat-1 were constructed using a 
GeneArt® Seamless PLUS Cloning and Assembly Kit (Invitrogen) according to 
manufacturer´s instructions. DNA fragments were generated by PCR with Phusion® 
High-Fidelity DNA Polymerase (NEB) with proofreading capacity. All promoter 
fragments for tissue-specific gfat-1 expression were amplified from genomic DNA of 
wildtype C. elegans. The gfat-1 ORF and 3UTR of 3,354 bp as well as the pDC6 
vector were amplified from the gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1-3´UTR plasmid 
(Denzel et al., 2014). Promoter, ORF and vector fragments were fused in a single 
reaction using the following manufacturer´s instructions. 
Assembled plasmids were transformed by 45 sec heat shock at 42°C into chemically 
competent E. coli DH5α (self made) and positive clones selected by Ampicillin 
resistance. 
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Plasmids were purified using Mini- or Midikits (Qiagen) following manufacturer’s 
instructions and the correct assembly of fragments was confirmed for each plasmid 
by sequencing (eurofins Genomics). 
 
Target   Sequence 
myo-3P FW CAGGTCGACTCTAGATATGGTGGCCGATTTTGAGT RV TACCGGATCCTCTAGATTAGATGGATCTAGTGGTCG 
rgef-1P FW TCTAGAATCCCGTTTGGGACAAGAA RV TACCGGATCCTCTAGACGTCGTCGTCGTCGATGCCG 
ges-1P FW GCAGGTCGACTCTAGAAAGCTTAATGAAGTTTATTTC RV TACCGGATCCTCTAGACTGAATTCAAAGATAAGATA 
gfat-1 ORF FW ATGTGCGGAATTTTCGCCTA RV TTACTCGACGGTAACTGACT 
vector 1 
(tags) 
FW CTAGAGGATCCGGTACCGGTA 
RV GAAAATTCCGCACATACCGATCCCACCTCCGCCTTTG 
vector 2 
(backbone) 
FW GTTACCGTCGAGTAAAGCGTCCCGTCTTCTGCCCA 
RV TCTAGAGTCGACCTGCAGGC 
 
 
5.2.2   RNA extraction and quantitative RT-PCR 
 
Populations of about 500 L4 larvae or day1 adult C. elegans were harvested in M9 
and after 2 washing steps in cold M9 the worm pellet taken up in 700 µl QIAzol 
reagent (Qiagen) and snap frozen in liquid nitrogen. The samples were subjected to 
6 freeze/thaw cycles (liquid nitrogen/37°C water bath) and homogenization with 1.0 
mm Zirconia/Silica beads (FisherScientific) in a TissueLyser LT (Qiagen) for 15 min 
at full speed to crack the worms´ cuticle and release RNA. 120 µl Chloroform were 
added to 600 µl QIAzol solution, the components were mixed by vortexing and 
incubated for 2 min at RT. After 15 min centrifugation at 12000 x g and 4°C the 
aqueous phase was collected for total RNA extraction using the RNeasy Mini Kit 
(Qiagen) according to manufacturer’s instructions. The RNA quantitiy and quality 
were determined on a NanoDrop 2000c (peqLab) and cDNA was prepared using  
the iScript cDNA Synthesis Kit (BioRad). Power SYBR Green Master Mix (Applied 
Biosystems) was used to quantify cDNA on a ViiA 7 Real-Time PCR system (Applied 
Biosystems). For each sample four technical replicates were pipetted on a 384-well 
plate by use of the JANUS automated workstation (PerkinElmer). The expression of 
target RNA was calculated from comparative CT values, normalized to ama-1 as 
internal control, and compared to wildtype or untreated controls using the 
corresponding ViiA 7 software. All unpublished primers were validated by 
determination of their standard curves and melting properties. 
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     Target   Sequence published 
ama-1 FW GGATGGAATGTGGGTTGAGA Denzel et al., 2014 RV CGGATTCTTGAATTTCGCGC 
cdc-42 FW CTGCTGGACAGGAAGATTACG 
  
RV CTCGGACATTCTCGAATGAAG 
ctl-1 FW AGGTGATGTTCCTCTACTCGG RV TTCTTGGAACCTTGAGCAGG 
ctl-2 FW TGGTTAACAAGGACGGAAAGGC RV TCTTCACTCCTTGAGTTGGCTTG 
gfat-1 FW GTCCAACCACGCTACTCATTTGC 
Denzel et al., 2014 RV TGACAGGTCCAGAATGTTGTTTGG 
gna-2 FW ACATTCACGAAGCGGGAACACG RV GTGACAACTTGTAGACGCCAATCG 
gst-4 FW GCCAGCTTCCCATTTTACAAG 
  
RV TTGATCTACAATTGAATCAGCGTAAG 
sod-1 FW AATCCGAGATCCGTCACGTAGG 
RV CGTCTTGTCCGGCATGAACAAC 
sod-2 FW AGCTTGTTCAACCGATCACAGGA RV TGGTAAATCTGGCAGCGAGTGC 
sod-3 FW CACGAGGCTGTTTCGAAAGG 
Denzel et al., 2014 
RV GAATTTCAGCGCTGGTTGGA  
xbp-1 FW CCGATCCACCTCCATCAAC 
RV ACCGTCTGCTCCTTCCTCAATG  
xbp-1s FW TGCCTTTGAATCAGCAGTGG  RV ACCGTCTGCTCCTTCCTCAATG  
C17H12.8 FW TTTGAAAGAATGCTGAACAC 
Ermolaeva et al., 
2013 
RV CAATCGACAGTGAAATTCTC 
K08D8.5 FW CTTTTCATGGGATTGGATACTGCG 
RV GACTCTCACGTTTGCATTGTATGG 
T24B8.5 FW CTGTAACGAAGCAGATGTTAGAAGTG RV GGGCATTGTTCAGCAATATTTTCATC 
 
 
 
5.3   Biochemistry 
 
 
5.3.1   LC-MS/MS Analysis 
 
Synchronized populations of about 3000 day 1 adult worms in at least 4 biological 
replicates per strain were used for analysis. 
The worms were harvested in M9 and after 2 washing steps in cold M9 and 1 
washing step in ddH2O the pellets were snap frozen in liquid nitrogen. The samples 
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were subjected to 6 freeze/thaw cycles (liquid nitrogen/37°C water bath) and 
sonication pulses. The total protein content of the sample was measured using BCA 
Protein Assays (Thermo Fisher) and UDP-HexNAc extraction was achieved in 
Chloroform::Methanol (1:2) for 1h on a nutator. After spinning the samples 5 minutes 
at high speed in a tabletop centrifuge the same volume of supernatant of each 
sample was transferred to glass vials. The liquid was evaporated in a EZ-2 Plus 
Genevac (SP Scientific) with following settings: time to final stage 15 min, final stage 
4 h, low BP mixture. 
The determination of absolute amounts of UDP-HexNAc were carried out by Yvonne 
Hinze and Jeanette Hütges from the Proteomics Core facility as described previously 
(Denzel et al., 2014). 
 
 
5.3.2   Western blot analysis 
 
For Western blot analysis synchronized young adult or gravid day 1 adult worms 
were collected in M9, snap frozen in liquid nitrogen and lysed in 4x LDS sample 
buffer (Thermo Fisher) containing 50 mM DTT. After a boiling and a sonication step, 
equal volumes were subjected to reducing SDS-PAGE and transferred to 
nitrocellulose membranes. Following antibody staining of specific proteins, the bands 
were detected on a ChemiDoc MP Imaging System (BioRad) and the intensity 
quantified using the corresponding Image Lab software (BioRad). 
 
 
5.3.3   Immunoprecipitation 
 
A mixed population of gfat-1P::Flag::HA::CFP::gfat-1 and gfat-1P::Flag::HA::CFP 
worms was collected and washed in M9 buffer and lysed on ice in IP Lysis buffer 
(10 mM Tris/HCl pH 7.4, 150 mM NaCl, 0.5 mM EDTA, 1% NP-40, cOmplete Mini 
Protease and phosphatase Inhibitor Cocktail (Roche)) using a dounce homogenizer.  
The total protein content of the lysates was measured using BCA Protein Assays 
(Thermo Fisher). 50 µl Dynabeads Protein G (Thermo Fisher) were coated with 5 µg 
anti-FLAG M2 antibody (Sigma) following manufacturer´s instructions and incubated 
with 1 mg worm lysate at 4°C for 1 h. After three washing steps in IP Lysis buffer and 
two washing steps in IP Wash Buffer (as IP Lysis buffer but without NP-40) the 
precipitating proteins were either eluted with Flag peptide in 50mM Tris/HCl ph 7.4, 
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120 mM NaCl for analysis by Western Blot or Silver gel or directly digested from the 
beads by 30 min and over night incubation with 1.5 µg Trypsin Gold (Promega) in 
20 mM Tris pH 8.3 for mass spectrometric analysis. 
Non-selective visualization of all precipitating was achieved using a Pierce Silver 
Stain Kit (Thermo Fisher) according to manufacturer´s instructions. 
 
 
5.3.4   Fractionation of SDS soluble and SDS insoluble polyQ peptides 
 
Synchronized day 1 adult C. elegans were harvested and washed in M9 and lysed in 
RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% SDS, 0.5% SDO, 
1% NP40, cOmplete Mini Protease and phosphatase Inhibitor Cocktail (Roche)) by 
freeze/thaw cycles and sonication. The insoluble material was pelleted by 20 min 
centrifugation at 4°C and 16,000 x g. The supernatant was collected as soluble 
fraction and the pellet was washed in RIPA buffer and after centrifugation solubilized 
in urea/SDS buffer (8 M urea, 50 mM Tris pH 8, 2% SDS, 50 mM DTT). Protein 
fractions were then mixed with 4x LDS sample buffer (Thermo Fisher) and separated 
and visualized by SDS PAGE and immunoblotting. 
To detect total amounts of SDS soluble and insoluble polyQ fragments worms were 
directly collected in urea/SDS buffer, snap frozen in liquid nitrogen and proteins 
separated and detected by SDS PAGE and immunoblotting. 
 
 
5.3.5   SILAC labeling of C. elegans 
 
Stable isotope labeling with amino acids in C. elegans was carried out as described 
previously by Larance and colleagues (Larance et al., 2011) with the following 
adaptions: 
The agarose content of NGM-N plates was increased from 12 g/l to 13 g/l and plates 
were prepared without Nystatin, only heavy isotope 15N2/13C6-lysine was used for 
labeling, it was abstained from using orn-1 RNAi and total protein samples were 
digested with rLys-C (Promega) instead of trypsin, E. coli SLE1 bacteria were 
concentrated 10 fold instead of 50 fold, the C. elegans population was synchronized 
prior to analysis by 4h egglay instead of filtering, the proteome of the fourth 
C. elegans generation grown on SLE1 bacteria was analyzed. 
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5.3.6   Proteomic Analysis (by Xinping Li and Ilian Atanassov, MPI core facility) 
 
C. elegans samples for proteomic analysis were boiled in lysis buffer (100 mM Tris, 
6 M Guanidinium chloride, 10 mM Tris(2-carboxyethyl)phosphine hydrochloride, 
40 mM 2-Chloroacetamide) for 10 min, lysed at high performance in 10 cycles of 30 s 
soncation intervals in a Bioruptor Plus sonication device (diagenode) and boiled 
again. The samples were spun at 20000 x g for 20 min to get rid of debris.  
The samples were diluted 1:10 in 20 mM Tris pH 8.3 / 10% acetonitrile (ACN) and 
after the protein concentration was measured using BCA Protein Assays (Thermo 
Fisher) the samples were digested over night with according amounts of Trypsin 
Gold (Promega) or rLys-C (Promega) in case of SILAC experiments. 
The peptides were cleaned on a Supelco Visiprep SPE Vacuum Manifold (Sigma) 
using OASIS HLB Extraction cartridges (Waters). The columns were conditioned 
twice with Methanol, equilibrated twice with 0.1% formic acid, loaded with the 
sample, washed three times with 0.1% formic acid and the peptides eluted with 60% 
ACN / 0.1% formic acid. Then, the samples were dried at 30°C for roughly 4 h in a 
Concentrator plus speedvac (Eppendorf) set for volatile aqueous substances. The 
dried peptides were taken up in an adequate volume of 0.1% formic acid (usually in 
20 µl) and the samples were analyzed by the Max Planck Proteomic Core facility for 
analysis according to the following protocol:  
Peptides were separated on a 25 cm, 75 µm internal diameter PicoFrit analytical 
column (New Objective) packed with 1.9 µm ReproSil-Pur 120 C18-AQ media (Dr. 
Maisch) using an EASY-nLC 1200 (Thermo Fisher Scientific). The column was 
maintained at 50°C. Buffer A and B were 0.1% formic acid in water and 0.1% formic 
acid in acetonitrile. Peptides were separated on a segmented gradient from 2% to 
5% buffer B for 10 min, from 5% to 20% buffer B for 180 min, from 20% to 25% 
buffer B for 20 min and from 25% to 40% buffer B for 10 min. Alternatively, peptides 
were separated from 2% to 5% buffer B for 10 min, from 5% to 20% buffer B for 
180 min, from 5% to 20% buffer B for 90 min and from 20% to 40% buffer B for 
45 min at 200 nl/min. Eluting peptides were analyzed on a QExactive Plus or 
QExactive HF mass spectrometer (Thermo Fisher Scientific). Peptide precursor m/z 
measurements were carried out at 70000 (QExactive Plus) or 120000 (QExactive 
HF) resolution in the 300 to 1800 m/z range. Only the top ten most intense 
precursors with charge state from 2 to 7 were selected for HCD fragmentation using 
27% normalized collision energy. The m/z values of the peptide fragments were 
measured at a resolution of 17500 (QExactive Plus) or 15000 (QExactive HF) using 
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a minimum AGC target of 2e5 and 80 ms maximum injection time. Upon 
fragmentation, precursors were put on a dynamic exclusion list for 20 or 45 sec. 
To identify and quantify proteins the raw data were analyzed with MaxQuant version 
1.6.1.0 (Cox and Mann, 2008) using the integrated Andromeda search engine (Cox 
et al., 2011). Peptide fragmentation spectra were searched against the canonical 
sequences of the C. elegans reference proteome (proteome ID UP000001940, 
downloaded September 2018 from UniProt). Methionine oxidation and protein N-
terminal acetylation were set as variable modifications; cysteine 
carbamidomethylation was set as fixed modification. The digestion parameters were 
set to “specific” and “LysC/P”. The minimum number of peptides and razor peptides 
for protein identification was 1; the minimum number of unique peptides was 0. 
Protein identification	was performed at a peptide spectrum matches and protein false 
discovery rate of 0.01. The “second peptide” option was “on”. Successful 
identifications were transferred between the different raw files using the “Match 
between runs” option. SILAC quantification was performed using a minimum ratio 
count of two. The results from the protein quantification (ProteinGroups.txt) were 
filtered against Possible contaminants, “Reverse” and “Only” identified by site. The 
SILAC ratios were log2 transformed and tested for differential expression using 
limma (Ritchie et al., 2015). 
 
 
5.3.7   Antibodies 
 
The following primary antibodies were used in this study: Phospho-p38 MAPK 
(#3597 Cell Signaling, rabbit monoclonal), GFP (JL-8 Living Colors, mouse 
monoclonal and #2956 Cell Signaling, rabbit monoclonal), β-Actin (ab8224 abcam, 
mouse monoclonal), Histone H3 (ab1791 abcam, rabbit polyclonal), α-Tubulin 
(T6199 Sigma, mouse monoclonal), Phospho-eIF2α (#3597 Cell Signaling, rabbit 
monoclonal), 
The following horseradish peroxidase conjugated antibodies were used in this study: 
anti-mouse IgG (G-21040 Invitrogen, goat polyclonal), anti-rabbit IgG (G-21234 
Invitrogen, goat polyclonal) 
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5.4   Statistical analysis 
 
Results are presented as mean + SD or SEM or mean ± SD or SEM as indicated. 
Statistical analyses were performed using 1way ANOVA or 2way ANOVA with 
Tukey´s, Sidak´s or Dunnett´s multiple comparisons test or unpaired t-test. The 
program used was GraphPad Prism (GraphPad software). Significance levels are 
*, p<0.05, **, p<0.01, ***, p<0.001 and ****, p<0.0001 versus respective control. 
 
 
5.5   Software 
 
Most graphs were produced and statistical analyses performed using GraphPad 
PRISM 6. 
GFAT-1 sequence alignments were generated using Clustal Omega and ESPript 3.0 
(Sievers et al., 2011), (Robert and Gouet, 2014). A section of the molecular GFAT-1 
protein structure was depicted with PyMOL using pdb code 4AMV. 
Data from SILAC and GFAT-1 IP experiments was graphically displayed using 
Instant Clue (Nolte et al., 2018). 
Bands on Western blots were quantified using Image Lab Software (Bio-Rad 
Laboratories GmbH). 
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7. Appendix 
 
 
Contributions 
 
I performed all experiments described in this work independently, except for: 
 
RNA sequencing on gfat-1 gof (dh468) C. elegans strain and controls (Figure 11A) – 
done by Dr. Martin Denzel (former Antebi lab member) 
 
MS analysis of SILAC samples of gfat-1 gof C. elegans strain and controls 
(Figure 11B) and of eluate after GFAT-1 and control co-IP (Figure 20C and 20D) – 
done in collaboration with Dr. Ilian Atanassov and Dr. Xinping Li (Proteomic core 
facility, Max Planck Institute for Ageing Research) 
 
LC-MS analysis of UDP-HexNAc content in C. elegans samples (Figure 13D and 
18F) - done in collaboration with Yvonne Hinze and Jeanette Hütges (Metabolomic 
core facility, Max Planck Institute for Ageing Research) 
 
Site directed mutagenesis to generate expression vectors for GFAT-1K720R, 
generation of associated C elegans strains and conduction of related experiments 
(Figure 19C, 19D and 19E) – done by Master student Vignesh Karthikaisamy under 
my supervision 
 
Thanks to all these people for their important contributions. 
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Summplementary Material 
List of all genes tested in the selective RNAi suppressor screen for motility improvement 
B0218.3 pmk-1 
hits from 
RNAseq 
 
F07A11.3 npp-5 
known 
physical 
interactors of 
GFAT-1 and 
interactors 
identified by 
IP and MS 
C29F7.5 fkh-4 
 
F10G7.2 tsn-1 
C55C3.3   
 
F14B4.3 rpoa-2 
C55C3.6   
 
F17C11.9 eef-1G 
C55C3.7   
 
F18H3.3 pab-2 
F42G8.3 pmk-2 
 
F20D12.1 csr-1 
F42G8.4 pmk-3 
 
F21D5.1   
K10G6.1 lin-31 
 
F22B3.4 gfat-2 
T10D4.6a   
 
F26D10.10 gln-5 
T28F2.1   
 
F26D10.3 hsp-1 
T28F2.5   
 
F26E4.8 tba-1 
    
F26F4.10 rars-1 
C34B2.8 NDUFA13 
regulated in 
first SILAC 
experiment 
 
F28C6.3 cpf-1 
F22D6.4 nduf-6 
 
F32B6.2 mccc-1 
F45H10.3 NDUFA7 
 
F32H2.5 fasn-1 
F53F4.10 NDUFV2 
 
F37C12.9 rps-14 
F59A2.3 cri-3 
 
F39B2.10 dnj-12 
F59C6.5 NDUFB10 
 
F40A3.6   
W01A8.4 nuo-6 
 
F41E7.5 fipr-21 
Y54E10BL.5 nduf-5 
 
F42A10.1 abcf-3 
    
F43D9.4 sip-1 
B0024.12 gna-1 
known physical 
interactors of 
GFAT-1 and 
interactors 
identified by IP 
and MS 
 
F44E5.4   
B0303.3   
 
F45E4.2 plp-1 
B0336.10 rpl-23 
 
F46F11.2 cey-2 
B0432.4 misc-1 
 
F47B10.1 suca-1 
C02C6.1 dyn-1 
 
F49H12.5   
C04F6.1 vit-5 
 
F53A2.7 acaa-2 
C05E4.9 icl-1 
 
F54B3.3 atad-3 
C05G5.4   
 
F55A8.2 egl-4 
C07H6.5 cgh-1 
 
F55H2.6 clu-1 
C08H9.2  vgln-1 
 
F56D12.5 vig-1 
C13B9.3   
 
F56E10.4 rps-27 
C23G10.3 rps-3 
 
F56H1.4 rpt-5 
C23G10.4 rpn-2 
 
F57F10.1 abts-3 
C26F1.4 rps-30 
 
F58B3.5 mrs-1 
C27D11.1 egl-45 
 
H43I07.2 rpac-40 
C28D4.3 gln-6 
 
K01C8.1   
C28H8.3   
 
K01C8.9 nst-1 
C30C11.2 rpn-3 
 
K02F3.2   
C36E8.5 tbb-2 
 
K07C5.4   
C42D8.2 vit-2 
 
K09F5.2 vit-1 
C53A5.1 ril-1 
 
K11E8.1 unc-43 
D2023.2 pyc-1 
 
K11H3.3   
D2085.1 pyr-1 
 
M01E11.5 cey-3 
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R02D3.1   
known 
physical 
interactors of 
GFAT-1 and 
interactors 
identified by 
IP and MS 
 
Y74C10AR.1 eif-3.I 
known 
physical 
interactors of 
GFAT-1 and 
interactors 
identified by 
IP and MS 
R03D7.1 metr-1 
 
Y87G2A.5 glp-4 
R09A1.1 ergo-1 
 
Y87G2A.8 gpi-1 
R11A5.4 pck-2 
 
ZC434.5 ears-1 
R11A8.6 irs-1 
 
ZK381.4 pgl-1 
T01C3.7 fib-1 
 
ZK593.5 dnc-1 
T02G5.9 kars-1 
 
ZK669.4   
T04A8.5   
 
ZK829.4 gdh-1 
T05F1.1 nra-2 
 
ZK973.6 anc-1 
T05G5.3 cdk-1 
    T07A9.9   
 
B0025.1 vps-34 
autophagy 
T07D3.9   
 
B0261.2 let-363 
T08B2.7 ech-1.2 
 
B0336.8 lgg-3 
T10B10.2 ucr-2.2 
 
C32D5.9 lgg-1 
T20H4.3 pars-1 
 
M7.5 atg-7 
T21E12.4 dhc-1 
 
T19E7.3 bec-1 
T21G5.3 glh-1 
 
T22H9.2 atg-9 
T22D1.9 rpn-1 
 
ZK593.6 lgg-2 
T24C4.1 ucr-2.3 
    T27E4.3 hsp-16.48 
 
B0205.3 rpn-10 
proteasome 
T27E4.8 hsp-16.1 
 
C47E12.5 uba-1 
T28D6.2 tba-7 
 
F23F1.8 rpt-4 
W01B11.3 nol-5 
 
F25B5.4 ubq-1 
W06H3.1 immt-2 
 
F57B9.10 rpn-6.1 
W07E11.1   
 
T06D8.8 rpn-9 
W08E3.3 ola-1 
 
T19E7.2 skn-1 
W09B6.1 pod-2 
 
Y110A7A.14 pas-3 
W09C5.6  rpl-31 
 
Y38A8.2 pbs-3 
Y106G6H.2  pab-1 
    Y18D10A.17 car-1 
 
C15H9.6 hsp-3 
ER PQC, 
UPR and 
chaperones 
Y41E3.10 eef-1B.2 
 
C41C4.4 ire-1 
Y41E3.4 qars-1 
 
F43E2.8 hsp-4 
Y43F4B.5   
 
F45E6.2 atf-6 
Y46G5A.31 gsy-1 
 
F46C3.1 pek-1 
Y46H3A.2 hsp-16.41 
 
F54C9.2 stc-1 
Y48G9A.3 gcn-1 
 
R74.3 xbp-1 
Y54E10A.9 vbh-1 
 
T05E11.3 enpl-1 
Y54E2A.11 eif-3.B 
 
Y38A10A.5 crt-1 
Y55F3AM.8 immp-2 
 
Y53C10A.12 hsf-1 
Y59A8A.3 tcc-1 
 
ZK632.6 cnx-1 
Y62E10A.1 rla-2 
    Y66H1A.2 dpm-1 
    Y66H1B.2 fln-1 
    Y71F9AL.17 copa-1 
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C30H6.6 haf-1 
MT PQC, UPR 
and 
chaperones 
 
B0205.4   
glycosylation 
C37H5.8 hsp-6 
 
B0285.5 hse-5 
F22B7.5 dnj-10 
 
B0464.4 bre-3 
F46F11.4 ubl-5 
 
C03E10.4 gly-20 
Y22D7AL.5 hsp-60 
 
C08B11.8   
ZC376.7 atfs-1 
 
C08H9.3   
ZK1193.5 dve-1 
 
F12F6.3 rib-1 
    
F13H10.4 mogs-1 
C47E12.3 edem-1 
ERAD 
 
F14B6.6   
F19B6.2 ufd-1 
 
F21D5.1   
F45D3.5 sel-1 
 
F26H9.8 uggt-2 
F55A11.3 sel-11 
 
F48C1.1 aman-3 
    
F48E3.3 uggt-1 
C09B8.6 hsp-25 
chaperones 
 
F56H6.5 gmd-2 
C12C8.1 hsp-70 
 
K04G7.3 ogt-1 
F26D10.3 hsp-1 
 
K08F8.3 fut-1 
F38A5.13 dnj-11 
 
K09E4.2   
T05C12.7 cct-1 
 
T03G11.4 mans-3 
T27E4.3 hsp-16.48 
 
T09A5.11 ostb-1 
Y46H3A.3 hsp-16.2 
 
T12A2.2 stt-3 
    
T15D6.2 gly-16 
B0303.9 vps-33.1 
lysosomes 
 
T20B5.3 oga-1 
C05D11.2 vps-16 
 
T24D1.4 tag-179 
F20B6.2 vha-12 
 
T26A5.4 algn-1 
F32A6.3 vps-41 
 
Y110A2AL.14 sqv-2 
F41C3.5   
 
Y60A3A.14 algn-7 
M04G12.2 cpz-2 
 
Y66A7A.6 gly-8 
R10E11.8 vha-1 
    R13A5.1 cup-5 
 
C02C2.3 cup-4 
others 
W03C9.3 rab-7 
 
F38A6.1 pha-4 
    
K08F4.7 gst-4 
    
K11D9.2 sca-1 
    
R13H8.1 daf-16 
    
F15H9.4 sri-16 
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